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SUMMARY 
 
The present PhD thesis aims to discover new natural lipid A structures 
and to obtain semi-synthetic derivatives thereof to be tested as candidates 
for the pharmacological use as vaccine adjuvants. 
The term lipid A indicates a family of glycolipids representing the 
inflammation-inducing moiety of lipopolysaccharides (LPSs) and 
lipooligosaccharides (LOSs), that are amphiphilic molecules embedded 
in the Gram negative bacterial outer membrane, of which they are the 
major constituents and very often the major virulence factor. 
The general structure of LPSs is characterized by three distinct portions:  
 
•! The lipid A, generally composed of a !"D-GlcN-(1→6)-D-GlcN 
disaccharide (GlcN=2-amino-2-deoxy-glucopyranose) with a 
variable number (from three to seven) of acyl chains linked to the 
positions 2 and 3 of both glucosamine residues through amide or 
ester bonds, respectively. The structure is generally completed by 
one or two phosphate groups, linked at position O-4 of the non-
reducing unit (GlcN II) and/or at position O-1 of the pseudo-
reducing residue (GlcN I) with an #"configuration.1 
•! The core oligosaccharide, distinguishable in an inner core and an 
outer core. This oligosaccharide is linked to the lipid A and is 
well conserved among different strains of the same bacteria and 
consists of uncommon sugar residues such as heptoses (L-
glycero-D-manno-heptose and, less commonly, D-glycero-D-
manno-heptose) and Kdo (3- deoxy-D-manno octulosonic acid). 
•! The O-chain polysaccharide built up of oligosaccharide repeating 
units. The O-chain polysaccharide is the most variable portion of 
the LPS also within bacteria belonging to the same genus; it 
consists of up to 50 identical repeating units composed of two to 
eight different glycosyl residues (heteroglycans) or, in some 
bacteria, of identical sugars (homoglycans). This moiety can be 
absent and in that case LPSs are named LOSs. 
Furthermore, LPS elicits host immune response through the Toll-like 
receptors-4 (TLR-4) and Myeloid differentiation factor-2 (MD-2) 
receptorial complex expressed on macrophages and neutrophils. Toll-
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like receptors (TLRs) play an important role in the recognition of 
molecular signals of microbial invasion (Microbial Associated Molecular 
Patterns, MAMPs) from virus, bacteria, protozoa and fungi. In particular, 
TLR-4 ligands, such as lipid A, trigger innate immunity response in the 
host through chemokine and cytokine signalling cascades.2 This response 
is highly modulated by several structural features of lipid A,3 such as the 
number of phosphate groups and acyl chains as well as the length and 
the distribution of the latters.4 Indeed, hexa-acylated diphosphoryl lipid 
As possess strong inflammatory activity, that may be associated to a 
number of severe pathophysiological symptoms (fever, diarrhoea, blood 
pressure drop, septic shock), whereas underacylated lipid As can block 
or inhibit TLR-4, thus acting as TLR-4-antagonists. The deletion of the 
phosphate group at the anomeric position of GlcN I can furnish the 1-O-
dephosphorylated form of lipid A, known as monophosphoryl lipid A 
(MPLA), was revealed to have significantly reduced endotoxicity but 
retain the strong immunostimulatory activity. MPLA has been proved to 
be clinically safe as a vaccine adjuvant to treat infectious and neoplastic 
diseases. The development of new TLR-4-stimulators to be used as 
immuno-adjuvants has attracted much effort in the last years. To this 
aim, the research is focused on the obtainment of new example of lipid 
A structures, both through isolation from wild-type or engineered 
bacterial extracts1, 5 and by synthetic6 and semisynthetic approaches.7  
In the former frame, extremophiles may be a promising source of non-
toxic LPSs and lipid As. In particular, cold environments, due to the still 
low contamination by pathogenic microorganisms, may represent an 
untapped reservoir of immunomodulating molecules. The outer 
membrane of Gram-negative bacteria is mainly constituted by LPSs, and 
it was demonstrated that structural changes could be present in these 
macromolecules isolated from cold-adapted bacteria.  
In particular, the analysis of C. psychrerythraea strain 34H genome, 
evidences the features that allow the live at freezing temperatures and for 
this reason this bacterium is considered as a model for the study of cold 
adapted life-style. The structures of the lipid A moiety from C. 
psychrerythraea strain 34H and its partially deacylated derivative were 
completely characterized in this Ph.D. work by high-resolution mass 
spectrometry (HR-MS), NMR spectroscopy, and chemical analysis. The 
high heterogeneity of the lipid A structure, showed by the fatty acids 
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analysis, was confirmed by the complexity of MS and MS/MS spectra. 
These experiments indicated a complex acylation pattern ranging from 
tetra- to hepta-acylated glycoforms. Furthermore, this lipid A displayed a 
structure that is quite new among known LPSs. An unusual structure 
with a 3-hydroxy unsaturated tetradecenoic acid as a component of the 
primary acylation pattern was identified. In addition, the presence of a 
partially acylated phosphoglycerol moiety on the secondary acylation site 
at the 3-position of the reducing 2-amino-2-deoxyglucopyranose unit 
caused tremendous natural heterogeneity in such lipid A structure. 
 
 
 
Structure of C. psychrerythraea 34H lipid A.  
The double bond is arbitrarily shown in the cis configuration. 
 
The peculiar structural features showed by C. psychrerythraea 34H lipid 
A could be related to the cold-adaptation mechanisms adopted by this 
bacterium.8 Following the same strategy, during this Ph.D. work the lipid 
A moiety derived from the LPS of Psychrobacter arcticus 273-4 grown at 
4°C, a Gram-negative bacterium isolated from Kolyma region of Siberian 
permafrost core9, was completely elucidated. P. arcticus 273-4 is 
considered a psychro-tolerant microorganism, capable to grow at both 
low, even subzero temperatures, and even more than 20°C. The lipid A 
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and its partially deacylated derivatives were completely characterized by 
chemical analysis, electrospray ionization Fourier transform ion 
cyclotron (ESI FT-ICR) and Orbitrap mass spectrometry. As the 
chemical analysis and the mass spectrometry showed, the lipid A of P. 
arcticus is characterized by the presence of shorter acyl chains than lipid 
A from C. psychrerythraea 34H; decanoic acid (C10:0) as secondary acyl 
groups and mainly 3-hydroxy-dodecanoic acid [C12:0(3-OH)], 3-
hydroxy-tetradecanoic acid [C14:0(3-OH)] and minor amount of 3-
hydroxy-undecadecanoic acid [C11:0(3-OH)], 3-hydroxy-tridecanoic acid 
[C13:0(3-OH)] as primary acyl groups. Therefore, the lipid As moiety 
from both the studied psychrophilic bacteria display several structural 
features that could be related to the adaptation mechanisms and in 
particular an increased incorporation of unsaturated, short, and/or 
branched fatty acids to maintain membrane fluidity as part of a set of 
physiological actions necessary to survival in cold conditions.10 
Preliminary biological activity assays were performed to characterize the 
effect of C. psychrerythraea 34H and P. arcticus 273-4 lipid As on TNF 
secretion in the presence of a serial dilution of Escherichia coli O111:B4 
LPS. The elucidation of new lipid A structures is fundamental for the 
comprehension and the enlargement of the number of structure–activity 
relationships necessary for the design of new immunomodulatory 
molecules. Actually, these components are crucial for the development 
of modern formulations of recombinant or synthetic vaccines, in order to 
obtain strong and long-lasting responses also in elderly and 
immunocompromised patients.11  
These molecules are usually obtained by purification of wild-type or 
engineered bacterial extracts without very good results for the purity,1 as 
well as through total chemical synthesis, that requires lengthy procedures 
with a high number of synthetic steps and very difficult to apply on a 
large-scale production. 
An emerging approach is the use of semi-synthetic strategies that 
combine the advantages of a fermentative access to complex natural 
products with the development of site-selective chemical reactions 
modifying these structures. 
In particular, Prof. Corsaro and co-workers developed a semi-synthetic 
approach relying upon the use of lipid A in gram quantities from fed-
batch fermentation of E. coli,  after de-O-phosphorylation at O-1 position 
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of GlcN I, as a scaffold for the obtainment of several other lipid As and 
derivatives thereof through few, tailored chemical modifications.7 
These site-selective reactions were developed in this Ph.D. work, with a 
special focus on the functionalization of the primary hydroxyl group at 
position C-6 of GlcN II and on the modification of the lipid pattern. 
The former was attractive not only for the expected higher reactivity of 
the primary alcohol with respect to the secondary hydroxyls, but also 
because it could be biologically well tolerated since lipid As and the core 
part of LPSs are linked through a glycosidic bond between this position 
and the Kdo or, much more rarely, 2-octulosonic acid (Ko). In order to 
insert a chemical handle that would be easily and orthogonally 
derivatizable with respect to the other functionalities present on lipid A 
structure, the installation of a carboxylic acid function at position 6 of 
GlcN II was performed. This derivatization could not only serve as a 
suitable moiety for further functionalization, but also mimics the Kdo 
structure (lipid A-Kdo structures have been demonstrated to induce 
stronger immune responses than their parent lipid As).6, 12 
In order to insert a clickable moiety on such oxidized lipid A structure, 
this derivative was treated with diverse amines carrying a suitable 
functionalization at their $-position (double or triple bond, azide, S-trityl 
as protected thiol). The first aim was to find the best conditions for the 
amide formation reaction using a model amine such as 4-penten-1-
amine. The coupling was tested under several typical peptide coupling 
conditions. After having detected PyBOP® and TBTU as the best 
coupling reagent under appropriate conditions, these were employed to 
install the other clickable functionalities indicated above.  
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Insertion of a clickable moiety on E. coli monophosphoryl lipid A. 
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The production of these clickable lipid A derivatives opens a 
straightforward access to their conjugation with other interesting 
biomolecules, such as tumor-associated carbohydrate antigens (TACAs). 
In order to demonstrate the feasibility of this approach, the thiol-
equipped derivatives of Tn and TF antigens were synthesized and then 
conjugated with a clickable lipid A derivative carrying a double bond 
moiety, through a UV-mediated thiol-ene reaction, to give  two potential 
self-adjuvant anticancer vaccine candidates. A preliminary evaluation of 
the immunological activity of these lipid A-TACA antigen conjugates, as 
well as of other semi-synthesized lipid A derivatives, was performed.16 It 
was shown that most of them ameliorated production of 
proinflammatory cytokines IL-6, TNF-#, and IFN-% compared to 
control. The tested derivatives also induced chemokine CXCL8 (IL-8) 
and immunoregulatory cytokine IL-10 thus highlighting the promising 
immunobiological applications. Additionally, the described compounds 
exhibited very low toxicity which could facilitate their use in vaccines and 
give them an advantage over the currently used adjuvants.  
Following this strategy, a collaboration with Prof. Renaudet (Univ. 
Grenoble Alpes, CNRS, France) has been started, in order to develop 
the first Regioselectively Addressable Functionalised Template! (RAFT) 
scaffold-MPLA conjugates as potent multivalent immunogenic vaccine 
candidates. 
Moreover, we finely tuned the conditions suitable for the semisynthesis 
of other new lipid A derivatives, by selective modification of the lipid 
pattern (selective deacylation and re-acylation with shorter chains). In this 
way, a small collection of new lipid A derivatives was rapidly prepared, 
avoiding lengthy total synthetic approaches. Notably, potential access to 
several other modified lipid A structures could be opened by this 
strategy, because the reactions developed on E. coli lipid A scaffold 
should also be applicable on lipid A substrates from different bacterial 
sources. Some of the new compounds were assayed for preliminary in 
vitro immunological tests, showing somewhat reduced inflammatory 
activity and a cytokine production profile similar to the already used 
immunomodulant MPL& Salmonella Minnesota lipid A, thus 
highlighting the promising immunobiological applications. 
Finally, in the last part of this PhD work, two different fluorescent lipid A 
derivatives were semi-synthesized, with the aim to improve the 
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understanding of the potential role of lipid A in transmembrane protein 
stability, in mediating drug export and in the mechanisms of ABC 
transporters.  
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Semi-synthetic fluorescent mono- (left) and diphosphoryl (right) lipid A derivatives. 
 
In collaboration with Prof. Tampé (Institute of Biochemistry, at the 
Goethe-University in Frankfurt, Germany) these two derivatives were 
exploited in several biological assays in order to develop some in vitro 
fluorescence-based lipid A flippase assays, focused on the ABC 
transporters mechanisms comprehension (data still under investigation).17 
Finally, these two fluorescent derivatives, in collaboration with Prof. 
Huser (Department of Physics, University of Bielefeld, Germany), were 
subjected to a preliminary cell imaging test aimed to observe their 
staining with two different cell lines on a deconvolution microscope 
(experiments still in progress). 
 
 
References 
 
1.! Molinaro, A. et al., Chem. Eur. J. 2015, 21 (2), 500–519. 
2.! Medzithov, R. Nature 2008, 454, 428-435. 
3.! Park, B.S. et al., Nature 2009, 458, 1191-1196. 
4.! (a) Li, Y. et al., Mar. Drugs 2013, 11, 3197-3208; (b) Rietschel, E.T. 
et al., FASEB J. 1994, 8, 217-225. 
!XV!!
5.! (a) Needhama, B.D. et al., Proc. Natl. Acad. Sci. USA 2013, 110, 
1464-1469; (b) Carillo, S. et al., Chem. Eur. J. 2011, 17, 7053-7060. 
6.! Gao J., Guo Z., Med. Res. Rev. 2017, (in press)  
doi: 10.1002/med.21447.  
7.! (a) D’Alonzo, D. et al., Chem. Eur. J. 2016, 22, 11053-11063; (b) 
Pieretti, G. et al., Appl. Microbiol. Biotechnol. 2014, 98, 7781-7790. 
8.! Casillo A. et al., ChemBioChem 2017, 18, 1 – 11. 
9.! Vishnivetskaya, T. et al., Extremophiles 2000, 4,165–173. 
10.!Carty S.M. et al., J. Biol. Chem. 1999, 274, 9677 – 9685. 
11.! (a) Kwissa, M. et al., Expert Rev. Vaccines 2007, 6, 673 – 684; (b) 
Marciani, D.J. Drug Discovery Today 2003, 8, 934 – 943. 
12.! (a) Zughaier, S.M. et al., Infect Immun. 2004, 72, 371-380; (b) 
Yoshizaki, H. et al., Angew. Chem. Int. Ed. 2001, 40, 1475-1480. 
13.!Saito, Y. et al., Tetrahedron 2008, 64, 3578−3588. 
14.!Lee, J. W. et al., Tetrahedron Lett. 2001, 42, 2709−2711. 
15.!Jagadish, B. et al., J. Med. Chem. 2012, 55, 10378−10386. 
16.!Ziaco M. et al., J. Med. Chem. 2017, 60, 9757-9768. 
17.!Bechara, C. et al., Nat. Chemistry 2015, 7, 255 – 262. 
 
 
 
 
 
 
 
 
 
 
!XVI!!
 
!1!!
 
 
 
 
 
 
 
SECTION I 
 
Introduction 
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Chapter 1: Gram-negative bacteria 
 
1.1 The Kingdom of Life 
 
The three-domain system, which classifies organisms on Earth into three 
distinct kingdoms – Archea, Bacteria and Eukarya – was designed by the 
American microbiologist Carl Woese in the 1990. Otherwise, an 
alternative biological classification system currently used is known as “the 
six-kingdoms system of life” and include Archaebacteria, Eubacteria, 
Protista (comprising one-celled organisms), Fungi, Plantae and Animalia. 
While Archaebacteria and Eubacteria constitute the Archaea and 
Bacteria domains respectively (both representing the Prokarya kingdom), 
Protista, Fungi, Plantae and Animalia together form the Eukarya 
kingdom of life. Most prokaryotic cells have diameters in the range of 1-
10 μm, much smaller than most eukaryotic cells (typically 10-100 μm). 
Prokaryotes have a cellular organization different from that of 
eukaryotes; these latter have a membrane-enclosed nucleus and 
numerous membrane-enclosed organelles, whereas prokaryotic cells lack 
these structural features. Typically, Archea domain includes all the 
extremophiles prokaryotic organisms that live and thrive in inhospitable, 
from a human viewpoint, environments such as alkaline and acidic 
waters, boiling hot springs, high pressure waters, ultra-saline brines, 
without excluding a combination of aforesaid chemical and physical 
extremes which is typical of polyextremophilic microbes (Mesbah and 
Wiegel, 2008). Bacteria comprise a wide group of microorganisms 
characterized by a bewildering assortment of size, shapes and 
arrangements reflecting the diverse environments in which they grow and 
reproduce (Pommerville, 2010). Despite the high structural variability, 
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Bacteria can be divided on the basis of their basic cell morphologies: a 
bacterial cell with a rod shape is called “bacillus” whereas spherical and 
curved cells are called “cocci” and “spirilli” respectively (Raven and 
Johnson, 2001). Some rod-shaped and spherical bacteria form colonies 
adhering end-to-end after their cellular division forming chains, whereas 
spirilla bacteria generally do not form associations with other cells. 
However, early systems for classifying bacteria relied on differential stains 
such as the colorimetric assay developed by the Danish physician Hans 
Gram, in use to date, that allows the distinction of bacteria in Gram-
positive and Gram-negative on the basis of the different response to the 
test. The differences between Gram-positive and Gram-negative bacteria 
are related to diversities in the structure and chemical composition of 
their cell wall: Gram-positive bacteria have the thicker cell envelope, 
nearly uniformly dense layers, and stain the purple color of the crystal-
violet typically used in the Gram stain, whereas Gram-negative bacteria 
contain just a single or two layers and lose the purple-colored dye (Staley 
et al., 2007).  !
1.2 Bacterial cell envelope  
 
The complex system of layers that surrounds bacterial cells is referred 
collectively as the cell envelope. It consists of a cytoplasmic membrane 
(or plasma membrane), cell wall, and for some bacteria, capsule and 
glycocalyx from inner to outer surface. Both Gram-positive and Gram-
negative bacteria present the cytoplasmatic membrane, namely a 
phospholipid bilayer surrounding the cytoplasm and representing a 
physical semi-permeable barrier that regulates the transport of nutrients 
and metabolic products in and out the cell. This membrane is, in turn, 
enclosed by the cell wall, an important structure that maintains the 
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cellular shape and protects the cell from swelling and rupturing (Raven 
and Johnson, 2001). The bacterial cell wall differs markedly from 
archaeal and eukaryotic cells walls in containing peptidoglycan (or 
murein) which is a network of saccharide molecules connected by 
polypeptide cross-links. In detail, it is composed of β-(1→4)-linked 
disaccharide chains, alternating N-acetylglucosamine and N-
acetylmuramic acid residues in turn cross linked by short peptide stems 
composed of alternating L- and D-amino acids (Figure 1.1). It is possible 
to classify peptidoglycans on the basis of the third amino acid residue of 
the stem peptide; indeed, in Gram-negative bacteria this residue is the 
unusual meso-diaminopimelic acid (m- DAP), while in Gram-positive 
bacteria is commonly a lysine (Figure 1.1).  
 
Figure 1.1 Peptidoglycan structure in Gram-positive (left) and Gram-negative (right) 
bacteria. 
 
Furthermore, in Gram-positive bacteria the external portion of the cell is 
composed by 95% of rigid peptidoglycan cell wall that may be one of the 
reason why they retain the crystal-violet of Gram stain (Figure 1.2); on 
the contrary, in Gram-negative cells there is a thin layer of peptidoglycan, 
almost 5-10% of the cell wall, surrounded by an additional asymmetric 
phospolipid bilayer, termed outer membrane (OM) (Figure 1.2). This 
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external membrane is a unique feature of Gram-negative bacteria and 
represents the first barrier that protects bacterial cell from environmental 
stress factors, thus it is essential for bacterial survival. The outer 
membrane is separated by a gel-like compartment, termed periplasm, 
from the cytoplasmatic membrane and shows to have a structure similar 
to that of the plasma membrane, from which nonetheless differs for 
important physical and chemical properties. The inner portion of the 
OM is mainly composed of phospholipids, while the external leaflet is 
occupied for the 75% by glycolipids known as lipopolysaccharides (LPS) 
(Alexander and Rietschel, 2001). Furthermore, the outer membrane is 
also constituted by a large number of proteins, among which there is the 
Braun’s lipoprotein (BLP or murein lipoprotein), that acts as a bridge 
between the outer membrane and the peptidoglycan layer.  
 
Figure 1.2 Cell-wall structure of Gram-positive (left) and Gram-negative bacteria (right). 
 
1.3 Lipopolysaccharides (LPSs)  
 
Lipopolysaccharides are heat-stable amphiphilic molecules indispensable 
for viability and survival of Gram-negative bacteria, as they heavily 
contribute to the structural integrity of the OM and to the protection of 
the bacterial cell envelope (Holst et al., 1996).  
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Being intercalated into the outer membrane, they form hydrophobic 
interactions with the phospholipid bilayer composing the inner layer, 
giving rise to the typical asymmetry of Gram-negative bacteria OM (Holst 
et al., 1996). The highly ordered structure and low fluidity of the LPS 
monolayer, stabilized by electrostatic interactions of divalent cations (as 
Ca2+ and Mg2+) with negatively charged groups present on LPS molecules, 
are responsible for the increase of permeability to hydrophobic and 
higher molecular weight hydrophilic compounds, but also for the 
bacteria resistance to external stress factors. Indeed, most of the 
commonly used antibiotics directed against Gram-negative bacteria, such 
as polymyxin B, are able to destabilize abovementioned ionic 
interactions leading to the disruption of membrane integrity (Cardoso et 
al., 2007). In addition, since they are exposed toward the external 
environment, LPS molecules participate in crucial mechanisms of host-
bacterium interactions like colonization, virulence in the case of 
pathogen and opportunistic bacteria, adhesion and symbiosis (Silipo et 
al., 2010). Among all these activities, LPS has been shown to be the most 
potent immunostimulant molecule playing a key role in the pathogenesis 
of Gram-negative infections and triggering the immune system in a wide 
range of eukaryotic organisms ranging from insects to humans 
(Alexander and Rietschel, 2001). LPSs belonging to different bacterial 
species possess different structures, but also LPS of an individual 
bacterial strain is not a single molecule, possessing a specific chemical 
structure, but rather a blend of various molecules characterized by an 
intrinsic size and structural heterogeneity (Raetz, 1990; Raetz and 
Whitfield, 2002). Furthermore, bacteria of the same species producing 
diverse LPS molecules under different growth conditions were also 
found. Despite the high structural heterogeneity, all LPSs broadly 
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comply with a common basic architecture composed of well-conserved 
domains in which three distinct regions encoded by different gene 
clusters, can be distinguished (Figure 1.3). Indeed, they consist of a 
polysaccharide (also known as O-antigen, O-side chain or O-specific 
polysaccharide) characterized by a highly variable structure which 
constitutes the chemical basis for the serological classification of bacterial 
strains. O-antigen is covalently linked to an oligosaccharide part (core), in 
turn, linked to a glycolipid portion (lipid A) that is the most conserved 
region of the entire macromolecule, even among different species 
belonging to the same genus (Holst et al., 1996).  
 
Figure 1.3 Schematized structure of Gram-negative LPSs. 
 
The lipid A moiety is embedded in the outer leaflet of the OM whereas 
the sugar chain is oriented outwards (Raetz and Whitfield, 2002). The 
O-polysaccharide chain is not ubiquitous, as it can be absent or partly 
truncated in some Gram-negative strains. Bacterial colonies can be 
catalogued by gross colony morphology as rough or smooth on the basis 
of the occurrence of the O-side chain, being absent in the former and 
present in the latter (Lüderitz et al., 1966). The terminology currently 
used to designate the different LPS types, namely with or without the O-
polysaccharide portion, is S- LPS or R-LPS (or lipooligosaccharide, 
LOS), respectively (Raetz and Whitfield, 2002). !
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1.3.1 The lipid A moiety: structure and activity  
 
Lipid A represents the hydrophobic and endotoxic principle of the LPS 
molecule since it acts as a potent stimulator of the host innate immune 
system (see paragraph 1.4.2). It possesses a highly conservative structure 
consisting of a β-(1→6)-linked D-glucosamine disaccharide backbone 
substituted with a number of amide- and ester-linked 3-hydroxy fatty 
acids at the positions 2 and 3 (Figure 1.4), respectively. The acyl groups 
that are directly linked to the sugar backbone are defined primary and 
some of them are further acylated at the hydroxy groups by secondary 
acyl chains. Furthermore, the sugar backbone is generally α-
phosphorylated at position O-1 of the reducing glucosamine (GlcN I) 
and at position O-4' of the non-reducing glucosamine (GlcpN II) (Figure 
1.4) (Zahringer et al., 1999). The firstly characterized lipid As were from 
Escherichia coli (Figure 1.4) and Salmonella enterica LPSs in 1983. E. 
coli lipid A is built up of the following sugar backbone [P→4-β-D-GlcN-
(1→6)-α-D-GlcN-1→P] acylated at position 2 and 3 of both GlcNs by 
four C14:0 (3-OH) (Figure 1.4). The primary fatty acids located on the 
GlcNII were both esterified at their hydroxyl group by two secondary 
acyl chains: one C14:0 (3- OH) was esterified by a C12:0 while the other 
by a C14:0 (Figure 1.4). 
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Figure 1.4 Lipid A from Escherichia coli. 
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Despite their general architecture, lipid As also present a micro-
heterogeneity due to the presence of subtle chemical differences 
depending on a wide number of factors including bacterial adaptation, 
incomplete biosynthesis, changing of environment, presence of external 
stimuli and chemical modifications resulting from the procedures used 
for lipid A extraction from bacterial cells. Micro-heterogeneity has been 
observed in the acylation (number, type and distribution of acyl chains) 
and phosphorylation patterns, and, less commonly, also in the 
disaccharide backbone as in the case of bacterial species as Aquifex 
pyrophilus (Hellerqvist et al., 1971), Brucella abortus (Hellerqvist et al., 
1969), whose GlcN residues may be replaced with 2,3-diamino-2,3-
dideoxy-D-glucopyranose (GlcN3N) residues. Moreover, phosphate 
groups can be derivatized with further phosphate groups, producing a 
pyrophosphate, but also by other polar substituents such as 4-amino-4-
deoxy-L-arabinopyranose (4-amino-arabinose, Ara4N) and 2-amino-
ethanol group (EtN), or by acid residues such as galacturonic acid 
(GalA); phosphate groups can be absent, as in the case of Bdellovibrio 
bacteriovorus lipid A, characterised by the replacement of phosphate 
groups with two mannose residues generating a totally neutral lipid A. 
Concerning the acylation pattern, fatty acids can be attached to the 
disaccharide backbone either symmetrically (3+3, e.g. Neisseria 
meningitidis) or asymmetrically (4+2, e.g. Escherichia coli). Finally, lipid 
A fatty acids present less frequently further peculiar structural features 
such as a methyl branch, different functional and hydroxyl groups, length 
of the chains up to 28 carbon atoms, odd numbered carbon chains and 
unsaturation. Even the subtlest variation in chemical structure of lipid A 
can affect the LPS molecule bioactivity, since this latter is strictly 
structure-related; indeed, the lipid A intrinsic conformation is 
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responsible for its agonistic and antagonistic activity on innate immune 
system (Brandenburg et al., 1993; Rietschel et al., 1994; Seydel et al., 
2000; Fukuoka et al., 2001; Oikawa et al., 2004).  
A plethora of studies aimed to the elucidation of the LPS structure-
activity relationship have highlighted that the hexa- acylated 
bisphosphorylated lipid A with an asymmetric 4:2 fatty acid distribution, 
found in the majority of enterobacteria, as the aforesaid E. coli lipid A, is 
considered to have the highest immunostimulatory capacity in 
mammalian cells. In contrast, the hypoacylated synthetic precursor of E. 
coli lipid A, the tetra- acylated lipid A (Lipid IVa), showed to have weak 
agonistic effects for some species of mammals and is well known to 
possess a strong antagonistic activity on human cells (Golenbock et al., 
1991).  
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Figure 1.5 Lipid A chemical structure diversity in Gram-negative bacteria. 
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These different biological effects are correlated to two interconnected 
structural parameters: the molecular shape of the lipid A and the tilt 
angle between the di-glucosamine backbone and fatty acid chains that is 
the inclination of lipid A hydrophilic moiety respect to the hydrophobic 
portion (Netea et al., 2002). In details, the molecular shape possessed by 
lipid A influences its ability to be recognized by host immune system 
receptors, indeed it has been shown that at 37°C, in aqueous solution 
and in physiological conditions, the most agonistic lipid A has a 
truncated cone form that drives to a hexagonal supramolecular structure, 
while lipid As presenting an antagonistic activity assume a cylindrical 
shape leading to a lamellar structure (Netea et al., 2002). Regarding the 
tilt angle, it has been found that the most active form has a conical 
structure with a tilt angle >50°, while the antagonist structures present 
smaller values of tilt angles (Seydel et al., 2000): species with a tilt angle 
<25°, such as lipid IVA and the penta-acylated and symmetrically (3+3) 
hexaacylated lipid As, act as antagonists; species with an angle between 
25-50°, as monophosphorylated lipid A, have a lower bioactivity (Figure 
1.6) (Seydel et al., 2000). 
 
Figure 1.6 Tilte angle of lipid A depends from the acylation pattern. 
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These physical parameters are reflected in the different binding- mode of 
the LPS molecule to its physiological receptor, the TLR4/MD-2 
complex, since they regulate the lipid A affinity to the MD-2 
hydrophobic binding pocket that is pivotal for the innate immune 
receptor activation. 
 
1.3.2 The core oligosaccharide moiety: structure and activity  
 
Core oligosaccharide is a complex component of the LPS molecule 
since it can be characterized by up to fifteen monosaccharides which can 
be organised giving either a linear or a branched structure (Holst, 1999). 
In the core LPS portion two different regions can be distinguished on 
the basis of the monosaccharide composition, termed inner core and 
outer core (Holst, 1999). The inner core region is directly linked to the 
lipid A structure is well conserved among different strains of the same 
bacteria and consists of uncommon sugar residues such as heptoses (L-
glycero-D-manno-heptose and, less commonly, D-glycero-D-manno-
heptose) (De Soyza et al., 2008) and Kdo (3- deoxy-D-manno 
octulosonic acid) (Figure 1.7). This latter is considered a diagnostic 
marker for all Gram-negative bacteria. It connects the core 
oligosaccharide to the lipid A backbone with an α-configured ketosidic 
linkage in almost every LPSs investigated to date.  
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Figure 1.7 Structure of the Kdo residue. 
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The L-glycero-D-manno-heptose residues are often decorated with 
charged substituents like phosphate, pyrophosphate, Ara4N or uronic 
acids, as found in bacteria belonging to Pseudomonas genus and in many 
other species. It is speculated that all the substituents bearing a positively 
charged free amino group, as Ara4N residues, might play a role in 
pathogenesis since they reduce the negatively charged surface on the 
outer membrane rendering it positively charged or in an isoelectric state 
that, in turn, confers resistance to antibiotic compounds and 
antimicrobial peptides (Raetz and Whitfield, 2002; Hamad et al., 2012). 
The outer core region is the most exposed portion, often branched, and 
characterised by a higher structural variability than the inner core region. 
It is typically characterised by common hexoses such as glucose, 
galactose, N-acetyl glucosamine and N-acetyl galactosamine and it may 
also contain residues as 6-deoxy-L-mannose (L-Rha) and N-acetyl-2,6-
dideoxy-D-glucosamine (D- QuiNAc). 
 
1.3.3 The O-polysaccharide moiety: structure and activity  
 
The O-chain polysaccharide is the most variable portion of the LPS also 
within bacteria belonging to the same genus; it consists of up to 50 
identical repeating oligosaccharide units composed of two to eight 
different glycosyl residues (heteroglycans) or, in some bacteria of 
identical sugars (homoglycans). A single bacterium produces LPSs with 
O-chains characterised by a wide range of lengths as a result of 
incomplete synthesis of the polysaccharide chain (Raetz and Whitfield, 
2002); this different degree of polymerization is responsible for the 
“ladder-like” pattern, showed by SDS-PAGE (Kittelberger and Hilbink, 
1993) typical of a smooth LPS. The high structural variability of the O-
polysaccharide is ascribable to the large number of sugar residues (in 
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both pyranose and furanose rings, anomeric and absolute configurations) 
that can build up the repeating units as well as to the glycosidic sequence 
and to the presence of non-carbohydrate substituents such as 
phosphates, amino acids, sulphates, acetyl or formamide groups, often 
present in a non-stoichiometric fashion (Adinolfi et al., 1996). The 
function of these substituents is frequently unknown although it can be 
speculated that bacteria can modify their LPSs to mask themselves to the 
host immune system. 
  
1.4 LPS and elicitation of host immune response  
 
1.4.1 Innate immunity and adaptive immunity  
 
From the moment of birth and throughout our lifetime, humans are 
continuously exposed to a multitude of potential pathogen bacteria, 
through inhalation, direct contact and ingestion. The ability to avoid 
most of these infections depends on the adaptive immune system which 
remembers the previous encounters with specific pathogens and destroys 
them when they attack again (Alberts et al., 2007). Adaptive immune 
responses, however, are slow to develop on the first exposure to a new 
pathogen, since it is required the activation and expansion of specific 
cells that take approximately seven days prior to give an effective 
response. For this reason, the first days of exposure to a new pathogen 
see the intervention of the innate immune system (Alberts et al., 2007). 
Indeed, innate immune system is the first line of defence against invading 
organisms while the adaptive immune system acts as a second line of 
defence and also affords protection against re- exposure to the same 
pathogen; moreover, the innate immune responses are not specific to a 
particular pathogen in the way that the adaptive immune responses are.  
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The strategy of recognition typical of the innate immune system relies on 
the detection of constitutive and conserved microbial molecular targets, 
that are common to many pathogens but are absent in the host; these 
latter are known as PAMPs (Pathogen Associated Molecular Patterns) 
and are recognised by specific receptors, the PRRs (Pattern Recognition 
Receptors) present on the surface of some phagocytic cells that rapidly 
destroy them. It is worth to note that in vertebrates, the skin and other 
epithelial surfaces, including those lining lung and gut, provide a physical 
barrier between the inside of the body and the outside world, thus can be 
considered part of the innate immune system (Alberts et al., 2007). The 
microorganisms that pass this first barrier are recognised by the sentinels 
of innate immunity which are phagocytes, or white blood cells, or 
leukocytes, that are distinguishable in: neutrophils, polymorphonuclear 
neutrophilic leukocytes (PMN), macrophages and monocytes (Figure 
1.8). 
 
 
Figure 1.8 Overview of the innate and adaptive immune responses. 
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Macrophages and neutrophils show a variety of cell surface receptors, 
which make them able to recognise different types of microorganisms; 
the attack of a ligand to these receptors induces actin polymerization that 
allows the plasma membrane of phagocytes to surround the pathogens 
and to incorporate them forming a phagosome which becomes acidified 
(Figure 1.9). In addition to being phagocytic, macrophages and 
neutrophils have granules, called lysosomes, that contain lysozyme and 
hydrolases; the phagosome fuses with one or more lysosomes to generate 
a phagolysosome in which the lysosomal contents are released to 
degrade bacterial cell wall (Figure 1.9). After degradation, 
phagolysosomes exhibit the antigenic determinants on their cell surface 
with the consequent triggering of the mechanism of specific immune 
response (Figure 1.9) (Janeway et al., 2001). 
 
Figure 1.9 Phagocytosis mechanism as starting point of the innate immunity. 
 
Compared to the innate immunity, specific immunity (or acquired or 
adaptive immunity) represents a more sophisticated system of defence. A 
peculiarity of this second line of defence is the ability to discriminate 
between exogenous and autologous antigens (Janeway et al., 2001). 
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Therefore, acquired immunity strengthens the role of the innate immune 
response, amplifying, focusing and directing this response against foreign 
agents. It is possible to schematically distinguish two types of specific 
immunity: humoral and cell-mediated immunity (Figure 1.10). The main 
components of acquired immunity are two other types of white blood 
cells that are called lymphocytes, which are divided into B lymphocytes 
(expression of humoral immunity and developed in the bone marrow) 
and T lymphocytes (expression of cell-mediated immunity and 
developed in the thymus). The acquired immune response consists in a 
first step of antigen-processing by macrophages and dendritic cells 
(termed “antigen presenting cells” or APC) and a second step of 
presentation to T and B lymphocytes which ensure the recognition by 
specific receptors (TCR and BCR, T and B cell receptors) expressed on 
their cell membrane. The binding of the antigen to these receptors 
determines the activation, proliferation and differentiation into effector 
cells by a process of clonal selection. In details, in the humoral immune 
response, activated B cells (or plasma cells) secrete antibodies (or 
immunoglobulins) that circulate in the bloodstream and permeate other 
body fluids, where they bind specifically to the foreign antigen that 
stimulated their production, causing its destruction (Figure 1.10). In cell-
mediated immune response, some T cells, termed cytotoxic, attack the 
leukocytes which present the antigenic determinants complexed to 
proteins of the major histocompatibility complex of class I (MHC I), and 
destroy them (Figure 1.10).  
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Figure 1.10 The humoral and cell-mediated immune responses. 
 
Other T cells, the helper T immature cells, recognise the complex 
formed between the antigen and MHC class II proteins, and produce 
cytokines, known as macrophage colony-stimulating factor and gamma 
interferon, which promote the activity of macrophages. Moreover, the 
helper T cells secrete interleukin-2, which stimulates the proliferation of 
abovementioned cytotoxic T cells (Alberts et al., 2007). Following 
expulsion of the antigen, the immune response gradually comes to an 
end. Some cells, produced during clonal expansion, undergo a phase of 
differentiation into memory cells, which are capable, in case of a possible 
new encounter with the same antigen, to respond more quickly and with 
higher efficiency (Alberts et al., 2007). 
 
 
!19!!
1.4.2 LPS and innate immunity  
 
As described in the above paragraph 1.4.1, innate immune response is 
activated after recognition of bacterial conservative molecular targets 
termed PAMPs, by specific innate immune receptors, termed PRRs 
(Janeway, 1989). PAMPs have three common features that make them 
ideal targets for innate immune recognition (Medzhitov, 2001):  
 
•! are produced only by microbes and not by host 	  
•! are invariant between microorganisms of a given class 	  
•! are essential for microbial survival	  
 
In case of Gram-negative bacteria, lipopolysaccharides respond to all 
aforesaid three features, being recognised as PAMPs by a component of 
a family of PRRs known as Toll-Like Receptors (TLRs). Upon 
recognition of the real endotoxic principle of LPS, the lipid A moiety, 
the host innate immune system is immediately activated. The core 
oligosaccharide or, in smooth bacterial colonies, the O-chain, are the 
antigenic determinants recognised by the adaptative immunity. TLRs 
comprise a family of ten transmembrane receptors in humans, which are 
characterised by an extracellular leucine-rich repeat (LRR) domain and 
an intracellular Toll/IL-1 receptor (TIR) domain (Hashimoto et al., 
1988; Medzhitov et al., 1997). Among all TLRs, TLR4 is the receptor 
designated to recognise the LPS macromolecule, but its detection 
requires several accessory molecules. The first host protein involved in 
LPS recognition is a serum protein, the LBP (LPS- binding protein) that 
forms a high affinity complex with lipid A released from bacterial lysis or 
replication, or still bound to the outer membrane of the intact microbial 
cell (Pålsson-McDermott and O'Neill, 2004). The N-terminal domain of 
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LBP is responsible for lipid A binding while the C-terminal domain is 
specific for further recognition by CD14 (Figure 1.11). This latter can be 
found in two forms, soluble (secreted into serum) and membrane bound 
(as glycophosphoinositol-linked protein on the surface of macrophages) 
(Haziot et al., 1996), and has a crucial role in the enhancement of host 
response to endotoxins since it facilitates the recognition of LPS by the 
final receptor complex TLR4/MD-2. It was demonstrated that CD14-
deficient mice have a profound defect in responsiveness to LPS, thus 
showing the pivotal role of CD14 in LPS-recognition process (Haziot et 
al., 1996). Once CD14 binds to the LPS, it has been shown that CD14 
can chaperone LPS from LBP to TLR4 at the cell surface. This latter is 
linked, through its extracellular domain, to a small glycoprotein, MD-2 
(myeloid differentiation factor 2), which turns out to be absolutely 
necessary for the proper functioning of TLR4 receptor; indeed, the same 
MD- 2 protein is able, by itself, to recognise lipid A with a good affinity, 
and also to discriminate different lipid A types. Therefore, TLR4 might 
be considered as a "pseudo-receptor", since, in the absence of MD-2, 
does not recognise its ligand. The TLR4/MD-2 complex has been shown 
to bind LPS with higher affinity than soluble MD- 2 (Akashi et al., 2003). 
However, the binding affinity of MD-2 or the MD-2/LPS complex for 
TLR4 is the same (Visintin et al., 2005). TLR4 with the MD-2 protein 
forms an heterodimer that recognizes a common structural motif in 
different LPS molecules. The binding of LPS to TLR4/MD-2 receptorial 
complex can activate two different immune response pathways (Figure 
1.11) (Park et al., 2009).  
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Figure 1.11 Schematized model of LPS signaling. 
 
In the first case, it results in activation of the transcription factor NF-κB, 
which regulates the expression of genes encoding for inflammatory 
cytokines; whereas the second pathway results in activation of MAP-
kinases which regulate the transcription of genes involved in increasing 
the stability of particular regions of the mRNA. In both cases, the final 
result is the amplification of the transduction signal with the consequent 
massive production of inflammatory proteins thus eliciting the 
inflammatory process (Figure 1.11) (Park et al., 2009). If the 
inflammatory response is amplified and uncontrolled, due to the high 
toxicity of the LPS from the infecting pathogen, there may occur a 
fulminating septic shock syndrome.  
 
 
!22!!
References  
!! Adinolfi M. et al., Carbohydr. Res., 1996, 284, 119-133.  
!! Akashi S. et al., J. Exp. Med., 2003, 198, 1035-1042.  
!! Alberts B. et al., Molecular Biology of the Cell, 4th edition (Ed.: 
Garland Science), New York, chapter 24, 2007.  
!! Alexander C., Rietschel E.T. J. Endotoxin Res., 2001, 7, 167-
202.  
!! Brandenburg K. et al., Eur. J. Biochem., 1993, 218, 555-563.  
!! Cardoso L.S., et al., Microb. Cell Fact., 2007,6, 1.  
!! De Soyza A. et al., Innate Immun., 2008, 14, 127-144.  
!! Fukuoka S. et al., Biochim. Biophys. Acta., 2001, 1510, 185-197.  
!! Golenbock D.T. et al., J. Biol. Chem., 1991, 266, 19490-19498. 
!! Hamad M.A. et al., Mol. Microbiol., 2012, 5, 962–974.  
!! Hashimoto C. et al., Cell, 1988, 52, 269-279.  
!! Haziot A. et al., Immunity, 1996, 4, 407-414.  
!! Hellerqvist C.G. et al., Acta Chem. Scand., 1971, 25, 955-961.  
!! Hellerqvist C.G. et al., Carbohydr. Res., 1969, 9, 237-241. 
!! Holst O. et al., FEMS Immunol. Med. Microbiol., 1996, 16, 83-
104.  
!! Janeway C.A. Jr. Cold Spring Harb. Symp. Quant. Biol., 1989, 
54, 1-13.  
!! Janeway C.A. Jr. et al., Immunobiology, 5th edition (Ed.: 
Garland Science), New York, 2001.  
!! Kittelberger R., Hilbink F., J. Biochem. Biophys. Methods, 1993, 
26, 81-86.  
!! Lüderitz O. et al., Ann. NY Acad. Sci., 1966, 133, 347-349.  
!! Medzhitov R., Nat. Rev. Immunol., 2001, 1, 135-45.  
!! Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr., Nature, 
!23!!
1997, 388, 394- 397.  
!! Mesbah N.M., Wiegel J., Ann. NY Acad. Sci., 2008, 1125, 44-
57.  
!! Netea M.G. et al., Trends Immunol., 2002, 23, 135–139. 
!! Oikawa M. et al., Org. Biomol. Chem., 2004, 2, 3557- 3565.  
!! Pålsson-McDermott E.M., O'Neill L.A., Immunology, 2004, 
113,153-162.  
!! Park B.S. et al., Nature, 2009, 458, 1191-5. 
!! Pommerville J.C., Alcamo’s foundamental of microbiology, 9th 
Edition, (Eds.: Jones & Bartlett Publishers), Burlington, Chapter 
4, 2010. 
!! Raetz C.R., Annu. Rev. Biochem., 1990, 59, 129-70. 
!! Raetz C.R., Whitfield C., Annu. Rev. Biochem., 2002, 71, 635-
700. 
!! Raven P.H., Johnson G.B., Biology 9th Edition, (Ed.: McGraw 
Hill), Chapter 34, 2011. 
!! Rietschel E.T. et al., FASEB J., 1994, 8, 217-225. 
!! Seydel U. et al., Eur. J. Biochem., 2000, 267, 3032-3039. 
!! Silipo A. et al., Prokaryotic cell wall compounds structure and 
biochemistry (Eds. Konig H., Herald C., Varma A.) Springer-
Verlag, Berlin, Germany, 133-154, 2010. 
!! Staley J.T. et al., Microbial Life 2nd Edition, chapter 4, 2007. 
!! Visintin A. et al., J. Immunol., 2005, 175, 6465-6472.  
!! Zahringer U., Lindner B., Rietschel E.T., Endotoxin in Health 
and Disease (Eds.: H. Brade, S. M. Opal, S. N. Vogel, D. C. 
Morrison), Marcel Dekker, New York, Basel, 93- 114, 1999.  
!!! 24!
Chapter 2: Structural characterization of LPS and 
LOS 
 
2.1 Extraction and purification of LPS and LOS  
 
The first approach aimed to the structural elucidation of LPS/LOS is 
represented by their extraction from intact microbial cells. This is 
conventionally achieved through two complementary procedures, that 
lead to the selective isolation of R-LPS (LOS) and S-LPS, exploiting their 
different amphiphilic character; indeed, the latter has higher 
hydrophilicity, due to the presence of the polysaccharide moiety of the 
O-chain, whereas the former, which lacks such portion, has a more 
pronounced hydrophobic character. Thus, these different physico-
chemical properties allow to perform a selective extraction of the LOS 
and LPS, with a high degree of purity. Lyophilized bacterial cells are 
firstly washed with acetone, water and ethanol to remove cell 
contaminants. After this initial step of purification, the procedure of 
extraction can take place. Typically, rough-type LPSs are extracted with a 
phenol-chloroform-petroleum ether procedure (PCP) (Galanos et al., 
1969), while smooth-type LPSs are extracted with the hot phenol-water 
protocol (Westphal and Jann, 1965). The PCP extraction consists in the 
treatment of dried bacterial cells with phenol/chloroform/light petroleum 
ether in proportions 5:8:2 v/v/v; LOS is precipitated from pure phenol 
adding drops of water. After this extraction, cells undergo a second 
treatment with 1:1 v/v 90% phenol/water at 68°C. The two phases are 
then extensively dialysed and liophilised. As previously mentioned, 
typically the presence of the long O-chain moiety increases the 
hydrophilic nature of endotoxins, thus LPS molecules are extracted in 
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the water phase even though several factors, as the occurrence within the 
repeating unit of hydrophobic groups as well as charged 
monosaccharides or the length of the polysaccharide chains, may 
modulate LPS solubility in water. Thus, it can be detected either in the 
water or in the phenol extract.  
After the extraction procedure, enzymatic treatments to remove proteins 
and nucleic acids are executed. The typical protocol consists in 
LPS/LOS purification with nucleases (DNAse and RNAse) and protease 
followed by dialysis in order to remove digested material. The screening 
for detection of LPS is realised by SDS polyacrylamide electrophoresis 
gel (SDS-PAGE) followed by silver nitrate staining which allows to define 
the typology of the extracted material and its purification degree 
(Kittelberger and Hilbink, 1993). The presence of LPS is testified by the 
observation of the typical “ladder-like” pattern of the electrophoretic 
migration, due to the presence of molecules differing in their structure 
for the number of repeating units composing the O-polysaccharide 
moiety. Conversely, LOS appears as a dark band that quickly migrates at 
the bottom of the gel, denoting the lower molecular weight of LOS 
lacking O-chain domain.  
 
2.2 Structural determination of the saccharide moities  
 
Structural investigation of LPS/LOS is a difficult task since their 
amphiphilic nature determines the tendency to form micelles with low 
solubility in both aqueous and apolar organic solvents. Several strategies 
have been developed to overcome this obstacle, including the usage of 
solvent mixtures and chemical modifications or degradation of the 
molecules to improve dissolution in simple solvent systems.	 The 
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common protocol consists in the analysis of the lipid portion and 
saccharide moiety separately by using several hydrolysis techniques, as 
aqueous 1% acetic acid or acetate buffer. The above mild conditions are 
sufficient to cleave selectively the acid-labile glycosidic linkage between 
the Kdo residue and the non-reducing glucosamine of the lipid A, thus 
releasing the oligo-/polysaccharide moiety in the water solution.  
This linkage is very labile due to:  
 
I.! the absence of a whichever electron withdrawing group at 
position adjacent to anomeric (C-3 in this case since anomeric is 
C-2) that favors the formation of the reaction intermediate 
oxonium ion; 	  
II.! the passage from chair to half-chair conformation during the 
formation of the oxonium ion fastened by the presence of non-
substituted carbons; 	  
III.! the presence of a hydroxyl group in axial configuration at C-5 that 
contributes to a steric energy release in the formation of the 
intermediate ion. 	  
 
The insoluble lipid A moiety can then be recovered by centrifugation 
and several washes with distilled water, whereas the supernatant is 
constituted by O-antigen still linked to core region. This does not 
complicate the structural investigation of the O-antigen since, in terms of 
monosaccharide residues number, the contribute of the core fraction is 
negligible respect to the O-chain. A disadvantage of the above described 
methodology, based on an acid treatment, is that it produces a Kdo 
reducing unit with a structural microheterogeneity (α and β anomers of 
pyranose and furanose rings, condensed or anhydro forms) that can 
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render the study of the core oligosaccharide of LOS by NMR 
spectroscopy particularly difficult. Thus, typically, the procedure to 
determine the primary structure of the core oligosaccharide portion 
considers the de-lipidation of the intact LOS by means of alkaline 
treatment in two steps: first, a mild hydrazinolysis in anhydrous 
conditions to remove ester-linked fatty acids from lipid A; second, a 
strong alkaline hydrolysis is performed to obtain the cleavage of amide-
linked acyl chains too (Holst, 2000). The obtained product is 
represented by a homogenous phosphorylated oligosaccharide, 
comprehensive of the lipid A disaccharide backbone, that can be easily 
studied through chemical and spectroscopical investigations. Obviously, 
base-labile substituents of glycidic or non-glycidic nature are lost during 
this procedure. Therefore, it is possible to use the acid approach as a 
complement to the alkaline degradation, in order to evaluate the 
occurrence of base-labile groups lost during the alkaline treatment (i.e. 
pyrophosphate groups).  
The primary structure determination of the saccharide portions so far 
obtained currently exploits state-of-art NMR experiments and soft-
ionisation mass spectrometry techniques, together with compositional 
and linkage chemical analyses that allow the determination of: 
 
•! the quali-quantitative composition of sugar residues 
•! the absolute configuration of each monosaccharide 
•! the cyclisation ring sizes 
•! the glycosylation points of each monosaccharide 
•! the anomeric configuration of the glycosidic linkages 
•! the monosaccharide sequences 
•! the location of non-carbohydrates substituents  
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Additional information on the nature and the sequence of 
monosaccharides can be obtained from ad hoc selective cleavages of the 
polysaccharide such as partial acid hydrolysis, acetolysis, Smith 
degradation, β-elimination and solvolysis. 
  
2.2.1 Chemical analyses of the saccharide moieties 
 
Chemical analyses are useful to obtain important preliminary 
information regarding primary structure of poly/oligosaccharides. The 
procedure that provides the usage of Gas-Chromatography coupled with 
Mass-Spectrometry (GC-MS), can only be realized after conversion of 
the monosaccharides into apolar and volatile derivatives. There is a 
plethora of protocols that can be employed to identify the 
monosaccharide type as well as the glycosylation positions, thus the 
appropriate choice of the derivatisation method can highlight specific 
features of the sugar residues within the native LPS/LOS structure. 
Typically, the qualitative analysis by GC-MS is achieved by treating the 
oligo- /polysaccharide with MeOH/HCl leading to solvolysis of the 
molecule and to the formation of the O-methyl glycoside for each 
monosaccharide. Subsequent acetylation with acetic anhydride in 
pyridine produces the per-acetylated O-methyl glycosides (AMG), that 
can be injected and analysed by GC-MS. Comparison of the retention 
times from the GC analysis and the fragmentation pattern from the MS 
spectra with opportune standards allows to the identification of the 
monosaccharide residues. Quantification analysis can then be obtained 
by using an internal standard, that usually is per-acetylated inositol. Since 
the AMG protocol provides a solvolysis in acid conditions, several 
isomers for each monosaccharide may form (i.e. pyranose and furanose, 
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both as α and β anomers) resulting in the occurrence of many peaks in 
the corresponding chromatogram. Although not severely influencing the 
identification of the monosaccharides, this can lead to their 
misquantification. Therefore, an alternative and complementary 
approach that can be used leads to the formation of acetylated alditol 
derivatives. In this case, after strong acid hydrolysis with trifluoroacetic 
Acid (TFA), the carbonyl moiety of the monosaccharide residues is 
reduced with NaBH4, thus providing a single molecule from each 
monosaccharide. The alditols are then acetylated and finally analysed via 
gas-chromatographic techniques.  
A further procedure of chemical analysis that delivers the distinction 
between enantiomers provides that the solvolysis is executed with an 
enantiomerically pure alcohol as 2-(+)-octanol or 2-(+)-butanol. Thus, the 
absolute configuration of each monosaccharide residues can be 
determined (Leontein and Lönngren, 1978). Indeed, after acetylation 
and injection to GC-MS, the comparison of the retention time of the per-
acetylated 2-(+)-octyl glycosides with the ones of a mixture of per-
acetylated 2-(±)-octyl glycosides of standard monoses in D or L 
configuration allows the assignment of the monosaccharide 
configuration.  
The determination of ring size and glycosylation site of the 
monosaccharides is a further information obtainable through GC-MS 
analysis. The procedure consists in an extensively O-methylation of the 
oligo/polysaccharide with CH3I in strongly alkaline conditions. Then, the 
permethylated oligo-polysaccharide is hydrolysed in acid conditions and 
reduced with a marked boro hydride (NaBD4). The alditols so obtained 
have free hydroxyl groups only at the positions previously involved in 
glycosidic linkages and cyclisation, and can be then acetylated. These 
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partially methylated acetylated alditols can be analysed by GC-MS and 
the fragments observed in the MS spectra are diagnostic for specific 
substitution patterns of acetyl and methoxyl groups, since molecule 
fragmentations preferably occur in correspondence of a methoxyl group, 
better sustaining the released positive charge because of resonance 
effects. To obtain the desired structure information it is necessary to 
consider that the position of the acetyl groups in the fragments accounts 
for the attachment point or for the position of cyclysation of the pyranose 
or furanose ring whereas the methyl groups are located on positions not 
involved in linkages. The reduction of the carbonilic function with 
sodium borodeuteride discriminates between the fragments originated 
from the reduced position (even masses) and those originated from the 
last position (odd masses) (Hakomori, 1964). Information obtained from 
these chemical analyses helps and confirms the interpretation of 
subsequent NMR and MS experiments.  
 
2.2.2 NMR spectroscopy analysis of the saccharide moieties  
 
Nuclear Magnetic Resonance (NMR) represents the most useful and 
decisive technique in the field of structural investigation of 
carbohydrates. This is due to the possibility of analysing molecules in 
solution in a native state, owing to the good solubility observed for oligo- 
and polysaccharides in aqueous solutions. During the structural study of 
saccharides, nuclei usually observed are 1H, 13C and 31P, the last being 
necessary to detect phosphate groups and unusual phosphorous-
containing substituents.  
Analysing a typical monodimensional 1H-NMR spectrum of an oligo-
/polysaccharide, it is possible to distinguish three different regions: 
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•! The region between 5.5 and 4.6 ppm tipically relatived to the 
anomeric protons signals 
•! The region between 4.6 and 2.6 ppm where the ring proton 
signals are located 
•! The region between 2.5 and 1.0 ppm that is typical of the deoxy 
position signals  
 
Furthermore, from a 13C NMR spectrum it is possible to obtain 
information about:  
 
•! 95-105 ppm: anomeric carbon atoms involved in a glycosidic 
linkage 
•! 80-60 ppm: oxymethylene or carbinolic carbon atoms 
•! 60-45 ppm: carbon atoms linked to nitrogen 
•!  30 ppm: aliphatic methylene carbons of deoxy-sugar residues 
•! 25-15 ppm: methylene carbon atoms of 6-deoxy-sugar residues 
and of acetyl substituents. 
 
The region relative to the ring proton signals is considerably narrow, and 
usually the identification of all chemical shifts is not possible on the basis 
of the sole one dimensional NMR analysis. Thus, a combination of 
homo- and hetero-nuclear 2D- NMR experiments (such as DQF-COSY, 
TOCSY, NOESY, 1H,31P- HSQC, 1H,13C-HSQC, 1H,13C-HMBC) are 
required in order to assign all the spin systems, to determine the location 
and the nature of non-carbohydrate substituents and to characterise the 
monosaccharide sequence. In detail, TOCSY and DQF-COSY spectra 
allow the correct identification and assignment of all ring protons, and on 
the basis of these data, the assignment of all 13C resonances usually 
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follows from the analysis of the 1H,13C-HSQC spectrum; the intra-residue 
pattern of dipolar correlations in the 2D NOESY and ROESY spectra 
gives the proof for specific configurations; as example, NOE correlations 
between H-1/H-3 and H-5 are univocally diagnostic for a β-gluco-
configuration, on the other hand a NOE connectivity between H-1 and 
only H-2 is indicative of a α-gluco-configuration. In general, proton 
orientations on the rings can be deduced from the 3JH,H coupling constant 
values that follow the Karplus law and assume high values (8 ÷ 10 Hz) in 
case of trans-diaxial orientation of vicinal protons and considerably lower 
values (< 4Hz) in case of equatorial/axial or equatorial/equatorial 
orientation. These values can be attained from DQF-COSY spectrum. 
Anomeric proton and carbon chemical shifts are the first suggestion for 
the determination of the anomeric configuration of each monomer, since 
usually α-configured proton signals appear at lower fields respect to 
corresponding β-anomers, whereas the opposite situation occurs for 
carbon chemical shifts. Anomeric configurations are then confirmed by 
the 3JH1,H2 and by 1JC1,H2 values. In detail, in monosaccharides with the H-2 
in axial orientation (as glucose, galactose), a 3JH1,H2 around 8 Hz is 
indicative of a β- orientation, whereas below 3 Hz of an α-configuration. 
Sugars with the H-2 in equatorial orientation (as mannose) show in both 
anomeric configuration a 3JH1,H2 value below 3 Hz. Moreover, a 1JC1,H1 below 
165 indicates a β-anomer, above 170 Hz a α-anomer. The downfield 
shift of ring proton signals (acylation shift) is useful to determine O- and 
N-acylation sites. O- phosphorylated protons undergo a similar down-
field shift. In the 1H,13C-HSQC spectrum, the down-field shift, or 
glycosylation shift, of carbon resonances (2 ÷ 10 ppm), allows to locate 
the positions of glycosidation and these may find confirmation in 
information previously obtained by means of chemical analyses. 
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Information regarding the cyclisation ring is obtained by the observation 
in the 1H,13C-HMBC spectrum of intra-residual long range correlations, 
i.e. H-1/C-5 and C-1/H-5 for pyranosidic rings or H-1/C-4 and C- 1/H-4 
for furanosidic rings. These latter are also identified by a low field 
displacement of all the ring resonances for the monosaccharide. 
Information concerning the sequence of the monosaccharides within the 
oligosaccharide (or the repeating unit of the polysaccharide) are then 
deduced from the observation of the inter-residual dipolar correlations in 
2D NOESY and ROESY spectra (Figure 2.1) and from the existence of 
scalar long range correlations, in the 1H,13C-HMBC spectrum, among the 
1H and 13C nuclei involved in glycosidic linkages. Eventually, 1H,31P-
HSQC allows the localisation of the phoshorylation sites within the 
saccharide structure.  
 
 
Figure 2.1 Inter-residue NOE correlations between disaccharides 
 
2.2.3 Mass spectrometry analysis of the saccharide moieties  
 
Mass spectrometry represents to date an essential technique in the 
structural characterisation of lipopolysaccharides and 
lipooligosaccharides especially with the development of soft ionisation 
techniques like MALDI (Matrix Assisted Laser Desorption Ionisation), 
ESI (ElectroSpray Ionisation), and the fragment analysis in MS/MS 
experiments. Apart from the Electron ionisation (EI) normally used in 
GC-MS analyses, mass spectrometric techniques allowing the definition 
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of the molecular weight of the intact molecule are particularly useful, 
since they can provide additional information to the 1D and 2D NMR 
analyses that sometimes can be hard to construe. Usually, for 
carbohydrates, MALDI and ESI MS spectra are performed in negative 
ion mode, due to the presence of a great number of potentially ionising 
groups (carboxyl or phosphate functions), nevertheless spectra in positive 
ion mode are also performed  
MALDI-TOF analysis, in particular, gives an ideal profile of the sample 
by sketching all the molecules composing it, thus giving a picture of the 
eventual presence of different glycoforms differing for the presence of 
one or more glycidic or non-glycidic residues. This methodology consists 
in a soft ionisation of the sample that is suspended in a specific matrix 
assisting the analyte in ionisation phenomenon. The matrix has 
important roles among which the protection of the sample from the laser 
energy assuring a soft ionisation with formation of single charged ions. 
Recently it has been pioneered the birth of new MALDI MS approaches 
through development of new methods of preparation and experimental 
study of the intact sample yielding a “picture” of the whole endotoxin, 
without any loss of structural information that can arise when the MS 
analysis is executed on degraded derivatives provided for the standard 
structural elucidation protocols (Sturiale et al., 2005). These procedures 
provide good spectra of intact molecular ions of lipopolysaccharides 
comprehensive of the heterogeneity inferred by the lipid A presence, 
showing high sensitivity also at relatively high molecular mass. The usage 
of high energy laser source allows to cleave the labile linkage between the 
Kdo and the glucosamine backbone lipid A, in a similar way to the 
acetate buffer treatment (see paragraph 2.2). In case of LOS, in the 
deriving spectra there are three regions of signals originated by the lipid 
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A, the core oligosaccharide and the intact LOS. In LPS, due to the 
dispersion of molecular weight of the O-polysaccharide, information on 
the size of the repeating unit can be deduced.  
 
2.3 Structural determination of the lipid A moiety  
 
The lipid fraction obtained by precipitation, after mild acid treatment of 
LPS (or LOS) consists of a mixture of intrinsically heterogeneous lipid A 
molecules. The structural approach makes an extensive use of mass 
spectrometry analysis by MALDI-TOF and ESI MS techniques, as well 
as NMR spectroscopy and chemical analyses both on the native and 
selectively degraded lipid A fractions. The lipid A structure 
characterisation requires the determination of: 
•! the saccharide backbone 
•! the amide and the ester linked fatty acids 
•! the distribution of the acyl chains on the sugar backbone 
•! the phosphorylation sites 
•! the sites of heterogeneity relative to the acylation pattern  
(number, type and distribution of the acyl chains) or the non-
stoichiometric presence of phosphate substituents.  
The determination of the nature, ring size, attachment point and 
absolute configuration of the sugar components of lipid A is performed 
has already described (see paragraph 2.2.1).  
 
2.3.1 Chemical analyses of the lipid A moiety  
 
Fatty acids determination is usually achieved through GC- MS analysis of 
their methyl ester derivatives. Lipid A is first treated with aqueous HCl, 
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then neutralised with NaOH, and acyl chains are then extracted in 
CHCl3, methylated with diazomethane and analysed by GC-MS. O-
linked acyl chains can be extracted from the entire molecule through an 
alkaline treatment with NaOH, followed by methylation with 
diazomethane and analysis by GC-MS. The choice of cleavage 
conditions allows the selective detection of the linkage type of the fatty 
acids (Rietschel, 1976). 
 
2.3.2 Mass spectrometry analysis of the lipid A moiety  
 
Mass spectrometry is the most common approach used in lipid A 
structural determination. MALDI-TOF and ESI MS data allow gaining 
insights into the number of lipid A species present in the fraction, the 
presence of polar heads and the distribution of acyl residues on each 
GlcN units of the disaccharide backbone (Que et al., 2000). Novel 
general approaches gaining structural insights on the native and 
selectively degraded lipid A fractions have been developed. In particular, 
combining MALDI MS or ESI MS and selective chemical degradations 
it is possible to understand the acylation profile of the molecule. Firstly, 
the amide linked fatty acids are identified by MS analysis of completely 
de-O-acylated lipid A with anhydrous hydrazine (Holst, 2000). An 
enormous advantage in lipid A structural analysis is the treatment with 
aqueous NH4OH (Silipo et al., 2002). This procedure selectively cleaves 
the ester- linked acyloxyacyl groups, leaving untouched the amide- linked 
acyloxyacyl groups. Thus, MS analysis of the ammonium hydroxide 
treated lipid A allows the detection of the secondary fatty acid 
distribution, which is one of most demanding issues in the structural 
determination of the LPS/LOS lipidic moiety (Sforza et al., 2004; 
Sturiale et al., 2005). MALDI spectra can be executed in positive and 
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negative mode. The use of the former is expedient to differentiate the 
fatty acid allocation between the two GlcNs of lipid A in case of 
asymmetric distribution; this is possible since during the execution of 
positive ion MALDI MS spectra a selective ionisation after fragmentation 
of the GlcN backbone occurs, and the only oxonium ion that is visible is 
relative to the non-reducing GlcN (Domon and Costello, 1988). On the 
other hand, both negative and positive mass spectra furnish indication of 
the presence of non-stoichiometric phoshorylation sites. The intact or 
fully de-O-deacylated lipid A are also used to study the location of the 
phosphorylation sites.  
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Chapter 3: Extremophiles, an overview 
3.1 Life-Forms in inhospitable environments 
 
Belonging to both two dominia of Archaea and Bacteria, and to either 
Gram-positive and Gram-negative family, extremophiles are life-forms 
capable to live and thrive in inhospitable, from a human viewpoint, 
environments such as alkaline and acidic waters, boiling hot springs, high 
pressure waters, ultra saline brines, without excluding a combination of 
aforesaid chemical and physical extremes which is typical of 
polyextremophilic microbes (Mesbah and Wiegel, 2008). On the basis of 
the physical or chemical parameters, these microrganisms can be 
distinguished in: acidophiles and alkalophiles that live at extreme pH 
values; thermophiles that are able to live at extremely high temperatures, 
ranging from 40°C up to 100°C; psychrophiles able to survive in frozen 
habitats, i.e. glaciers or polar seas; halophiles that live in extreme salt 
concentrations from 3M to saturation of NaCl; barophiles that require 
elevated pressure for proliferation and xerophiles that can be isolated 
from extremely anhydrous environments. Several studies of 
extremophiles have helped redraw the three-domain system of life. 
Indeed, the typical dogma held that living organisms could be grouped 
into two domains: Bacteria, with a simple structural architecture, and 
Eukarya, whose cells are more complex. The discovery of 
microorganisms in environments that were assumed to be sterile 
supported to the once heretical proposal that yet a third group, the 
Archaea, exists. Many microbiologists believe that ancestors of today’s 
archeal species might represent a type of organism that first inhabited 
Earth when it was a young and hot planet. These unique features led the 
American microbiologist Carl Woese to propose these microorganisms 
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be lumped together and called Archeabacteria, as already described in 
Section I, Chapter 1. Anatomically, archaeans differ from bacteria since 
their cell membrane is composed by isoprenoid and isoprenyl glycerol 
ether-linked lipids, with fully saturated acyl chains (Gulik et al., 1985). 
The presence of these lipids and the production of exopolysaccharides 
allowing the formation of biofilms, are responsible for the extraordinary 
stability shown by extremophiles. The notable resistance offered by these 
components to hydrolysis at acidic and alkaline pHs and at high 
temperature, has been proposed as the feature that allowed the 
development of archaeal extremophile strains. Recently, researchers 
have focused on DNA and completely sequenced a number of bacterial 
and archaeal genomes; noticeably, these studies have demonstrated that 
some genes of archaea are similar to bacterial genes and others to 
eukaryotic ones. On the other hand, a large fraction of archaeal genes 
appear to be unique. These unshared genes establish archaea’s separate 
identity. Owing to their unique features, extremophiles have attracted 
much interest since they showed to possess a high biotechnological 
potential with a number of important industrial applications comprising 
bioremediation and biomining processes (Taylor et al., 2012). Of 
particular interest are the enzymes that help extremophiles to function in 
hostile circumstances. The commonly used enzymes degrade or stop 
working when exposed to heat or other extreme conditions, and so 
manufacturers that rely on them must take specific steps to protect the 
molecules during reactions or storage.  
Since enzymes from extremophiles – termed “extremozymes” – remain 
active when other enzymes would fail, they can potentially remove the 
need for those steps, thereby increasing efficiency and reducing costs 
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(Madigan and Marrs, 1997). Furthermore, they can form the basis of 
entirely new enzyme-based processes (Madigan and Marrs, 1997).  
 
3.2 Psychrophiles 
 
Much of life on Earth has evolved to colonize low-temperature 
environments. In fact, at temperatures permanently below 5°C, the cold 
biosphere represents by far the largest fraction of the global biosphere 
(Siddiqui et al., 2013). Permanently cold environments cover about one-
fifth of the surface of the Earth including terrestrial ice sheets of 
Antarctica and Greenland, mountain glaciers and sea ice in Antarctic and 
Arctic Ocean. Sea ice covers a larger area of the Earth than glaciers, 
approaching 10% of the ocean’s surface, but with an average thickness of 
only 2–3 meter, the global volume of sea ice is much lower than that of 
the glacial environment. In these environments, the temperature plays a 
critical role in the selection and survival of a variety of organisms such as 
bacteria, archaea, yeasts, algae, insects, fishes and plants. These cold-
adapted organisms are termed psychrophiles. The term psychrophile 
(from Greek psychros meaning cold and philes meaning loving) was first 
used by Schmidt-Nielsen in 1902 (Morita 1975). For many years, cold-
adapted organisms have been classified into two partially overlapping 
groups: psychrophiles, having minimum, optimum and maximum 
growth temperature at or below 0°C, 15°C and 20°C, respectively, and 
psychrotolerant, with growth maximum temperature above 25°C, but 
with the capacity to grow at very low temperatures (Morita, 1975). 
Recently, among the additional definition proposed, such as "moderate 
psychrophiles" (Helmke et al., 2004), and "psychro-active" (Laucks et al., 
2005), the terms "eurypsychrophiles" and "stenopsychrophiles" have been 
favored (Feller et al., 2003; Bakermans et al., 2004; Cavicchioli, 2006). 
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Stenopsychrophile, formerly "true psychrophile", refers to a 
microorganism with a restricted growth-temperature range; in fact, they 
are most frequently isolated from thermally stable cold marine 
environments. Eurypsychrophile, formerly psychrotolerant, describes a 
microorganism that prefers permanently cold environment, but can also 
tolerate a wide range of temperatures reaching up into the mesophilic 
range; these microbes dominate, in fact, cold terrestrial ecosystems 
(Helmke et al., 2004). The genomic differences in cold adaptation 
between stenopsychrophiles and eurypsychrophiles have yet to be 
thoroughly investigated (Bakermans et al., 2004). However, this 
distinction is ignored at present and all the cold-tolerant bacteria could 
be dubbed as psychrophiles (Chattopadhyay et al., 2014).  
Cold adaptation of microorganisms is the result of intrinsic genome-wide 
changes that facilitate the growth at low temperatures. Comparative 
studies of cold-adapted microorganisms are beginning to reveal which 
adaptations are common to all the psychrophiles and which are specific 
to the particular environment each psychrophile inhabits. Cold marine 
environments are distinctly different from cold terrestrial ones like 
permafrost; marine environments tend to have high thermal stability as 
well as stable solute concentrations, while terrestrial environments do 
not. Consequently, genomic analysis of microorganisms isolated from 
marine environments likely reflects adaptations to stable low 
temperatures, while the ones from terrestrial environments may reveal 
unique mechanisms of cold adaptation related to heterogeneous 
environmental chemistry due to the extreme temperatures fluctuations. 
Ecological limiting factors, such as nutrient and water availability, salinity, 
pressure, UV irradiation and temperature, are all characteristics of cold 
environments. Psychrophilic microorganisms in glacial ice are restricted 
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to small amounts of unfrozen water inside the permafrost soil or the ice, 
and to brine channels. In some terrestrial habitats, these stresses dictate 
that psychrophilic communities develop niches, not only in brine 
channels, but also frequently associated with lithic habitats, such as 
cryptoendolithic and chasmolithic environments (De Maayer et al., 
2014). 
 
3.3 Molecular and physiological adaptation 
 
Cold temperatures impose severe physicochemical constrains on cellular 
function by negatively influencing cell integrity, water viscosity, solute 
diffusion rate, membrane fluidity and macromolecular interactions (De 
Maayer et al., 2014). The ability of an organism to survive and grow in 
cold conditions is therefore dependent on a various number of adaptive 
strategies (Figure 3.1). The analysis of numerous psychrophilic genomes 
and metagenomes has indicated the presence of a large number of 
features contributing to genome plasticity, such as plasmids, transposable 
and other mobile genetic elements. One of the most obvious 
disadvantages of life at very low temperatures is the low rates of catalysis: 
psychrophilic enzymes must therefore be suitable adapted to maintain 
adequate catalytic rates for cellular function. These enzymes are 
generally characterized by higher flexibility and lower thermostability 
than their mesophilic counterparts. One of the strategies is to reduce the 
content of amino acids such as arginine and proline; the last one is 
involved in the formation of multiple hydrogen bonds and salt bridges, 
and reduces the conformational flexibility. Following a downshift of 
temperature from 37°C to 10°C in mesophilic E. coli, the synthesis of 
most of the cellular proteins is repressed for a lag period of 4–5 h. 
Among these proteins, the most prominently up-regulated genes are 
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those encoding cold-shock proteins (CSPs), a family of small, single-
stranded nucleic acid binding proteins that regulate a variety of cellular 
processes including transcription, translation, protein folding and 
membrane fluidity (De Maayer et al., 2014). These stress proteins have 
been found to occur both in mesophilic and psychrophilic bacteria. A 
second class of proteins, called cold acclimation proteins (Caps), is found 
to be constitutively expressed in psychrophilic bacteria while in 
mesophiles are expressed only in response to cold exposure. The CSPs 
are believed to facilitate transcription and translation at low temperature 
in the mesophilic bacteria. However, the exact role of CSPs in cold 
adaptation of psychrophiles is yet to be elucidated (Chattopadhyay 
2006).  
 
Figure 3.1: Common physiological adaptations in a psychrophilic prokaryote. 
 
Furthermore, the increased solubility of oxygen at low temperatures 
poses an increased risk from reactive oxygen species (ROS), and 
different approaches seem to be involved in protecting against free 
radical damage. C. psychrerythraea contains three copies of catalase 
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genes as well as two different superoxide dismutase (SOD) genes, one of 
which is a nickel-containing SOD never reported before in 
proteobacteria (Methé et al., 2005).  
It has long been known that one of the most significant impacts of low 
temperature is on membrane fluidity, essential for its structural integrity 
and for the cellular functionality. In fact, recent transcriptome analyses 
have shown that exposure to cold temperatures induces a rapid up-
regulation of genes involved in membrane biogenesis, such as fatty acids, 
LPS, peptidoglycan and outer membrane proteins biosynthesis (De 
Maayer et al., 2014). The lipid composition governs the physical 
properties of the membranes and hence it is not surprising that this 
varies with the thermal habitat of the microorganism. In general, a 
reduction in temperature leads to a higher content of unsaturated, 
polyunsaturated and methyl-branched fatty acids, and/or a shorter acyl-
chain length. This altered composition is thought to have a key role in 
increasing membrane fluidity by introducing steric constrains that change 
the packing order and reduce the number of interactions in the 
membrane. Lipopolysaccharides (LPSs) are the major constituent of the 
bacteria outer membrane that forms a protective barrier around the cell, 
and their biosynthesis is increased by lowering the temperature. Some of 
the genes encoding for enzymes involved in the LPS biosynthesis, as 
lipopolysaccharide biosynthesis polimerase and lipid A biosynthesis 
acyltransferase (LpxP) are induced (Gao et al., 2006). It is believed that 
the induction of LpxP is related to the function of enhancing the outer 
membrane fluidity after cold shock with the acylation of lipid A with 
palmitoleate instead of laureate (Carty et al., 1999). Carotenoid pigments 
represent another class of membrane fluidity modulators. Both polar 
and non-polar pigments are produced by Antarctic bacteria and have 
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been postulated to buffer membrane fluidity and assist maintaining 
homeoviscosity during temperature fluctuations (De Maayer et al., 2014). 
One of the main consequences of lowering temperature is the formation 
and the propagation of cytoplasmic ice crystals, resulting in the 
destruction of membranes, gas bubbles formation and organelles 
disruption, determining a total cellular damage (Fuller 2004). 
Psychrophilic microorganisms display the expression of compatible 
solutes biosynthesis - glycine, betaine, sucros, threalose and mannitol- 
during growth at low temperature. Compatible solutes act globally and 
not specifically, allowing the microorganisms to occupy broader thermal 
niches and to react quickly to changes in temperature (Chin et al., 2010). 
In particular, the threalose disaccharide may prevent the denaturation 
and aggregations of proteins, scavenge free radicals and stabilize cellular 
membranes. To contrast low temperatures, some species of fungi, 
bacteria, plants and insects produce antifreeze proteins (AFP) and 
glycoproteins (AFGPs), also known as thermal hysteresis proteins. These 
possess the ability to inhibit the formation of ice and can lower the 
freezing temperature of a solution non-colligatively, without affecting its 
melting temperature.  
Moreover, it is known that some bacteria produce ice-nucleating agents 
(INAs) that serve as templates for ice crystallization and provide 
resistance to desiccation (Margesin et al., 2007). Sea ice through its 
seasonal lifetime is recently known to hold high concentrations of sugar-
based exopolymers in its liquid brine inclusions. These 
exopolysaccharides (EPSs) are understood to serve as natural 
cryoprotectants not only against potential ice-crystal damage, but also by 
further depressing the freezing point of the liquid water remaining 
available within the ice matrix (Marx et al., 2009). The ability of a 
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microorganism to surround itself with a highly hydrated shell helps to 
buffer the cell against the osmotic stress of high salt concentrations, and 
may provide it with protection against desiccation, and predation by 
protozoans (Kumar et al 2007). Therefore, EPSs are essential in the 
aggregate formation, in the mechanism of adhesion to surfaces, in the 
uptake of nutrient and in the formation of biofilm (Poli et al., 2010). EPS 
is a common component of biofilm and its production is an important 
feature of the mature biofilm (Fux et al., 2003). In addition, EPSs form 
the matrix that embeds the bacteria, where additional free bacteria can 
be entrapped (Costerton et al.,1995; Bianciotto et al., 2001). The 
mechanisms of adaptation to cold stress have received considerable 
attention in the last few decades, particularly for the biotechnological 
potentiality of these organisms and their biomolecules. 
 
3.4 Industrial and biomedical applications 
 
The scientific interest in cold-adapted molecules has increased 
substantially in recent years, as evidenced by the growing number of 
recently isolated examples. The necessity of all components of a 
microbial cell to adapt to the cold implies that a broad range of cellular 
products is available for biotechnological applications. The vast majority 
of studies related to biotechnological applications have focused on cold-
adapted enzymes that possess high catalytic activity at low temperature 
and low thermostability at elevated temperatures. Cold-adapted enzymes 
are of great interest because their employment could avoid heating and 
consequently save energy. This is very important, especially in food 
industry since this could prevent heat-sensitive substrates from chemical 
degradation. In addition to their enzymes, cold-adapted microorganisms 
have a range of molecules of interest in terms of investigation, patenting 
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and commercial products. For examples, polyunsaturated fatty acids 
could be used as dietary supplements for aquaculture, livestock and 
human diets; pharmaceutical and cosmetic industries are more interested 
in physical properties of EPS, like high viscosity, gelling capacity or high 
resistance in a wide range of temperature and pH (Freitas et al., 2011). 
From the biomedical point of view, bacterial LPSs isolated from cold 
environments may also be a source of potential immunostimulant 
molecules. During these years, an ever-growing attention has been 
devoted to the research of new lipid As, obtained either from engineered 
bacterial extracts (Needhama et al. 2013) or synthetic (Gao et al., 2017; 
Maiti et al. 2010; Shimoyama et al. 2011) and semisynthetic approaches 
(Pieretti et al. 2014; D’Alonzo et al. 2016), that could find application as 
possible adjuvants. In this context, extremophiles may be a promising 
source of non-toxic LPSs and lipid As derived from these. In particular, 
cold environments, due to the still low contamination by pathogenic 
microorganisms, may represent an untapped reservoir of 
immunomodulating molecules. Indeed, lipid As isolated from several 
psychrophiles have been reported to antagonize E. coli LPS toxicity, 
while others have proved able to act as weak agonists. Both types are 
interesting, due to the possibility of exploiting them for the treatment of 
inflammatory conditions and as immunoadjuvants, respectively. 
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Chapter 4: Colwellia psychrerythraea strain 34H 
 
The family Colwelliaceae is a part of the order of Alteromonadales, 
located within class Gammaproteobacteria. It contains twelve 
psychrophilic or psychrotolerant species (Deming et al., 1988), two of 
which are also barophilic (Collins et al., 2010). The species of family 
Colwelliaceae are principally Gram-negative, rod- to curved rod-shaped 
cells and facultative anaerobic. Deming et al. (1988) first described the 
genus Colwellia for a psychrophilic microorganism isolated from 
Flounder eggs collected in Norway. This name was given in honor of the 
american microbiologist Professor Rita Colwell (Bowman 2014). 
Colwellia species are ubiquitous present in cold and polar marine 
ecosystem, including ice brine channels, marine biofilms and aquaculture 
system. Nowadays, only the genome of the sea ice bacterium Colwellia 
psychrerythraea strain 34H had determined. Analysis of the genome 
suggests that a collection of synergistic changes in the overall genome 
content and amino acid composition supports its psychrophilic lifestyle 
(Methe et al., 2005). Colwellia psychrerythraea strain 34H, isolated from 
subzero Arctic marine sediments (Huston et al., 2004), grows at 
temperatures as low as -12°C, with optimal and maximal growth 
temperatures of 8-9°C and 19°C, respectively (Huston et al., 2004). The 
analysis of C. psychrerythraea genome evidences the features that allow 
living at freezing temperatures and for this reason this bacterium is 
considered a model to study cold adapted life-style. 
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4.1 Lipopolysaccharides and lipid A structures 
 
The cells extracted by the PCP method revealed a rough-LPS (LOS), as 
already found for other psychrophilic microorganisms (Corsaro et al., 
2004; Corsaro et al., 2008; Carillo et al., 2011). The structure, obtained 
by chemical analysis, NMR spectroscopy and ESI mass spectrometry, is 
reported below (Figure 4.1) (Carillo et al., 2013): 
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Figure 4.1: Core structure of LOS from C. psychrerythraea 34H. 
 
Only few sugar units, some of which are acidic monosaccharides, 
constitute the core region. This structural feature, together with the 
presence of several phosphate groups, gives to the LOS a high charge 
density. Furthermore, it is worth noting the lack of heptose residues in 
the inner core of LOS; in their place, an α-mannose residue is linked to 
the Kdo. This structural feature is commonly found in Rhizobiaceae 
family, but has never been found in extremophiles. Finally, colitose and 
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phosphoglycerol, already found in some O-polysaccharides chains 
(Silipo et al., 2005; Kenyon et al., 2011), are present (Figure 4.1).  
 
4.1.1 Isolation and compositional analysis of lipid A 
 
Extraction of Colwellia psychrerythraea 34H dried cells, grown at 4°C, by 
the phenol/chloroform/light petroleum (Galanos et al. 1969) yielded 
about 1.1% of LOS (Carillo et al., 2013). The LOS sample was 
recovered as precipitate after washing in chloroform/methanol (1:2, v/v) 
to a concentration of 5 mg mL-1 to remove phospholipids as supernatant. 
The lipid A fraction was obtained by 1% acetic acid hydrolysis of LOS 
suspension. The lipid A was recovered as pellet after centrifugation of 
the crude reaction, washed twice with water and freeze-dried. Sugar 
analysis revealed the presence of D-glucosamine as unique 
monosaccharide. Fatty acid methyl esters, obtained after methanolysis of 
the lipid A and extraction with hexane, were recognised in the GC-MS 
chromatogram by comparison of their retention times with standards and 
from their EI-MS spectra. GC-MS analysis revealed the presence of 3-
hydroxy-dodecanoic [C12:0(3-OH)] and 3-hydroxy-tetradecenoic acids 
[C14:1(3-OH)], as hydroxylated species. The presence of an unsaturated 
hydroxylated species was quite uncommon. The analysis also revealed 
the occurrence of decanoic (C10:0), dodecanoic(C12:0), dodecenoic 
(C12:1), tetradecanoic (C14:0), tetradecenoic (C14:1), and hexadecenoic 
(C16:1) acids. In addition, signals attributable to hexadecanoic (C16:0) 
and octadecanoic (C18:0) acids suggested the presence in the LOS 
sample of membrane phospholipids. Finally, less abundant signals were 
attributed to pentadecanoic (C15:0) and pentadecenoic (C15:1) acids. 
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4.1.2 Mass spectrometry analysis of lipid A 
 
The characterization of  Colwellia psychrerythraea 34H lipid A, started 
and partially reported in the PhD thesis of Dr. Casillo, was continued 
and completed during this PhD work. Indeed, as already reported, the 
lipid A, was analyzed by ESI FT-ICR mass spectrometry in the negative-
ion mode. The obtained mass spectrum was complex and showed five 
signal clusters (Figure 4.2, Table 4.1), corresponding to a number of 
glycoforms differing for their acylation and phosphorylation degree.  
Figure 4.2: Negative ions ESI FT-ICR mass spectrum of the  
lipid A from Colwellia psychrerythraea 34H. 
 
Table 4.1: Composition of the main species present in the negative ions ESI FT-ICR 
mass spectrum of the lipid A from Colwellia psychrerythraea 34H. 
Species [M-H]
- 
calculated 
[M-H]- 
observed Composition 
K1 1301.751 1301.744 (GlcN)2P2[C12:0(3OH)]2[C14:1(3OH)][C12:0] 
K2 1499.916 1499.905 (GlcN)2P2[C12:0(3OH)]3[C14:1(3OH)][C12:0] 
K3 1653.919 1653.907 (GlcN)2P2[C12:0(3OH)]3[C14:1(3OH)]GroP- [C12:0] 
K4 1808.058 1808.042 (GlcN)2P2[C12:0(3OH)]3[C14:1(3OH)]GroP- [C12:0][C10:0] 
K5 2046.290 2046.287 (GlcN)2P2[C12:0(3OH)]3[C14:1(3OH)]GroP- [C12:0] [C10:0][C16:0] 
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In particular, they ranged from tetra-acylated to hepta-acylated 
glycoforms, of which the most abundant are named K1–K5. For the 
species K1 with [M-H]- at 1301.744 m/z, with composition 
GlcN2P2[C12:0(3-OH)]2[C14:1(3-OH)][C12:0] (m/z calculated: 1301.751 
Da), revealed a tetra-acylated lipid A with only three hydroxylated fatty 
acids. The species K2 at 1499.905 m/z (m/z calculated: 1499.916 Da), 
was identified as penta-acylated lipid A with an additional C12:0(3-OH), 
suggesting an asymmetric distribution of hydroxylated primary fatty acids. 
The species at 154.002 Da higher, indicated as K3, differed from K2 in 
the uncommon presence of a glycerol phosphate residue (GroP). 
Although the presence of GroP linked to saccharides belonging to the O-
chain of a LPS is not unusual, (Wang et al. 2008; Jachymek et al. 1999) 
the linkage of GroP to lipid A has only been reported in lipid A from 
Vibrio fischeri (Phillips et al. 2011), which shares high phylogenetic 
proximity with Colwellia (Methe et al. 2005). 
Most-abundant species K4 at m/z 1808.042 was identified as a hexa-
acylated species carrying an additional C10:0 ('m=154.135 Da). Species 
K5 at m/z 2046.287 displayed an additional C16:0 ('m=238.248 Da). 
All the species comprise heterogeneity in unsaturation owing to 
substitution of C12:0 with C12:1 ('m=-2 Da). In addition, heterogeneity 
due to the presence of C14:1 ('m=+ 26 Da) or C10:0 (-28 Da) instead of 
a C12:0 fatty acid was displayed. Finally, further heterogeneity was 
observed for K4 and K5 in the length of the fatty acids and in the 
presence of an uneven number of C atoms, which is in agreement with 
the compositional analysis by GC–MS (C15 :0 and C15 :1). Lipid A was 
then treated with NH4OH (Silipo et al. 2002), which hydrolyzed only the 
acyl and acyloxacyl esters and left the acyl and acyloxacyl amides intact. 
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Lipid A NH4OH was analyzed by negative-ion ESI FT-ICR MS, and the 
spectrum displayed four signals clusters centered at species M1–M4 
(Figure 4.3, Table 4.2). 
 
  
Figure 4.3: Negative ions mass spectrum of the lipid ANH4OH from Colwellia 
psychrerythraea 34H. 
 
Species 
[M-H]- 
calculated 
[M-H]- 
observed 
Composition 
M1 921.419 921.405 GlcN2P2[C12:0(3OH)][C14:1(3OH)] 
M2 1023.622 1023.603 GlcN2P[C12:0(3OH)][C14:1(3OH)][C12:0] 
M3 1103.589 1103.568 GlcN2P2[C12:0(3OH)][C14:1(3OH)][C12:0] 
M4 1301.754 1301.721 GlcN2P2[C12:0(3OH)]2[C14:1(3OH)][C12:0] 
 
Table 4.2: Composition of the main species of the lipid ANH4OH observed  
in the ESI FT-ICR mass spectrum. 
 
Less abundant signals, appearing at higher ('m=+26 Da) and lower ('m= 
-28 Da) m/z values relative to the m/z values of species M1–M4 and M2–
M4, respectively, were attributed to the presence of C14:1 or C10:0, 
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respectively, instead of C12:0. In addition, all the main species, except 
for M1, presented a shift in mass of 'm=-2 Da; this suggested secondary 
acylation by dodecenoic acid instead of dodecanoic acid. All the species 
clearly indicated that C12:0(3-OH) and C14:1(3-OH) were linked as 
amides to either GlcN I or GlcN II. 
To obtain more detailed information on the distribution of fatty acids 
and the linkage of GroP on the disaccharidic backbone, lipid A was 
studied in the positive-ion mode with a Q-Exactive Plus Orbitrap 
(Thermo, Bremen). The mass spectrum showed intensive adduct ions 
[M+Et3N+H]+ of corresponding negative-ion species K1–K5 (Figure 4.4), 
however, with slightly different relative intensities. 
  
 
Figure 4.4: Positive-ionQ-Exactive Plus mass spectrum of lipid A from 
C.psychrerythraea 34 H. The mass numbers given in bold indicate the[M+Et3N+H]+ 
ions that were selected for MS/MS. 
 
In general, the MS/MS spectra showed the expected loss of Et3N 
('m=101 Da) and the cleavage of the phosphate linked to GlcN I 
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('m=97.89 Da). Further fragmentation led to the appearance of both the 
B1 and Y1 fragments (Domon et al. 1988), together with fragments 
resulting from the loss of fatty acids mainly as free acids instead of 
ketenes.  
The B1 fragment ions at m/z 846.55 and 818.52, with compositions of 
GlcNP[C14:1(3OH)][C12:0(3OH)][C12:0] and 
GlcNP[C14:1(3OH)][C12:0(3OH)][C10:0], respectively, were found in 
the MS/MS spectra (Figures 4.5–4.7), which definitively established the 
substitution on GlcN II. Indeed, whereas the analysis of the lipid A 
NH4OH product had previously indicated C14:1(3-OH) as an acyl 
amide at the 2-position, the presence of C12:0(3-OH) at the 3-position 
was deduced from the B1 fragment. Taking together the results of the 
analysis of the lipid A NH4OH and B1 fragment ions, the occurrence of 
C12:0 as an acyloxacyl of C14:1(3-OH) was inferred. Moreover, the 
fragmentation spectra of the main species showed the presence of signals 
corresponding to the elimination of C12:0 as a free acid ('m=200.18 
Da) from B1, which thus confirmed that C14:1(3-OH) was acylated by 
the same fatty acid in all of the main species (Figures 4.5–4.7). Starting 
from penta-acylated species K2, the MS/MS spectrum of the 
corresponding signal at m/z 1603.04 (Figure 4.5) displayed the B1 
fragment ion at m/z 846.55 and a signal at m/z 1403.94 corresponding to 
the simultaneous elimination of a phosphate group and water (B2 
fragment). Less-intense fragments were observed at m/z 1203.76 and 
1187.94 owing to the loss of C12:0 or C12:0(3OH), respectively (Figure 
4.5). 
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Figure 4.5: MS/MS spectrum of m/z 1603.04. TEA = triethylamine. 
 
This finding indicated that both fatty acids were linked as esters (Kussak 
et al. 2002). The spectrum also contained the signal at m/z 558.40, which 
could be attributed to the Y1 fragment lacking a phosphate group, and 
this definitely confirmed the structure of the penta-acylated species 
reported in the inset of Figure 4.5. To establish the position of the GroP 
moiety, the [K3+Et3N+H]+ adduct ion at m/z 1757.04 was selected for 
MS/ MS analysis (Figure 4.6), and the obtained spectrum was clearly 
related to that of the penta-acylated form. In fact, whereas the B1 
fragment remained the same, the Y1 ion shifted in mass by 'm=+154.0 
Da, which thus indicated the localization of the phosphoglycerol on 
GlcN I. In addition, the simultaneous loss of 'm=97.89 Da (phosphate 
group and water) and 'm=388.19 Da (moiety composed of the 3-
hydroxydodecanoic acid and phosphoglycerol group) from the [K3+H]+ 
parent ion at m/z 1557.94 (B2 fragment) suggested that the GroP moiety 
was linked to C12:0(3OH), which was in turn linked to the 3- position of 
GlcN I.  
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Figure 4.6: MS/MS spectrum of m/z 1757.04. TEA = triethylamine. 
 
If selected for MS/MS analysis, the hexa-acylated lipid A species at m/z 
1911.12 gave the fragmentation reported in Figure 4.7. In this spectrum, 
the Y1 ion fragment at m/z 866.54 indicated that the proximal GlcN 
moiety had the additional decanoic acid linked as an acyloxacyl ester.  
Furthermore, the signal at m/z 1187.77 arose from the elimination of 
524.31 + 97.89 Da from the [K4+H]+ parent ion; this suggested that the 
glycerol moiety was substituted by decanoic acid.  
 
Figure 4.7: MS/MS spectrum of m/z 1911.12. TEA = triethylamine. 
 
The last fatty acid was assigned to the sn-1 position thus to form a 
lysophosphatidic acid moiety, as demonstrated by NMR spectroscopy 
(see paragraph 4.1.3). Upon selecting higher-molecular-weight species for 
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MS/MS analysis, the spectra obtained	 revealed the additional 
substitution of the phosphoglycerol	 moiety. Indeed, the fragmentation 
spectrum of the hepta-acylated species [K5+Et3N+H]+ at m/z 2149.25 
(Figure 4.8), containing an additional hexadecanoic acid with respect to 
K4, gave	 a fragment ion due to the loss of 780.55 Da (m/z 1169.76). 
 
Figure 4.8: MS/MS spectrum of m/z 2149.25. TEA = triethylamine. 
 
This	 fragment is consistent with the mass predicted for the loss of	 the 
entire substituent at the O-3 position of GlcN I as free acid	 plus a water 
molecule. The same GroP substitution was revealed in the MS/MS 
spectrum of the species at 28 Da lower	 than the mass of K5 (Figure 4.9), 
for which the B1 fragment ion	 indicated a decanoic acid as the 
secondary fatty acid. 
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Figure 4.9: MS/MS spectrum of m/z 2121.23. TEA = triethylamine. 
 
Other	 hepta-acylated species were analyzed by inducing fragmentation 
and revealed a different substitution on the GroP moiety	 (Figure 4.10); 
this indicated heterogeneity in the acylation of this	 moiety. 
 
Figure 4.10: MS/MS spectrum of m/z 2203.30. TEA = triethylamine. 
 
Finally, all the signals marked by an asterisk cannot be straightforwardly 
explained by the normal fragmentation pathways known for	 lipid A 
structures. These fragment ions are observed only from lipid A species 
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carrying the GroP and might be due to gas-phase rearrangements during 
CID. The m/z values observed for these ions in the reported MS/MS 
spectra (Figures 4.6-4.10) are in excellent agreement with the suggested 
structures. However, further experiments have to be performed to 
confirm this suggestion (Scheme 4.1). 
 
Scheme 4.1: Suggested structures for the fragment ions marked by an asterisk in the 
reported MS/MS spectra (Figures 4.6-4.10). 
 
4.1.3 NMR spectroscopy of lipid A 
 
In addiction to the data obtained from the mass spectrometry 
experiments, the NMR spectroscopy was here used to prove some 
details of the lipid A structure. To confirm the presence of a 
phosphoglycerol residue covalently linked to lipid A, 2D NMR 
spectroscopy experiments were performed (1H,1H COSY, 1H,1H 
TOCSY, 1H,13C HSQC-DEPT, 1H,13C HMBC, and 1H,31P HMBC). Two 
signals were detected in the proton anomeric region of the HSQC 
experiment at (=5.02 and 4.57 ppm, whereas the carbon signals 
resonated at (=91.0 and 98.0 ppm, respectively (Table 4.3). 
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Table 4.3: NMR spectroscopy data of C. psychrerythraea 34H lipid A. 
 
These two crosspeaks are diagnostic of the # configuration of GlcN I 
and the ! configuration of GlcN II, respectively. All the proton and 
carbon chemical shifts of the GlcN disaccharide were assigned and 
reported (Table 4.3, Figure 4.11).  
 
Figure 4.11: 1H,13C HSQC-DEPT NMR spectrum in 4:1 v/v CDCl3-CD3OD of the lipid 
A from C. psychrerythraea 34H grown at 4 °C showing the (a) anomeric and carbinolic 
region; (b) methylene and methyl groups region; and (c) double-bonds region. 
 
In addition, it was possible to assign the position of the double linkage of 
C14 :1(3-OH). In fact, the carbon signal at (=67.3 ppm, assigned to the 
! carbon atom of the 3-hydroxy fatty acids, was correlated in the HMBC 
experiment with both diastereotopic #-CH2 protons at (=2.39/2.50 ppm 
and with a CH olefinic proton at (=5.26 ppm, which thus indicated that 
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the double linkage was located between carbon atoms C4 and C5 (Figure 
4.12). The NMR spectroscopy data also revealed the presence of a GroP 
moiety linked to lipid A. In the HSQC-DEPT experiment, the 
crosspeak at ( = 5.09/69.8 ppm was attributed to the CHOH group of 
the lysophosphatidic acid moiety. In particular, one of the signals of the 
CH2 group of the Gro residue occurring at ( = 3.87/63.1 ppm in the 
HSQC-DEPT experiment was correlated in the 1H, 31P HMBC 
experiment with a 31P signal at (=-12.7 ppm, the chemical shift of which 
indicated the phosphodiester linkage (Helander et al. 1994) (Table 4.3). 
In addition, one of the signals of the CH2 group of the Gro residue (( = 
4.04 ppm) correlated with a carbonyl signal at ( = 173.3 ppm in the 
1H,13C HMBC experiment (Figure 4.12), which in turn correlated with 
the #-CH2 protons of the acyl ester at ( = 2.21 ppm. 
  
 
Figure 4.12: 1H,13C HMBC NMR spectrum in 4:1 v/v CDCl3-CD3OD of the lipid A 
from C. psychrerythraea 34H grown at 4 °C showing the (a) carbinolic region; and (b) 
carboxylic region. 
 
These last correlations indicated that in the most-abundant species, the 
CH2OH position of the Gro moiety was always acylated. All together, 
these results established the four fatty acids at the primary acylation sites 
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on lipid A of C. psychrerythraea 34H and also showed 
microheterogeneity at the secondary acylation site at the 2’-position and 
in the GroP moiety (Scheme 4.2). 
 
 
Scheme 4.2: Structure of C. psychrerythraea 34H lipid A. 
The double bond is arbitrarily shown in the cis configuration. 
 
4.1.4 Evaluation of biological activity 
 
Biological activity assays were performed to characterize the effect of C. 
psychrerythraea lipid A on TNF secretion in the presence of a serial 
dilution of Escherichia coli O111:B4 LPS.  
Therefore, we used the human monocytic cell line THP-1, which we 
differentiated into mature macrophages a 24h-long pre-treatment with 
200 mM phorbol 12-myristate 13-acetate (PMA). Macrophage-like 
THP1 cells express MD-2 and CD14, which are necessary for the 
transfer of monomeric LPS to the TLR4 cell surface receptor and 
further downstream signalling (Park et al. 2009). Cells were 
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simultaneously stimulated with different concentrations of C. 
psychrerythraea lipid A and E. coli O111:B4 LPS or were further left 
untreated.  
After 24h, medium was taken, and the amount of secreted TNF was 
measured by ELISA. As seen in Figure 4.13, C. psychrerythraea lipid A 
did not show a clear effect on LPS-induced TNF production in THP-1 
cells. To conclude, C. psychrerythraea lipid A has no agonistic or 
antagonistic effect on LPS-induced TNF production on human 
macrophages. 
 
 
Figure 4.13: Effect of C. psychrerythraea lipid A on LPS-induced TNF production in 
THP-1 cells. Cells were incubated with the indicated amounts of C. psychrerythraea 
lipid A in the presence or absence of different concentrations of E. coli O111:B4 LPS, 
as indicated. 
 
4.2 Conclusions 
 
C. psychrerythraea 34H represents a good model to understand how 
cold-adapted bacteria contrast harsh environmental conditions. The 
structure of C. psychrerythraea 34H lipid A was established, the 
characterization of which may help to understand the structure–function 
relationships (Casillo et al. 2017). The results of chemical, MS, and 
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NMR spectroscopy analyses revealed a structure that is quite unusual for 
lipid As. The primary acylation pattern was found to be asymmetric, and 
reducing GlcN was found to be substituted at positions 2 and 3 by two 3-
hydroxydodecanoic acids, whereas the distal GlcN was found to carry a 
3-hydroxydodecanoic acid and 3-hydroxy- tetradecenoic acid at positions 
3’ and 2’, respectively. To our knowledge, a 3-hydroxy unsaturated 
tetradecenoic acid together with a phosphoglycerol moiety on a 
secondary acylation site at the 3-position of the reducing GlcN are found 
only in Vibrio fischeri lipid A (Phillips et al. 2011). In addition, the level 
of micro-heterogeneity in the Colwellia structure is high owing to the 
presence of unsaturated secondary fatty acids and to a wide range of 
lengths for the saturated chains. Finally, another site of heterogeneity is 
constituted by the phosphoglycerol moiety, which evokes in turn acylated 
at positions sn-1 and sn-2 to some extent, to produce the hexa-acylated 
and hepta-acylated glycoforms, respectively.  
The lipid A moiety displays several structural features that could be 
related to the adaptation mechanisms adopted by C. psychrerythraea 
34H. The presence of unsaturated fatty acids in phospholipids and lipid 
As from cold-adapted bacteria and mesophiles grown at a temperature 
lower than their optimal one is well documented (Carty et al. 1999). In 
this context, the structure of C. psychrerythraea 34H lipid A here 
reported is in agreement with the genomic data of the microorganism, 
the coding sequences of which indicate both unsaturated and 
polyunsaturated fatty acid biosynthesis (Hashimoto et al. 2015). In 
contrast, a comparison with lipid A structures from other Colwellia 
species revealed substantial differences, the most important of which was 
the absolute absence of the phosphoglycerol moiety in both the C. 
piezophila and C. hornerae species (Sweet et al. 2015). In addition, no 
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unsaturated fatty acids have so far been reported for the structures from 
these two Colwellia species grown whether at 4 or 15°C.  
More intriguing is the simultaneous presence of the phosphoglycerol 
moiety on both the core (Carillo et al. 2013) and lipid A moieties of C. 
psychrerythraea 34H LPS. One can assume that these unusual structural 
features of the LPS molecule have an effect on the outer membrane of 
C. psychrerythraea 34H cells. In particular, the high salt concentration to 
which C. psychrerythraea 34H cells are exposed in brine channels forces 
the cells to be in osmotic balance with the environment, and the 
phosphoglycerol moiety could act as an osmolyte (Thomas et al. 2002). 
Biological activity assays performed in the human macrophage cell line 
THP-1 did not show an agonistic or antagonistic effect of C. 
psychrerythraea lipid A on tumor necrosis factor production in these 
cells at any concentration used.  
To summarize, a new lipid A structure from C. psychrerythraea 34H was 
characterized; it enlarges the number of structure–activity relationships 
data available for the design of new immunomodulatory molecules 
(D’Alonzo et al. 2016; Marzabadi et al. 2017; Choma et al. 2017).  
 
4.3 Experimental section 
 
4.3.1 Isolation of the LPS  
C. psychrerythraea 34H was isolated from Arctic marine sediments 
(Methé et al. 2005) and was grown at 4°C as previously reported (Carillo 
et al. 2011). Dried bacteria cells (4.8 g) were extracted by the PCP 
method (Fuller, 2004), which gave 52 mg of LPS (yield 1.1 % of dried 
cells). The LPS sample was recovered as precipitate after washing in 
chloroform/methanol (1:2, v/v) to a concentration of 5 mg mL-1 to 
remove phospholipids as supernatant. 
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4.3.2 Mild acid hydrolysis of the LPS  
The LPS (23 mg) was incubated with 1% aqueous CH3COOH (3mL) for 
3h at 100°C. The sample was then centrifuged at 10000g for 30min, and 
two fractions were recovered: lipid A (7.5 mg) as pellet and the 
saccharide portion (15.5 mg) as surnatant. 
 
4.3.3 Chemical analysis  
The lipid A fraction (0.5 mg) was analyzed as acetylated methyl glycoside 
derivatives (AMG). Briefly, HCl/CH3OH (1mL, 1.25M) was added to 
the sample, and the reaction was performed at 80°C for 20 h. The crude 
mixture was extracted with hexane (2x). The hexane layer, containing the 
fatty acids as methyl ester derivatives, was analyzed by GC–MS. The 
analyses were performed with an Agilent Technologies gas 
chromatograph 6850A equipped with a mass-selective detector 5973 N 
and a Zebron ZB-5 capillary column (Phenomenex, 30m)0.25mm i.d., 
flow rate 1 mL min-1, He as carrier gas). The following temperature 
program was used for lipid analysis: 110°C for 3 min, 140 to 280°C at 
10°C min-1. 
  
4.3.4 Lipid A purification  
Lipid A (5 mg) was purified through a short Celite column (*5cm3). Gel-
filtration chromatography was performed with a Sephadex LH-20 
(1x50cm, flow rate 48 mL h-1, eluent CHCl3/MeOH 3:2, v/v) to obtain 
1.6 mg of pure product.  
 
4.3.5 NH4OH hydrolysis of lipid A 
Lipid A (0.5 mg) was incubated with concentrated aqueous NH4OH (200 
µL), as reported (Silipo et al. 2002). The sample was dried and analyzed 
by ESI FT-ICR mass spectrometry.  
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4.3.6 NMR spectroscopy 
1D and 2D NMR spectra were recorded with a Bruker DRX-600 (1H: 
600 MHz, 13C: 150 MHz) instrument equipped with a cryoprobe in 
CDCl3/CD3OD (4 :1, v/v; residual CHCl3 as internal standard, 1H: ( = 
7.26 ppm; 13C: ( = 77.0 ppm) at 298 K. All two-dimensional homo- and 
heteronuclear experiments (COSY, TOCSY, HSQC-DEPT, and 
HMBC) were performed by using standard pulse sequences available in 
the Bruker software. The mixing time for TOCSY was 100 ms. 31P NMR 
spectra were recorded with a Bruker Avance-DRX 400 (31P: 160 MHz) 
instrument, and chemical shifts are relative to an external standard 
(phosphoric acid). 
  
4.3.7 ESI FTICR mass spectrometry 
Electrospray ionization Fourier- transform ion cyclotron resonance mass 
spectrometry was performed by using an APEX Qe (Bruker Daltonics) 
equipped with a 7 Tesla actively shielded magnet and a dual 
ESI/MALDI ion source. For negative-ion mode, samples (10 ng mL-1) 
were dissolved in propan-2-ol/water/Et3N (50:50:0.001, v/v/v) and were 
sprayed at a flow rate of 2 mL min-1. The capillary entrance voltage was 
set to 3.8 kV, and the dry gas temperature was set to 200°C.  
 
4.3.8 Q-Exactive Plus Orbitrap 
For MS/MS analyses in the positive-ion mode, the lipid A samples were 
analyzed with a Q-Exactive Plus (Thermo, Bremen, Germany) by using 
the H-ESI source with 4.0 kV, a sheath gas flow rate of 5 au, and a 
transfer capillary temperature of 250°C. The sample was dissolved in 
propan-2-ol/water/30mm ammonium acetate (50:50:4 v/v/v) adjusted 
with acetic acid to pH 4.5. For enhanced fragmentation analysis, 
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triethylamine was added as described (Kondakova et al. 2005), and 
measurements were performed in direct infusion mode by using a 
syringe pump at a flowrate of 5 mL min-1. The S-lens RF (Radio 
Frequency) level was set to 100 and a source fragmentation of 50 eV was 
applied. The complete isotopic cluster of a precursor was selected by 
using 10 Da isolation window. The resolution was set to 280000 full 
width at half maximum (FWHM) defined at m/z 200. For MS/MS, 
normalized collision energy (NCE) was set to either 13 or 14 NCE. For 
further in-depth MS/MS analysis of selected molecular species, nano-ESI 
experiments were performed by using the Nanomate Triversa (Advion, 
Ithaca, US). The spray voltage was set to 1.1 kV, and the additional 
backpressure was set to 7.6 kPa. The source fragmentation was set to 
100 eV, and the precursor selection was performed with unit resolution 
specifically to isolate the monoisotopic signal. 
 
4.3.9 Reagents and cell cultures 
The human myelomonocytic THP1 cell line was obtained from ATCC 
(Manassas, USA). Phorbol 12-myristate 13-acetate (PMA) was purchased 
from Sigma–Aldrich. E. coli O111:B4 LPS was purchased from 
InvivoGen (Invitrogen). Lipid A was reconstituted in DMSO to provide 
1 mg mL-1 stock solutions. Further dilutions were made in cell medium 
[RPMI1640 (Life Technologies)] supplemented with 10% fetal calf 
serum (FCS), l-glutamine (2 mM), sodium pyruvate (0.4 mM), and 2-
mercaptoethanol (4 µM) so that the final amount of DMSO in the cell 
culture did not exceed 0.01%.  
 
4.3.10 Biological activity assay in human macrophage-like cell line THP1 
THP-1 cells were grown in RPMI1640 cell-culture medium 
supplemented with 10% FCS, l-glutamine (2mM), sodium pyruvate (0.4 
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mM), and 2-mercaptoethanol (4 µM). Cells were seeded in a 96-well 
plate at 105 cells well-1 in complete medium (140 µL) and were stimulated 
with PMA (200 nM) for 24 h to induce differentiation into macrophage-
like cells. The next day, the cells were washed with complete culture 
medium to discard the cells that did not adhere, refreshed with complete 
medium (180 µL), and left for 1 h to recover. Cells were simultaneously 
stimulated with C. psychrerythraea lipid A in the presence or absence of 
E. coli O111:B4 LPS at the indicated concentrations. The C. 
psychrerythraea lipid A and E.coli O111:B4 LPS were added as 
solutions in complete medium (10 µL) to reach a 200 µL total volume of 
the well after stimulation. The cells were incubated overnight (18–24 h) 
at 37°C and 5% CO2, and the supernatants were analyzed for TNF 
production by ELISA (BD Biosciences). Data are representative of three 
independent experiments. Error bars indicate standard error of the 
mean of triplicate samples.  
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Chapter 5: Psychrobacter arcticus strain 273-4 
 
Until now, only LPSs from marine Arctic (Corsaro et al. 2008; Carillo et 
al. 2013) and Antarctic (Carillo et al. 2011; Corsaro et al. 2001) Gram-
negative microorganisms have been characterized, but very little is known 
about isolates from permafrost. It has been shown that viable bacteria are 
abundant in Siberian permafrost (Vishnivetskaya et al. 2000; Carillo et al. 
2011), and the most frequently isolated from the Kolyma permafrost of 
northeast Siberia include Arthrobacter, Exiguobacterium, 
Flavobacterium, Sphingomonas, and Psychrobacter (Rodrigues et al. 
2009; Rivkina et al. 2000; Vishnivetskaya et al. 2000). Psychrobacter is 
considered an indicator genus for permafrost and other polar 
environments (Shi et al. 1997), suggesting that many of its members are 
adapted to low temperatures and have evolved molecular-level changes 
that aid survival at low temperatures.  
Psychrobacter arcticus 273-4 is a Gram-negative bacterium isolated from 
a 20,000-to-30,000-year-old continuously frozen permafrost horizon in 
the Kolyma region in Siberia that was not exposed to temperatures 
higher than 4 °C during isolation (Rivkina et al. 2000). 
 
5.1 Lipopolysaccharides and lipid A structures 
 
As already reported in a previous work (Casillo et al. 2015), the 
structural characterization of the carbohydrate backbone of the LOS of 
Psychrobacter arcticus 273-4 grown at 4 °C was already performed. The 
structure showed a particular inner core region, with a residue of glucose 
linked to the Kdo in place of a manno-heptose. This structural feature 
has been found only in Colwellia psychrerythrae 34H, which showed a 
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mannose residue linked to the Kdo (see paragraph 4.1). 
Generally, the oligo- and polysaccharides produced by marine bacteria 
are distinguished by the acidic character (Muldoon et al. 2003), and by 
the occurrence of unusual sugars (Kenne et al. 1983), non-sugar 
substituents (Komandrova et al. 2010; Hanniffy et al. 1999; Nazareno et 
al. 2003; Carillo et al. 2013) or highly phosphorylated structures 
(Corsaro et al. 2004). Although P. arcticus 273-4 was isolated from Arctic 
permafrost it displays similar characteristics of cold-adapted marine 
isolates, due to the presence of the unusual residue of  N-acetylmuramic 
acid (NAM), commonly encountered as a component of bacterial cell-
wall peptidoglycan, already found in the O-specific polysaccharide of 
Yersinia ruckerii (Beynon et al. 1994) and Proteus penneri (Zych et al. 
1998), but found for the first time in an oligosaccharide core (Casillo et 
al. 2015). It is well known that cold-adapted microorganisms are able to 
modify the fluidity of the cellular membrane in response to a lowering of 
temperature by producing a higher content of unsaturated, 
polyunsaturated and methyl-branched fatty acids in phospholipids 
(Chintalapati et al. 2004; Driessen et al. 1996). Instead, how bacteria 
modify the glycolipid portion of LPS structures in response to the cold 
stress is still poorly understood. Even though only few LPS structures 
from cold-adapted bacteria have been characterized (Corsaro et al. 2008; 
Carillo et al. 2013; Corsaro et al. 2001; Carillo et al 2011), their attractive 
feature is the production of rough lipopolysaccharides. Moreover, it is 
worth noting that Psychrobacter arcticus 273-4, a permafrost isolate, 
shares this feature with marine isolates. Thus, the LOS isolated from P. 
arcticus 273-4 grown at 4°C was hydrolyzed under mild acidic conditions 
to cleave the unstable Kdo glycosidic linkage between the lipid A and the 
saccharidic region. After centrifugation, the supernatant containing the 
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core oligosaccharidic portion of the LOS was separated from a 
precipitate constituted by the lipid A. After further purifications steps, 
the characterization of lipid A portion, has been a topic of this thesis. 
The lipid A from P. arcticus grown at 25°C, was already reported 
(Korneev et al 2014). During this thesis, we therefore speculated and 
evaluated the influence of the temperature on the lipid A structure. 
 
5.1.1 Isolation and compositional analysis of lipid A 
 
The extraction of P.arcticus 273-4 dried cells by hot phenol-water 
method gave LPS in about 3.1% yield (Casillo et al. 2015). The LPS was 
subjected to 5% acetic acid hydrolysis to obtain lipid A fraction. The 
lipid A was recovered as pellet after centrifugation of the crude reaction, 
and washed twice with water and then freeze-dried. The fatty acid methyl 
ester derivatives were obtained after methanolysis of lipid A sample and 
extraction with hexane, and analyzed by gas chromatography mass 
spectrometry (GC-MS) (Figure 5.1).  
 
Figure 5.1: Chemical composition of lipid a portion. 
 
The analysis showed the presence of mainly 3-hydroxy-dodecanoic acid 
[C12:0(3-OH)], 3-hydroxy-tetradecanoic acid [C14:0(3-OH)], decanoic 
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acid (C10:0), and a minor amount of 3-hydroxy-undecadecanoic acid 
[C11:0(3-OH)], and 3-hydroxy-tridecanoic acid [C13:0(3-OH)]. In 
addition, signals attributable to longer chains (C16:0; C:16:1; C18:0; 
C18:1) suggested the presence of membrane phospholipids. 
Phospholipids contaminants were removed from LPS by extraction with 
a chloroform-methanol mixture, and a very low contamination due to 
phospholipids was revealed by GC-MS. The presence of phosphate 
groups was deduced from NMR spectra of delipidated core 
oligosaccharide and confirmed by mass spectrometry (Casillo et al. 
2015). 
 
5.1.2 Mass spectrometry analysis of Lipid A 
 
The charge-deconvoluted ESI FT-ICR mass spectrum obtained in 
negative ion mode (Figure 5.2) revealed for the lipid A from P. arcticus, 
mainly three signal clusters (M1-M3) representing tetra-, penta-, and 
hexa-acylated lipid A species (Table 5.1). 
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Figure 5.2: Charge-deconvoluted negative ions ESI FT-ICR mass spectrum of lipid A 
from P. arcticus 273-4. 
 
Table 5.1. Composition of the main species present in the charge-deconvoluted 
negative ions ESI FT-ICR mass spectrum of the lipid A from P. arcticus 273-4. 
 
Chemical analysis and mass spectra results, allowed to assign to the tetra-
acylated specie M1 (calculated molecular mass 1248.715 Da) the 
following composition: GlcN2P2[C12:0(3-OH)]3(C10:0). The specie M2 
at 1446.87 m/z (calculated molecular mass 1446.880 Da), was identified 
Species 
[M-H]-
Calculated 
[M-H]- 
Observed 
Composition 
M1 1248.715 1248.70 GlcN2P2[C12:0(3-OH)]3(C10:0) 
M2 1446.880 1446.87 GlcN2P2[C12:0(3-OH)]4(C10:0) 
M3 1601.019 1601.00 GlcN2P2[C12:0(3-OH)]4(C10:0)2 
M4 1724.016 1724.01 GlcN2P2PEtN[C12:0(3-OH)]4(C10:0)2 
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as penta-acylated lipid A with an additional C12:0(3-OH). Finally, 
species at 154.13 u higher, indicated as M3, differs from the M2 for the 
additional presence of a decanoic residue. This species at 1601.00 m/z 
(calculated molecular mass 1601.019 Da), was attributed to the hexa-
acylated lipid A, with the following composition: GlcN2P2[C12:0(3-
OH)]4(C10:0)2. Moreover, M4 signal cluster displays an additional 
phosphoethanolamine respect to M3. All the species display 
heterogeneity caused by variation of the fatty acids chain length (±14.01 
Da, ±28.03 Da), with the replacement of one or more C12:0(3-OH) 
chains with C14:0(3-OH) or C11:0(3-OH), together with the lack of a 
phosphate group (79.96 Da). 
To understand the position of the secondary fatty acids, the lipid A from 
P.arcticus was treated with conc. NH4OH (Silipo et al. 2002), a 
procedure that allows to hydrolyse acyl and acyloxacyl esters, leaving 
intact acyl and acyloxacyl amides. 
 
 
Figure 5.3: Charge-deconvoluted negative ions ESI FT-ICR mass spectrum of the Lipid 
ANH4OH from Psychrobacter arcticus 273-4. 
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Table 5.2. Composition of the main species of the Psychrobacter arcticus 273-4 Lipid 
ANH4OH observed in the ESI FT-ICR mass spectrum.  
Species 
[M-H]- 
calculated 
[M-H]- 
observed 
Composition 
M1 896.411 846.41 GlcN2P2[C12:0(3OH)]2 
M2 1050.550 1050.54 GlcN2P[C12:0(3OH)]2[C10:0] 
M3 1248.715 1248.70 GlcN2P2[C12:0(3OH)]3[C10:0] 
M4 1402.854 1402.84 GlcN2P2[C12:0(3OH)]3[C10:0]2 
M5 1601.019 1601.00 GlcN2P2[C12:0(3OH)]4[C10:0]2 
 
The charge deconvoluted negative ions ESI FT-ICR mass spectrum of 
the lipid ANH4OH (Figure 5.3; Table 5.2) revealed the presence of five main 
signals. The most abundant signal M2 with measured mass of 1050.54 u 
corresponded to a molecular species the composition of which was 
identified as GlcN2P2[C12:0(3-OH)]2(C10:0) (calculated molecular mass 
1050.550 Da), thus indicating that the decanoic acid was linked as 
acyloxyamide. In order to obtain the exact distribution of fatty acids on 
each glucosamine residue, the lipid A was analyzed by MS and MS/MS 
in the positive ion mode, perfomed with a Q-Exactive Hybrid 
Quadrupole Orbitrap.  
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Figure 5.4: Positive-ion Q-Exactive Hybrid mass spectrum of lipid A from 
Psychrobacter arcticus 273-4. 
 
The positive ions MS spectrum showed the presence of three species 
K1-K3 (Figure 5.4), as found in negative ion mode, even if a different 
relative intensity among the signals was detected.  
 
Figure 5.5: MS/MS spectrum of m/z 1602.01. 
 
The glycoform at m/z 1602.01, corresponding to the hexacyl- 
diphosphorylated specie, was selected for the fragmentation. The 
MS/MS spectrum showed the presence of a B+ fragment ion at m/z 
946.64 Da, corresponding to GlcNP[C12:0(3-OH)2(C10:0)2, thus 
!
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indicating that both the secondary fatty acids were linked to the distal 
non-reducing end glucosamine (Figure 5.5).  
 
5.1.3 Evaluation of biological activity 
 
Preliminary biological activity assays were performed to characterize the 
effect of Psychrobacter arcticus 273-4 lipid A on TNF secretion in the 
presence of a serial dilution of Escherichia coli O111:B4 LPS, as 
described for C. psychrerythraea in paragraph 4.1.4.  
As shown in Figure 5.6, P. arcticus lipid A seemed to be quite agonist on 
LPS-induced TNF production in THP-1 cells and displays only a slight 
agonistic effect at the highest concentration. However, further 
experiments to evaluate these properties in details are needed. 
 
Figure 5.6: Effect of P. arcticus lipid A on LPS-induced TNF production in THP-1 
cells. Cells were incubated with the indicated amounts of P. arcticus lipid A in the 
presence or absence of different concentrations of E. coli O111:B4 LPS, as indicated. 
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5.2 Conclusions 
 
In addition to the complete structure of the sugar backbone of the LPS 
from the permafrost isolate Psychrobacter arcticus 273-4, that was 
already reported (Casillo et al 2015), here we investigated the structure of 
the lipid A portion. The results of chemical and mass spectrometry 
analyses revealed a symmetric primary acylation pattern, substituted at 
positions 2, 3 and 2’, 3’ by two 3-hydroxydodecanoic acids, respectively. 
Instead, the secondary acylation pattern is characterized by the presence 
of two shorter decanoic acid (C10:0) chains linked to the distal non-
reducing end glucosamine. In addition, the level of micro-heterogeneity 
in the P. arcticus structure is characterized by the presence of 3-hydroxy-
tetradecanoic acid [C14:0(3-OH)] and minor amount of 3-hydroxy-
undecadecanoic acid [C11:0(3-OH)] and 3-hydroxy-tridecanoic acid 
[C13:0(3-OH)] as primary acyl groups instead of the 3-hydroxy-
dodecanoic acid [C12:0(3-OH)]. Biological activity assays performed in 
the human macrophage cell line THP-1 show an agonistic effect of 
Psychrobacter arcticus lipid A on tumor necrosis factor production in 
these cells and a slight agonistic effect at the highest concentration used. 
 
5.3 Experimental section 
 
5.3.1 Bacteria growth and LPS isolation 
P. arcticus strain 273-4, was isolated from permafrost soil located in 
Siberia. Shake flask cultivation were performed in Luria-Bertani broth 
(Sambrook et al. 2001) at 4°C in aerobic condition. When the liquid 
cultures reached late exponential phase (about 90 h, OD600nm 4) cells were 
collected by centrifugation for 15 minutes at 7000 rpm at 4 °C. Dried 
bacterial cells (3.1 g) were extracted first by PCP method to give very 
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poor yield of LOS (0.03% w/w of dried cells) and then by hot 
phenol/water method (Galanos et al. 1969; Westphal et al. 1965).A 240 
mg amount of water extract  was dialyzed (cut-off 3500 Da) and then 
digested with proteases, DNAses and RNAses to remove contaminating 
proteins and nucleic acids. The sample was dialyzed (cut-off 3500 Da) to 
afford 96 mg of LOS sample (yield 3.1 % w/w of dried cells). 
 
5.3.2 Mild acid hydrolysis 
The LOS (20 mg) was hydrolyzed with 1% aqueous CH3COOH (2 mL, 
100 °C for 4 h). The resulting suspension was then centrifuged (7500 
rpm, 4 °C, 30 min) and the pellet was washed twice with water, and two 
fractions were recovered: lipid A (7.5 mg) as pellet and the saccharide 
portion (12.5 mg) as surnatant. 
 
5.3.3 Chemical Analysis 
The lipid A fraction (0.5 mg) was analyzed as derivatives methyl 
glycoside acetylated (AMG) as indicated in paragraph 4.3.3. 
 
5.3.4 NH4OH hydrolysis of lipid A 
Lipid A (0.5 mg) was incubated with conc. aqueous NH4OH (200 µL) as 
reported (Silipo et al. 2002). The sample was dried and analyzed by ESI 
FT-ICR mass spectrometry. 
 
5.3.5 Mass spectrometry analysis 
Performed by Prof. B. Lindner and Dr. D. Schwudke, Division of 
Bioanalytical Chemistry, Leibniz-Center for Medicine and Biosciences, 
Germany. Electrospray ionization Fourier transform ion cyclotron (ESI 
FT-ICR) mass spectrometry was performed in negative ion mode using 
an APEX QE (Bruker Daltonics) instrument equipped with a 7 Tesla 
actively shielded magnet. For negative ions mode, samples (≈10 ng mL-1) 
!93!!
were dissolved in 2-propan-ol/water/Et3N (50:50:0.001, v/v/v) and 
sprayed at a flow rate of 2 µL min-1. The capillary entrance voltage was 
set to 3.8 kV, and the dry gas temperature to 200°C. 
 
5.3.6 Q-Exactive hybrid quadrupole orbitrap 
For MS/MS analyses in the positive-ion mode, the lipid A samples were 
analyzed with a Q-Exactive Plus (Thermo, Bremen, Germany) by using 
the H-ESI source with 4.0 kV, a sheath gas flow rate of 5 Da, and a 
transfer capillary temperature of 250°C. The sample was dissolved in 2-
propan-ol/water/30 mM ammonium acetate (50:50:4, v/v/v) adjusted with 
acetic acid to pH 4.5. For enhanced fragmentation analysis, triethylamine 
was added as described in literature (Nazarenko et al. 2003), and 
measurements were performed in direct infusion mode by using a 
syringe pump at a flowrate of 5 µL min-1. The S-lens RF (Radio 
Frequency) level was set to 100, and a source fragmentation of 50 eV was 
applied. The complete isotopic cluster of a precursor was selected by 
using 10 Da isolation window. The resolution was set to 280000 full 
width at half maximum (FWHM) defined at m/z 200. For MS/MS, 
normalized collision energy (NCE) was set to either 13 or 14 NCE. For 
further in-depth MS/MS analysis of selected molecular species, nano-ESI 
experiments were performed by using the Nanomate Triversa (Advion, 
Ithaca, US). The spray voltage was set to 1.1 kV, and the additional 
backpressure to 7.6 kPa. The source fragmentation was set to 100 eV, 
and the precursor selection was performed with unit resolution 
specifically to isolate the monoisotopic signal. 
 
5.3.7 Reagents and cell cultures 
See paragraph 4.3.9. 
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5.3.8 Biological activity assay in human macrophage-like cell line THP1 
See paragraph 4.3.10. 
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SECTION III 
 
Semisynthetic derivatives from Escherichia coli 
lipid A 
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Chapter 6: Multigram-scale extraction and purification 
of lipid A from E. coli 
 
Lipid A is involved in binding to Toll-like receptor 4 (TLR4) and 
responsible for the potent inflammatory effects of LPS, that may be 
associated with a variety of severe symptoms such as fever, diarrhea, 
blood pressure drop, and septic shock (see paragraph 1.4.2). 
Nonetheless, the studies about the structure–activity relationship of 
natural lipid A and various synthetic analogues have shown that the 
phosphorylation grade as well as the number, length, and distribution of 
acyl chains on lipid A are crucial for its endotoxicity (see paragraph 
1.3.1) (Li et al. 2013; Rietschel et al. 1994). For example, it is well-known 
that diphosphorylated and highly acylated lipid As, such as the major 
hexa-acylated species from Escherichia coli (1, Figure 6.1), are generally 
optimally recognized by TLR4 (Park et al. 2009), but their clinical use is 
precluded due to high toxicity. However, their strong inflammatory 
activity can be significantly reduced by removing the anomeric phosphate 
group. The reduced toxicity of monophosphoryl lipid A (2, Figure 6.1) 
has been attributed to the selective induction of the TLR-4–TRIF 
signaling pathway over the TLR-4–MyD88 one (Mata-Haro et al. 2007), 
leaving the immunostimulatory properties unaffected. Furthermore, 
underacylated (three or four chains) or overacylated (seven chains) lipid 
A species can often inhibit TLR4, thus acting as TLR4-antagonists in 
humans. Therefore, therapeutic regulation of the innate immune 
response by suitable lipid A structures is an interesting approach towards 
TLR4-active immunomodulators, that can be useful for the treatment of 
several pathologies such as allergies, neuroinflammation and cancer, as 
well for a highly efficient formulation of vaccines (Marzabadi et al. 2017). 
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Indeed, the monophosphoryl lipid A from Salmonella enterica ser. 
Minnesota RC 595, selectively deacylated at position O-3 of GlcN I 
(MPL® 3, Figure 6.1) (Mata-Haro et al. 2007), was recently introduced 
for human use (Casella et al. 2008) in HPV vaccine Cervarix and HBV 
vaccine Fendrix in combination with Alum, an already employed 
immunoadjuvant. Moreover, MPL® has entered clinical trials stage 
investigations for its employment as an adjuvant in the therapy of a 
number of different types of cancer too: stage IV melanoma, ovarian 
cancer, lung cancer, leukemia, sarcoma, Merkel cell carcinoma, and non-
Hodgkins lymphoma (Marzabadi et al. 2017; for recent and ongoing 
studies see: https://clinicaltrials.gov.). 
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Figure 6.1: Chemical structure of the lipid A species extracted from E. coli 
(diphosphoryl lipid A 1, monophosphoryl lipid A 2) and MPL® from S. Minnesota 3. 
 
Given these preliminary remarks, the research of new, efficient 
immunomodulators has increased in the last years, not only in terms of 
purification, structural characterization and biological evaluation of lipid 
A species from wild-type or engineered bacterial extracts (Molinaro et al. 
2015; Choma et al. 2017; Silipo et al. 2014; Casillo et al. 2017; Di 
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Lorenzo et al. 2017; Needhama et al. 2013; Carillo et al. 2011), but also 
of total chemical synthesis of suitably designed lipid A structures (Gao et 
al. 2017) including conjugates between lipid A and Tumor-associated 
carbohydrate antigens (TACAs) (Liao et al 2016; Zhou et al. 2015; Liao 
et al 2015; Wang et al 2012) or mimics thereof (Peri et al. 2014). 
Nonetheless, both approaches suffer some problems: in the former case 
they are mainly related to the difficulties of obtaining highly pure lipid A 
samples, due to frequent contamination with other biomolecules, such as 
glycerophospholipids. On the other hand, the total synthetic approach 
requires long and complex procedures with a high number of chemical 
steps, which hamper an application on a large scale. A third approach 
has recently emerged. It is based on semi-synthetic strategies, that 
combine the advantages of fermentative and scalable processes affording 
complex natural products in high quantity with the development of site-
selective chemical reactions modifying these structures. (Pieretti et al. 
2014) Indeed, the research of an optimized fed-batch 
fermentation/phenol-free purification procedure for the gram scale 
production of lipid A 1 from Escherichia coli K4 (Pieretti et al. 2014), 
and site-selective manipulations of its structure (D’Alonzo et al. 2016) 
represent an emerging, alternative and smart strategy for the obtainment 
of novel semisynthetic lipid A immunoadjuvant candidates. 
 
6.1 Isolation, purification and compositional analysis of  
lipid A from E. coli  K4 fermentation 
 
Lipid As are typically isolated in milligram quantities from bacterial cells 
through LPS extraction followed by selective hydrolysis of the labile 
glycosidic bond generally linking the lipid A moiety from the rest of the 
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LPS macromolecule. In alternative, during this PhD work, a successful 
protocol for the gram-scale production of 1 was repeated several times. 
To this aim, the first step is focused on a fed- batch fermentation process 
that overproduces LPS. One of the most common fermentation 
strategies used to reach high cell density cultivations is the dissolved-
oxygen (DO)-stat method. This strategy is based on the evidence that the 
concentration of dissolved oxygen increases rapidly when all the 
substrate in the medium is consumed; therefore, it allows to rapidly 
respond to the microorganisms metabolic needs avoiding the 
accumulation of toxic byproducts and addressing the metabolism 
towards the product of interest, also reducing production costs (Shay et 
al. 1987). This strategy was previously exploited on small-scale 
bioreactors for the fermentation of the recombinant E. coli K4/ EcK4r3 
strain (Cimini et al. 2013) and then repeated successfully on a pilot scale 
(90 L). The LPS material was generally collected from the fermentation 
broth through centrifugation and protease digestion followed by 
concentration/diafiltration and ultrafiltration purification steps. Selective 
cleavage of the 3-deoxy-octulosonic acid glycosidic bond linking lipid A 
and inner core in the LPS was then exploited by mild acid hydrolysis to 
give lipid A as a pellet from the crude mixture. From the chemical 
derivatization of a small aliquot of this material to fatty acid methyl esters 
(FAMEs, for the analysis of lipids) and peracetylated methyl O-glycosides 
(for the analysis of carbohydrates) followed by GC-MS analysis, it was 
possible to reveal the presence of several contaminants together with 
lipid A. Indeed, together with the expected 12:0, 14:0, and 14:0 (3-OH) 
FAMEs, 16:0 and 18:1 FAME lipid chains, which are typical constituents 
of glycerophospholipids from bacterial membranes (Oursel et al. 2007), 
were also detected. Saccharide contaminants were found too, as 
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indicated by the presence of several monosaccharide peaks in the GC 
chromatogram (Figure 6.2). Glucose (Glc), galactose (Gal), heptose, 
ribose, and quinovosamine (QuiN) could be associated to the presence 
in the pellet of residual E. coli K4 LPS and/or O-chain and core 
fragments thereof (MacLean and Perry 1997). E. coli K4 capsular 
polysaccharide and/or fragments thereof are also detected, by the peaks 
of 2-amino-2-deoxy-galactose (GalN) and glucuronic acid (GlcA) the two 
monosaccharide constituents of the chondroitin backbone of the E. coli 
K4 capsular polysaccharide (Rodriguez et al. 1988; Bedini et al. 2011). 
  
 
 
Figure 6.2: GC-MS analysis of crude lipid A from E. coli HCl hydrolysis step. 
 
As GC-MS analysis revealed, further purification of the lipid A material 
was mandatory. Most of the saccharide contaminants were eliminated in 
two purification steps, by filtrating over Celite pad and then selectively 
precipitating the lipid A in a 3:1 v/v methanol-chloroform mixture at a 3 
g/L concentration. In this way, the precipitate was enriched in the lipid A 
species, whereas the supernatant fraction (SF) contained 
glycerophospholipids and a minor quantity of lipid A. The latter could 
be recovered in turn by reiterating the precipitation process. The 
MALDI-TOF mass spectrometry analysis (Figure 6.3) of purified lipid A 
could confirm its structure, including a natural heterogeneity in the lipid 
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portion. Indeed, the most intense signal (1797.18 m/z) could be 
attributed to the major hexa-acylated species. The less intense signal at 
1360.47 m/z could be associated to a minor species lacking the C14:0 (3-
OH) chain at position O-3 of GlcN II, whereas the very small peak at 
1587.19 m/z to another minor species lacking only the C14:0 one. 
 
 
Figure 6.3: MALDI-TOF mass spectrum (negative ions mode) of lipid A 1. 
 
6.2 Selective de-O-phosphorylation of lipid A 
 
It is well-known that diphosphorylated and highly acylated lipid As, such 
as the major hexa-acylated species from Escherichia coli (1, Figure 6.1), 
are generally optimally recognized by TLR4,7 but their clinical use is 
precluded due to high toxicity. However, their strong inflammatory 
activity can be significantly reduced by removing the anomeric phosphate 
group. With E. coli diphosphoryl lipid A 1 in hands, the subsequent step 
was the regioselective cleavage of the phosphate group at the anomeric 
position of GlcN I, in order to weaken the endotoxic activity of the lipid 
A. The reaction conditions had to be mild enough not only to 
differentiate between the two phosphate groups but also to avoid the 
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cleavage of other acid-labile bonds such as the glycosidic connection 
between the two GlcNs or the ester linkages. Furthermore, the cleavage 
of the phosphate group at the anomeric position of GlcN I had to be 
quantitative. All these constrains were necessary in order to avoid the 
production of non-natural structural heterogeneity in monophosphoryl 
lipid A. Among the several reaction conditions tested, TLC and 
MALDI-TOF mass spectrometry analysis revealed that, on a gram scale, 
a regioselective and quantitative de-O-phosphorylation without 
modification of the acylation pattern was achieved exclusively by treating 
lipid A 1 with aqueous HF. The regioselective cleavage of the phos- 
phate on the GlcN I over that at position O-4 on GlcN II was both 
explained with the well known higher reactivity of the anomeric position 
to the acidic hydrolysis conditions and the steric hindrance of the latter, 
due to the presence of a bulky acyloxy-acyl ester moiety at position O-3 
of GlcN II (Tirsoaga et al. 2007).  
 
6.3 Structural characterization and biological assays 
 
The obtained MPLA 2 was purified by silica-gel column chromatography 
using a suitably optimized gradient elution. Pure MPLA was then 
subjected to MALDI-TOF mass spectrometry analysis and two-
dimensional NMR (Ribeiro et al. 1999) characterization (Figures 6.4-6.5 
and Table 6.1). In particular, the presence of signals for both α- and β- 
configured anomeric CH of GlcN I (δH=4.95, δC=90.6 ppm and δH=4.31, 
δC=101.1 ppm, respectively) confirmed the lack of the anomeric 
phosphate group and the presence of a free hemiacetal moiety. 
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Figure 6.4: MALDI-TOF mass spectrum (negative ions mode) of MPLA 2. 
 
 
Figure 6.5: HSQC-DEPT (600MHz, 298 K, 4:1 v/v CDCl3-CD3OD) spectrum of 
MPLA 2. 
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Table 6.1: NMR characterization data of monophosphoryl lipid A 2. 
 
 
The endotoxic activity of monophosphoryl lipid A 2 was compared with 
the diphosphoryl lipid A 1 and the supernatant fraction (SF) contained 
glycerophospholipids, by profiling the cytokine production in vitro. An 
attenuated activity was detected for MPLA, which exhibited a behavior 
rather similar to the recently introduced immunomodulator 
monophosphoryl lipid A from Salmonella Minnesota R595 (MPL®) 3, 
whereas 1 showed higher cytokine production levels (Pieretti et al., 2014) 
(Figure 6.6). 
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Figure 6.6: Cytokine concentrations in tissue-culture supernatants of THP1 cells 
stimulated by increasing concentrations of SF, 1 and 2 (1 μg/mL panel A, C, E; 20 
μg/mL panel B, D, F). Significant differences between stimulations were shown (*p < 
0.05 vs O111:B4; #p < 0.05 vs MPLA). The experiments were performed in triplicates 
and data were shown as means ± standard error.  
 
6.4 Conclusions 
 
In conclusion, monophosphoryl lipid A 2 with weakened endotoxic 
activity was obtained from an optimized fed-batch fermentation of E. coli 
K4, followed by a gram-scale, phenol-free extraction protocol suitably 
developed for the purification of lipid A from the fermentation broth, 
and then by a regioselective de-O-phosphorylation. The sequence of 
downstream steps for the obtainment of pure monophosphoryl lipid A 2 
from the fermentation broth is depicted in Figure 6.7.  
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Figure 6.7: Sequence of purification and chemical transformation steps from the 
fermentation broth to pure monophosphryl lipid A 2. 
 
The scalability of this combined fermentative-chemical approach allowed 
the obtainment of MPLA 2 in large amount and consequently its 
employment as a scaffold for the semi-synthesis of several potential 
immunostimulating lipid As and derivatives thereof through few tailored 
chemical modifications (see following chapters). 
 
6.5 Experimental section 
 
6.5.1 Fermentation of E. coli K4/EcK4r3 
 The wild-type strain was CCUG 11307 and the strain has been 
engineered as reported (Cimini et al. 2013). Fed-batch experiments were 
carried out in the laboratories of Prof. Schiraldi at the University of 
Campania “L. Vanvitelli” in a Biostat D100 reactor with a working 
volume of 90 L, connected to a DCU and a remote control unit. The 
standard medium used for fermenter production studies consisted of a 
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defined salt medium (KH2PO4 2 g/L; K2HPO4 9.7 g/L; Na3C6H5O7 0.5 
g/L; (NH4)2SO4 1 g/L; MgCl2 0.1 g/L) supplemented with glucose (10 g/L) 
as the main carbon source and yeast extract (2 g/L). A constant pH of 7.5 
was maintained via automated addition of 30% (v/v) NH4OH and 30% 
(v/v) H2SO4. Fed-batch experiments on a 90-L reactor started 
immediately after depletion of the carbon source in the medium, after 
approximately 6–7 h of batch growth. During the fed-batch phase, an 
exponential feeding strategy or a! dissolved oxygen (DO)-stat method was 
applied. In both cases, the substrate concentration was maintained within 
a desired range by the addition of an established amount of glucose/yeast 
extract feeding solution when the DO value increased up to 30%. The 
concentrated feeding solution contained 350 g/L of glucose, 70 g/L of 
yeast extract, and inorganic salts according to the medium recipe. For the 
duration of all cultivations, 5-mL samples were withdrawn from the 
reactors at regular time intervals for the determination of biomass, 
substrates, extracellular metabolites, and LPS concentration. 
Quantification of the LPS was performed by capillary electrophoresis on 
a Beckman Coulter high-performance capillary electrophoresis 
instrument (P/ACE MDQ, Palo Alto, CA, USA) equipped with a diode 
array detector and a UV lamp, according to recently described method 
(Restaino et al. 2009).  
 
6.5.2 Purification of lipid A  
The fermentation broth was centrifuged at 9,000g in a continuous 
centrifuge (Clara 80, Alpha Laval). The supernatant was first subjected to 
a treatment with protease and subsequently to concentration/diafiltration 
steps on a tangential filtration system (Sartoflow alpha, Sartorius Stedim). 
Composite polyethersulfone (PES) ultrafiltration membranes (Fluxa 
Filtri) with nominal molecular mass cutoffs of 100 kDa were used in 
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order to remove low molecular mass contaminants and to reduce the 
volume of about 8–10-fold. The concentrated sample was then heated at 
90°C for 2 h after acidification with HCl at pH 2.75 ± 0.05. At the end of 
the hydrolysis process, centrifugation was carried out to recover the 
pellet containing the lipid A and separate it from the supernatant. The 
pellet (67 g) was then extracted/washed with 96% ethanol at 50°C for 30 
min three times. After drying at 40°C for 36 h, 58 g of material was 
obtained. A 2.50-g aliquot was suspended in 4:1v/v CHCl3-CH3OH (250 
mL) and passed through a short Celite column (approx. 40 cm3). Roto-
evaporation of the eluate gave a brownish powder (0.57 g) that was in 
turn dissolved in CHCl3 (50 mL) and then treated with CH3OH (150 
mL). After standing at −20°C overnight, the formation of a white 
precipitate was observed. It was collected by centrifugation (Eppendorf 
5804R) at 4°C (7600g, 20 min), then washed twice with CH3OH (50 mL). 
After drying under a vacuum, a white powder (0.21 g, 1.5% w/w global 
yield from the pellet) was obtained.  
 
6.5.3 Chemical derivatization for GC-MS analysis  
The sample (2.0 mg) was suspended in 1.25 M HCl solution in CH3OH 
(1.0 mL) and heated at 80°C overnight. Volatiles were then removed and 
the residue was dissolved in 1:1 v/v pyridine-acetic anhydride (100 μL). 
The solution was heated at 100°C for 30 min. Volatiles were then 
removed. The residue was dissolved in CHCl3 (1 mL) and washed three 
times with water. The organic phase, containing both sugars as per-O-
acetylated methyl O-glycoside derivatives and lipids as (3-O-acylated)-
fatty acid methyl esters, was collected, filtered, and concentrated to give a 
residue that was injected for the GC-MS analysis as acetone solution.  
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6.5.4 Mass spectrometry  
GC-MS analysis were performed with an Agilent Technologies 6850A 
gas chromatography apparatus equipped with a mass selective detector 
5973N and a Zebron ZB-5 capillary column (Phenomenex, 30 m×0.25 
mm i.d., flow rate 1 mL/min, He as carrier gas). The samples were 
analyzed using the following temperature program: 150°C for 3 min, 
150→ 280°C at 3 °C/min. Matrix-assisted laser desorption ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) spectra were 
recorded on a Voyager DE STR instrument (Applied Biosystems, 
Framingham, MA) in the negative ions mode: compounds were 
dissolved in 4:1 v/v CHCl3-MeOH at a concentration of 0.1 mg/mL, and 
1 μL of these solutions were mixed with 1 μL of a 20 mg/mL solution of 
2,5- dihydroxybenzoic acid in 7:3 v/v CH3CN/H2O. 
 
6.5.5 De-O-phosphorylation of lipid A 1 to 2 
Lipid A 1 (1.00 g) was suspended in 48% w/w aqueous HF (50 mL). The 
mixture was stirred at 5°C for 48 h, then diluted with water (100 mL) and 
extracted three times with CHCl3 (150 mL). The organic phases were 
collected by centrifugation (Eppendorf 5804R) at 5°C (7600g, 20 min), 
then pooled, dried with anhydrous Na2SO4, filtered, and concentrated to 
give a residue that was dissolved in the minimum amount of 9:1 v/v 
CHCl3-CH3OH and charged on a Kieselgel 60 (63– 200 mesh; Merck) 
silica-gel column (approx. 90 cm3). Elution was performed with 9:1 v/v 
CHCl3-CH3OH (240 mL), 8:2 v/v CHCl3-CH3OH (50 mL), and 18:6:1 
v/v/v CHCl3-CH3OH-H2O (400 mL). The elution of the products was 
detected by analytical thin-layer chromatographies (TLCs) performed on 
aluminum plates precoated with Merck Silica Gel 60 F254 as the 
adsorbent and developed with 10% H2SO4 ethanolic solution and then 
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heated to 150°C. As the first eluted fraction, a mixture of glycerolipids 
was obtained (0.57 g) as a yellowish oil. As the second eluted fraction, 
pure lipid A 2 (0.20 g) was obtained as a white powder. 
 
6.5.6 NMR spectroscopy  
NMR spectra were recorded on a Bruker DRX-600 (1H 600 MHz, 13C 
150 MHz) instrument equipped with a cryoprobe, in 4:1 v/v CDCl3-
CD3OD (residual CHCl3 as internal standard, 1H δ 7.26 ppm; 13C δ 77.0 
ppm) at 298K. All two-dimensional homo and heteronuclear 
experiments (COSY, TOCSY, ROESY, and HSQC-DEPT) were 
performed by using standard pulse sequences available in the Bruker 
software. The mixing time for TOCSY and ROESY was 100 ms.  
 
6.5.7 Biological assays  
Biological activity of the obtained products was evaluated by stimulating 
the human monocytic leukemia cell line THP-1 (ATCC TIB-202). The 
enzyme-linked immunosorbent assay (ELISA) was selected as a specific 
and highly sensitive method for quantification of cytokine production, in 
vitro. In particular, monocytic THP-1 cells (LGC, Promochem, Milan, 
Italy) were grown in suspension in RPMI 1640 medium supplemented 
with 10 % fetal bovine serum at 37 °C in a humidified incubator with a 
5% CO2 atmosphere and stimulated with the 4:1 v/v CHCl3-MeOH 
supernatant fraction (SF), lipid A 1 and 2. LPS from E. coli O111:B4 
(Sigma, Milan, Italy) and monophosphoryl lipid A (MPLA) from 
Salmonella Minnesota R595 (Avanti Polar Lipids, Spectra 2000, Milan, 
Italy) were used as positive controls. Mabtech’s ELISAPRO kits and 
Enzo Life Science EIA Kit (BioRad, Milan, Italy) were used to quantify 
IL-6, IL-8, and TNF-α production in tissue-culture supernatants, 
following manufacturer’s instructions. 
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Chapter 7: Functionalization on the C-6 of GlcN II of 
E. coli  monophosphoryl lipid A 
 
The development of a protocol to access 2 in gram-scale quantities gave 
us the chance to use it as a synthetic building block, exploring its 
chemistry through the transformations conceived in Figure 7.1. 
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Figure 7.1: Structural modifications planned on MPLA from E. coli (2). 
 
Notably, despite the number of approaches leading to 2 and its 
congeners, even in large scale (Holst et al. 1993; Pieretti et al. 2014; 
Coler et al. 2011), to our knowledge, no systematic investigation of their 
reactivity has been performed so far. This is partly due to the difficulties 
in obtaining considerable amounts of lipid A compounds in high purity. 
In addition, the structural peculiarity of all lipid A derivatives (highly 
polar molecules with amphiphilic character having both base- and acid-
labile functionalities) renders their manipulation a challenging topic. A 
first look at lipid A reactivity was provided on the hydroxyl at C-6 of 
GlcN II (Figure 7.1). The modification of the lipid A scaffold at this 
position was attractive not only for the expected higher reactivity of such 
primary alcohol with respect to the secondary hydroxyls, but also 
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because it could be biologically well-tolerated. Indeed, lipid A derivatives 
and the core part of LOSs or LPSs are linked together through a 
glycosidic bond between GlcN II O-6 atom and the anomeric carbon of 
a 2-keto-octonic acid (3- deoxy-D-manno-2-octulosonic acid, Kdo or, 
much more rarely, D-glycero-D-talo-2-octulosonic acid, Ko). 
 
7.1 Site-selective chemical reactions 
 
To insert a chemical handle that would be easily and orthogonally 
derivatizable with respect to the other structural moieties present on lipid 
A, we attempted the installation of an azide or olefinic functionality on 2 
under several different conditions. By esterification with 6-azido-
hexanoic acid (Grandjean et al. 2005) in the presence of TBTU and 
Hünig’s base (Twibanire et al. 2011), a sluggish conversion was detected. 
Instead, the reaction with 6-azido-hexanoic anhydride (Montanez et al. 
2011) in the presence of 2,4,6-collidine and catalytic 4-(N,N-
dimethylamino)pyridine (DMAP) in CHCl3 (Yoshida et al. 2010) gave 
no reaction at all. No result was obtained also in the case of TMSOTf-
catalyzed etherification with allyl N-phenyl trifluoroacetimidate 
(Tsabedze et al. 2013)	 (Scheme 7.1). 
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Scheme 7.1: First attempts to derivatize the primary hydroxyl group of MPLA 2. 
 
The lower nucleophilicity of the C-6 hydroxyl prompted us to transform 
it into a different functionality. Its oxidation to the corresponding 
aldehyde by treatment with 2-iodoxybenzoic acid (IBX) in	 dimethyl 
sulfoxide (DMSO) (Zhdankin et al. 2011) was tested, but no reaction was 
observed. Eventually, 2 was treated with 2,2,6,6-tetramethylpiperidine-1-
oxyl (TEMPO) and	 NaOCl under phase-transfer conditions (NaBr,
NaHCO3, TBAB, 2:1 v/v CH2Cl2/H2O), followed by one-pot oxidation of 
the aldehyde with NaClO2 (Huang et al. 2006). Underthese conditions, 
a quantitative transformation of thestarting material into a more polar 
product could be observed by TLC. MALDI-MS analysis suggested the 
oxidation of a single hydroxyl to carboxylic acid, accompanied by a 
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partial loss of the C14:0(3-OH) lipid chain at position 3 of GlcNAc I, 
that is known to be the most base-labile (Myers et al. 1990) (m/z 
1730.28 and 1752.15 forthe major hexa-acylated species and its sodium 
salt, respectively; m/z 1504.39 and 1526.27 for the minor de-O-acylated 
counterpart and its sodium salt, respectively. (Figure 7.2A). 
 
 
Figure 7.2 : A) MALDI-TOF mass spectrum (negative ions mode) of pure 4; B) 1H and 
HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-CD3OD) of pure 4. 
A"
B"
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a 1H (600 MHz, 298K) and 13C (125 MHz, 298K) chemical shifts (in plain and in italic, respectively) expressed in δ relative to residual CHCl3 (1H: δ 7.26 ppm; 13C: δ 77.0 ppm) in 4:1 v/v CDCl3-CD3OD. 
b 31P (160 MHz, 298K) chemical shifts expressed in δ relative to 85% phosphoric acid (external standard). !
Table 7.1: NMR data referred to lipid A derivative 4 (major hexa-acylated specie) 
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From the full NMR characterization of the major hexa-acylated oxidized 
derivative by 2D-techniques (COSY, TOCSY, HSQC- DEPT and 
HMBC) (Figure 7.2B; Table 7.1), it emerged that GlcN II CH2OH 
signals were missing with respect to NMR data of starting lipid A 2 
(Figure 6.4 and Table 6.1), whereas the GlcN I anomeric CH signal was 
still present. This allowed the assignment of structure 4 to the oxidized 
lipid A derivative, with the GlcN II primary alcohol transformed into a 
carboxylic acid and the GlcN I hemiacetal moiety unaffected. 
Interestingly, the carboxylic acid function at position C-5 of GlcN II 
could not only serve as a suitable moiety for further derivatizations, but 
also adds a further negative charge to the molecule, similarly to lipid A- 
Kdo structures, that have been demonstrated to induce stronger immune 
responses than their parent lipid A (Zhang et al. 2008; Zughaier et al. 
2004; Yoshizaki et al. 2001). 
The lack of reactivity of the primary hydroxyl group of 2 to most of the 
reaction conditions mentioned above represented one of the major 
obstacles to the synthetic manipulation of 2 en route to novel lipid A 
derivatives. Although an unambiguous explanation for this unusual 
reactivity profile was not found, we hypothesized the existence of inverse 
micellar aggregates in organic solvents as a consequence of the 
amphiphilic nature of 2. Accordingly, the polar character of the hydroxyl 
group at the O-6 position of GlcN II as well as its proximity to the 
charged phosphate group could direct it inside the inverse micelle, thus 
impeding any interaction with reagents in solution. 
 
7.2 Insertion of a clickable moiety 
 
In order to insert a clickable moiety on lipid A structure, derivative 4 was 
treated with diverse amines carrying a suitable functionalization at their 
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!-position (double or triple bond, azide, S-trityl as protected thiol; see 5-
8, Scheme 7.2 and Table 7.2) (Ziaco et al., 2017). The first aim was to 
find the best conditions for the amide formation reaction using a model 
amine such as 4-penten-1-amine (Yazici et al., 2013). The coupling was 
tested under typical peptide coupling conditions, in the presence of a 
base [4-(dimethylamino)pyridine (DMAP), N,N-diisopropylethylamine 
(DIPEA) or 4-methylmorpholine (NMM)] and different kinds of 
carboxylic acid activators (El-Faham et al., 2011): i) a carbodiimide 
reagent such as N,N’-diisopropylcarbodiimide (DIPC), ii) a triazine 
activator such as 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT), iii) an 
uronium salt such as O-(benzotriazol-1-yl)-N,N,N’,N’-
tetramethyluronium tetrafluoroborate (TBTU), and iv) a phosphonium 
salt such as (benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate (PyBOP®), in some cases with a protic additive 
such as 1-hydroxybenzotriazole (HOBt).  
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Scheme 7.2: Insertion of a clickable moiety on E. coli monophosphoryl lipid A 4,  
(a) see Table 7.2 
 
A crucial issue for the optimization of the reaction conditions to 
transform derivative 4 into carboxyl amide 5 was to avoid, or at least to 
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minimize, the concomitant or even alternative amidation of the 
phosphate group. Indeed, studies pointed towards the synthesis of 
oligopeptides containing phosphotyrosine or its phosphonic analogue 
without preliminary protection of the phosphoric or phosphonic acid 
functionalities, revealed that such moieties can be activated under some 
standard carboxyl amide formation conditions. In particular, it was 
shown that carbodiimide-mediated reactions give amidation on both 
phosphoric and carboxylic acid of phosphotyrosine, whereas conditions 
employing uronium- or phosphonium-type reagents are selective for 
carboxylic acid derivatization, with the phosphoric/phosphonic moiety 
reacting more sluggishly (Perich 2004; Campagne et al. 1995). 
In order to investigate the behaviour of the carboxylic and phosphoric 
acid moiety of lipid A derivative 4, we firstly performed a MALDI mass 
spectrum (negative ions mode) of the crude reaction mixtures of 4 with 
4-penten-1-amine under different reaction conditions (Table 7.2, entries 
1-6). to find out signals of the desired 4-pentenyl amide derivative 5, the 
residual starting lipid A 4 and the potential byproducts due to 
concomitant activation of phosphate group too (see Figures 7.3-7.8). 
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Table 7.2 Amide formation reactions on lipid A derivative 4. 
a Isolated yield 
b As indicated by MALDI-MS (negative ions mode) analysis of the crude reaction mixture (see Figures 7.3-7.8) 
c See Figure 7.12 for the putative structure of byproducts. 
 
 
Figure 7.3: MALDI-TOF mass spectrum (negative ions mode) of the crude reaction 
mixture of Table 7.1, entry 1 (4 with 4-pentenyl-1-amine in the presence of DIPC and 
DMAP).  
Entry Amine 
Coupling 
conditions 
Solvent Product Yielda Phosphate activationb 
1 4-penten-1-amine DIPC, DMAP 
1:1 v/v 
DMF-CH2Cl2 
5 0% No 
2 4-penten-1-amine CDMT, NMM 
5:1 v/v 
THF-DMF 
5 39% Yes (byproduct 9)c 
3 4-penten-1-amine 
PyBOP®, HOBt, 
DIPEA 
1:1 v/v 
DMF-CH2Cl2 
5 69% 
Yes 
(byproduct 10a or 10b)c 
4 4-penten-1-amine 
PyBOP®, HOBt, 
H2O, DIPEA 
1:1 v/v 
DMF-CH2Cl2 
5 82 % 
Yes 
(byproduct 10a or 10b)c 
5 4-penten-1-amine TBTU, DIPEA 
1:1 v/v 
DMF-CH2Cl2 
5 68% 
Traces 
(byproduct 10a or 10b)c 
6 4-penten-1-amine 
TBTU, HOBt, 
DIPEA 
1:1 v/v 
DMF-CH2Cl2 
5 82% No 
7 5-hexyn-1-amine 
TBTU, HOBt, 
DIPEA 
1:1 v/v 
DMF-CH2Cl2 
6 62% No 
8 
6-azido-hexan-1-
amine 
PyBOP®, HOBt, 
H2O, DIPEA 
1:1 v/v 
DMF-CH2Cl2 
7 35% 
Yes 
(byproduct 11a or 11b)c 
9 
5-(tritylthio)-
pentan-1-amine 
PyBOP®, HOBt, 
H2O, DIPEA 
1:1 v/v 
DMF-CH2Cl2 
8 83% 
Traces 
(byproduct 12a or 12b)c 
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Figure 7.4: MALDI-TOF mass spectrum (negative ions mode) of the crude reaction 
mixture of Table 7.1, entry 2 (4 with 4-pentenyl-1-amine in the presence of CDMT and 
NMM). 
 
Figure 7.5: MALDI-TOF mass spectrum (negative ions mode) of the crude reaction 
mixture of Table 7.1, entry 3(4 with 4-pentenyl-1-amine in the presence of PyBOP®, 
HOBt, and DIPEA). 
 
Figure 7.6: MALDI-TOF mass spectrum (negative ions mode) of the crude reaction 
mixture of Table 7.1, entry 4(4 with 4-pentenyl-1-amine in the presence of PyBOP®, 
HOBt, H2O and DIPEA). 
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Figure 7.7: MALDI-TOF mass spectrum (negative ions mode) of the crude reaction 
mixture of Table 7.1, entry 5 (4 with 4-pentenyl-1-amine in the presence of TBTU and 
DIPEA). 
 
Figure 7.8: MALDI-TOF mass spectrum (negative ions mode) of the crude reaction 
mixture of Table 7.1, entry 6(4 with 4-pentenyl-1-amine in the presence of TBTU, 
HOBt and DIPEA). 
 
A carbodiimide reagent such as DIPC in combination with DMAP did 
not give any type of activation on the lipid A (entry 1, Figure 7.3), 
whereas uronium-, phosphonium- and triazine-type activators did it. 
Indeed, in the presence of a base such as NMM, CDMT activated both 
carboxylic and phosphoric acid moieties of 4 (entry 2, Figure 7.4), 
affording, as major hexa-acylated species, the desired product 5 (Figure 
7.9a, m/z 1797.31 for [M-H]-) and related minor species with a higher or 
lower number of methylenes in the lipid portion, together with the 
putative phosphotriazine ester byproduct 9 (Figure 7.12) (m/z 1936.34 
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for [M-H]-) and the residual starting compound 4 (m/z 1730.24 for [M-
H]- and related minor species as indicated for 5).  !
 
Figure 7.9: MALDI-TOF mass spectrum (negative ions mode) of the crude reaction 
mixture of 4 with 4-pentenyl-1-amine in the presence of (a) CDMT and NMM or (b) 
PyBOP®, HOBt and DIPEA (Table 7.1, entries 2 and 3, respectively; zoom on hexa-
acylated species).  
 
Purification of the crude reaction mixture was possible through gel 
filtration chromatography on a Sephadex® LH-20 column, affording the 
target double bond-equipped lipid A 5 in 39% yield (Figure 7.10).  
The covalent linkage of the 4-pentenyl moiety on the lipid A through a 
carboxyamide instead of a phosphoramide bond was confirmed by 
correlations of both GlcN II CH-5 ("H/C 3.65/72.1 ppm) and 4-pentenoyl 
amide #-CH2N ("H/C 3.12/38.2 ppm) signals with the same carboxyamide 
density ("C 170.2 ppm) in the heteronuclear multiple bond correlation 
(HMBC) NMR spectrum (Figure 7.11). 
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Figure 7.10: MALDI-TOF mass spectrum (negative ions mode) of pure 5. 
Figure 7.11: HSQC-DEPT (red and black) and HMBC (grey) NMR spectra (600 MHz, 
298K, 4:1 v/v CDCl3-CD3OD) of pure 5. 
 
The coupling of 4 and 4-penten-1-amine under PyBOP® activation in the 
presence of HOBt and DIPEA (entry 3, Figure 7.5) gave again a reaction 
on both carboxylic and phosphoric moieties. The desired lipid A 5 was 
isolated in 69% yield from residual starting material and a byproduct 
showing a peak at m/z 1914.34 (and at ±14.02 or 28.03 m/z, indicating 
minor species with a higher or lower number of methylenes in the lipid 
portion; Figure 7.9b) by means of a chromatography on Sephadex® LH-
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20. The structure of the byproduct was tentatively associated to a lipid A 
with a phosphate diester moiety (Figure 7.12, 10a). Indeed, 
benzotriazolyl phosphoesters have been shown to originate in some cases 
from activation of a phosphoric acid functionality in the presence of 
uronium and phosphonium reagents. They do not react further in the 
presence of amine nucleophiles, while activated carboxylic acids do it. 
Since phosphonic acid benzotriazolyl esters are analogously known to be 
poorly reactive with amines, but very prone to react with alcohol and 
water (Campagne et al. 1995), we tested the coupling between 4 and 4-
penten-1-amine under the PyBOP®/HOBt/DIPEA conditions with the 
addition of water, in order to hydrolyze in situ the putative phosphoric 
acid benzotriazolyl ester upon formation (Figure 7.6). An enhancement 
of yield from 69% to 82% was observed (Table 7.1, entries 3 and 4). 
Interestingly, by treating the crude reaction mixture of entry 3 with 
DIPEA and water in 1:1 v/v DMF-CH2Cl2, hydrolysis of byproduct 10 
was not observed by MALDI-MS analysis (data not shown). This 
suggested that the benzotriazolyl ester 10a had rearranged during the 
course of the coupling reaction into the more stable phosphoramidate 
10b (Figure 7.12) (Musiol et al. 1994). 
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10a or 10b: R = CH CH2
11a or 11b: R = CH2CH2CH2N3
12a or 12b: R = CH2CH2SC(Ph)3
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Figure 7.12: Putative structure for the byproducts obtained from phosphate activation 
of 4 under carboxyl amide formation reactions (see Table 7.1) 
 
A switch from a phosphonium- to an uronium-type activator such as 
TBTU afforded almost exclusively activation at carboxylic site with only 
trace amounts of 10a/10b (Table 7.1, entry 5; see also Figure 7.7). 
Nonetheless, the isolated yield of 5 was not excellent (68%), due to a 
significant amount of residual starting compound 4. By adding a protic 
additive to the reaction mixture, the yield could be increased to 82% 
(entry 6, Figure 7.8). After having detected PyBOP® and TBTU as the 
best coupling reagent under appropriate conditions (entries 4 and 6, 
respectively), these were employed to install clickable functionalities 
other than a double bond on lipid A 4. By reaction with 5-hexyn-1-amine 
(Saito et al., 2008) and 6-azido-hexan-1-amine (Lee et al. 2001), triple 
bond- and azide-equipped lipid A derivatives 6 and 7 could be obtained 
(entries 7 and 8, Figures 7.13-7.16; Table 7.1). A tritylthio moiety, as 
thiol group precursor, was also installed on 4 by reaction with 5-
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(tritylthio)-pentan-1-amine (Jagadish et al. 2012) to afford derivative 8 in 
83% yield (entry 9, Figures 7.17-7.18). 
 
Figure 7.13: MALDI-TOF mass spectrum (negative ions mode) of pure 6. 
 
 
Figure 7.14: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of pure 6. 
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Figure 7.15: MALDI-TOF mass spectrum (negative ions mode) of pure 7. 
 
Figure 7.16: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of pure 7. 
 
 
Figure 7.17: MALDI-TOF mass spectrum (negative ions mode) of pure 8. 
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Figure 7.18: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of pure 8. 
 
The obtained four novel clickable lipid A derivatives were completely 
characterized by NMR spectroscopic analysis (See Table 7.3). 
The production of these clickable lipid A derivatives opens a 
straightforward access to their conjugation with other interesting 
biomolecules, such as tumor-associated carbohydrate antigens (TACAs). 
This methodology stands as a valuable alternative to recently reported 
total synthetic approaches, based on highly complex syntheses of lipid As 
carrying at anomeric position of their pseudo-reducing end a suitable 
moiety for conjugation with TACA antigens (Liao et al. 2015/2016; Zhou 
et al. 2014/2015; Wang et al. 2009/2012; Tang et al. 2010).  
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! Sugar!portiona!!!!!!!!!!!!!!!!!1!!!!!!!!!!!!!!!2!!!!!!!!!!!!!!!!3!!!!!!!!!!!!!!!!!4!!!!!!!!!!!!!!!!5!!!!!!!!!!!!!!!!!!6! Lipid!portiona!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!C=O!!!!!!!!!!!!!!!!!!!!!!!!!!!             !!!!!!!!!!!!!!!"!!!!!!!!!!!!!!!!!!!!!!!!!!#!!!!!!!!!!!!!!!!!$7(%71)!!!!!!!!!!!!!!!!!!!!!!%! Other!signalsa! Phosphateb!
5"
GlcN!I!(!)! !4.95!90.5%
%
%
%
%4.00!
51.3%!
%
%4.99!
72.8%
%
%
%3.37!
67.7%!
%
%3.73!
72.8!
%
%3.72,!3.98!
67.1%
C14:0(37OH)![N72!GlcN!I]! 777!171.3% 2.08,!2.18!42.8% 3.75!68.0% 1.30!36.7% !!1.0971.18!
22.0%
29.0%
31.4%
0.7170.75!
13.5!
!!
$7pentenoyl!amide:!!
!:!3.12/38.2!
":!1.48/24.4!
#:!1.94/30.7!
$:!5.65/136.8!
&:!4.80,!4.91/114.5!
713.4!
C14:0(37OH)![O73!GlcN!I]! 777!171.1% 2.24,!2.35!41.7% 3.83!67.8% 1.37!36.7!GlcN!I!(")! !4.38!100.7% !4.82!74.6% !3.61!72.4! !3.74,!3.92!68.3%
C14:0(37OR)![N72!GlcN!II]! 777!171.2% 2.22,!2.33!40.7% 4.96!70.6% 1.39!33.5!C14:0(37OR)![O73!GlcNII]! 777!170.4% 2.42,!2.50!38.7% 5.05!69.8% 1.46!33.5!GlcN!II! 4.46!100.8% 3.79!53.3% 4.87!73.6% 3.52!69.3% 3.65!72.1% 777!170.2% C12:0! 777!173.7% 2.14!34.1% 1.45!24.5% 1.0971.18!22.0,%29.0,%31.4!C14:0! 777!173.6%
6"
GlcN!I!(!)! 5.35!93.1% 4.06!51.3% 5.05!73.4% 3.38!67.9% 3.74!73.9% 3.76,!3.90!67.1%
C14:0(37OH)![N72!GlcN!I]! 777!170.8% 2.09,!2.17!43.1% 3.75!68.2% 1.30!36.7% !!1.0971.18!
22.0%
29.0%
31.4! 0.7170.75!13.5%
!!!
&7hexynoyl!amide:!!
!:!3.08/38.5;!":!1.53/27.8!
#:!1.42/24.9;!$:!2.07/17.2;!
&:!777/83.4;!':!1.88/68.4!!!!
71.8!
C14:0(37OH)![O73!GlcN!I]! 777!170.0% 2.27,!2.36!41.9% 3.84!67.8% 1.34!36.7%C14:0(37OR)![N72!GlcN!II]! 777!170.8% 2.21,!2.33!40.7% 4.97!70.5% 1.41!33.7%
GlcN!II! 4.47!100.8% 3.77!52.8% 4.90!73.9% 3.55!70.2% 3.67!72.4% 777!170.2%
C14:0(37OR)![O73!GlcNII]! 777!170.2% 2.44,!2.51!38.6% 5.07!69.9% 1.44!33.7%C12:0! 777!173.7% 2.16!
33.9%
1.46!
24.5%
1.0971.18!
22.0,%29.0,%31.4!C14:0! 777!173.6%
7"
GlcN!I!(!)! 5.43!93.8% 4.05!51.6% 5.01!72.7% 3.44!67.7% 3.90!72.7% 3.73,!3.94!67.0%
C14:0(37OH)![N72!GlcN!I]! 777!170.3% 2.10,!2.20!42.9% 3.86!68.0% 1.29!36.6% !!1.0971.18!
22.0%
29.0%
31.4%
0.7170.75!
13.5!
!!!
'7azido7hexanoyl!amide:!!
!:!3.15/38.6;!":!1.48/28.4!
#:!1.27/26.0;!$:!1.27/26.0!
&:!1.82/25.6;!':!3.18/46.9!!!!
73.3!
C14:0(37OH)![O73!GlcN!I]! 777!170.3% 2.27,!2.38!41.8% 3.86!67.8% 1.36!36.6%C14:0(37OR)![N72!GlcN!II]! 777!171.5% 2.23,!2.34!40.6% 4.98!70.5% 1.43!33.6%
GlcN!II! 4.46!100.6% 3.80!52.5% 4.88!73.5% 3.56!70.2% 3.67!72.4% 777!169.5%
C14:0(37OR)![O73!GlcNII]! 777!170.4% 2.45,!2.52!38.5% 5.08!69.8% 1.46!33.6%C12:0! 777!173.7% 2.16!
34.1%
1.47!
24.6%
1.0971.18!
22.0,%29.0,%31.4!C14:0! 777!173.7%
8"
GlcN!I!(!)! 5.51!94.6% 4.14!51.0% 5.05!73.1% 3.36!68.0% 4.08!72.8% 3.73,!3.93!68.3%
C14:0(37OH)![N72!GlcN!I]! 777!171.6% 2.24,!2.34!42.6% 3.75!68.0% 1.28!36.8% !!1.0971.18!
22.0%
29.0%
31.4%
0.7170.75!
13.5!
&!7(tritylthio)7pentanoyl!amide:!
!:!3.01/38.6;!":!1.71/25.9!
#:!1.29/25.2;!$:!1.45/24.6!
&:!2.01/31.2!!Aromatics:!7.06/125.8;!7.13/127.1%7.26/128.9;!777/144.9%
CPh3:!777/66.3!
73.2!!
C14:0(37OH)![O73!GlcN!I]! 777!172.4! 2.27,!2.36!42.0% 3.85!67.9% 1.36!36.8%C14:0(37OR)![N72!GlcN!II]! 777!172.2! 2.27,!2.34!40.7% 5.00!70.6% 1.46!33.7!
GlcN!II! 4.52!101.0% 3.83!52.4% 4.87!73.7% 3.50!70.4% 3.64!72.8% 777!169.6%
C14:0(37OR)![O73!GlcNII]! 777!170.8! 2.44,!2.51!38.6% 5.07!69.8% 1.44!33.8%C12:0! 777!173.8! 2.15!
34.0%
1.46!
24.6%
1.0971.18!
22.0,%29.0,%31.4!C14:0! 777!174.0!
Table 7.3: NMR data referred to lipid A derivatives 5-8 (major hexa-acylated species) 
a!1H!(600!MHz,!298K)!and!13C!(150!MHz,!298K)!chemical!shifts!(in!plain!and!in!italic,!respectively)!expressed!in!δ!relative!to!residual!CHCl3!(1H:!δ!7.26!ppm;!13C:!δ!77.0!ppm)!in!4:1!v/v!CDCl37CD3OD.!
b!31P!(160!MHz,!298K)!chemical!shifts!expressed!in!δ!relative!to!85%!phosphoric!acid!(external!standard).!!
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7.3 Semi-synthetic “self-adjuvant” anticancer vaccine 
candidates 
 
TACAs are useful targets for the development of therapeutic cancer 
vaccines, but they are typically poorly immunogenic and T-cell 
independent antigens. To make them more immunogenic and T-cell 
dependent antigens, they have to be covalently linked to immunologically 
active carrier molecules to form conjugate vaccines. In recent years, fully 
synthetic TACA-based conjugate cancer vaccines have become a hot 
topic, because they possess a number of advantages, such as defined 
structures, reproducible physical, chemical and biological properties, and 
promising immunologic activity (Danishefsky et al. 2000; Guo et al. 
2009; Chen et al. 2013; Kaiser et al. 2010). For the development of “self-
adjuvant” synthetic cancer vaccine, MPLA can be a particularly useful 
carrier molecule. First, MPLA is a strong immunostimulator. Second, 
owing to its bacterial origin, MPLA can function as a “danger signal” to 
the immune system to enhance the immune responses to TACAs 
covalently linked to it (Buskas et al. 2005). Third, as mentioned before, 
the endotoxicity of lipid A could be dramatically reduced after removal 
of its anomeric phosphate group, whereas its beneficial 
immunostimulatory activity was unaffected. In reality, MPLA has been 
approved for clinical use as a vaccine adjuvant and immunostimulator 
(Casella et al. 2008). 
To probe the potential of MPLA as a carrier molecule for the 
development of self-adjuvant conjugate cancer vaccines, Guo and co- 
workers designed and synthesized a monophosphoryl derivative of N. 
meningitidis lipid A, which had lipid chains symmetrically distributed on 
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the two sugar units, coupled with a modified form of ganglioside 
monosialic acid (GM3), NPhAcGM3 13 (Figure 7.19).  
GM3 is a trisaccharide TACA, Neu5Acα(2→3)Galpβ(1→4)Glcp, with a 
Neu5Ac residue attached to the nonreducing end (Hakomori et al., 
1991; Hakomori et al., 1997). It exists in gangliosides or glycoproteins 
with the lipid tails or peptide chains inserting into cell membranes, and 
the trisaccharide is displayed on the cell surface, where it can be 
recognized by antibodies. GM3 is abundantly expressed on a number of 
tumors (Bitton et al., 2002), especially malignant melanoma. 
 
 
Figure 7.19: Chemical structure of the synthetic N. meningitidis MPLA–NPhAcGM3 
conjugate. 
 
Immunological studies of 13 in mice revealed that it alone, namely 
without the use of an external adjuvant, elicited robust IgG antibody 
responses. The results have demonstrated that MPLA could act not only 
as a carrier molecule to significantly improve the immunogenicity of 
TACAs but also as a built-in adjuvant to form self-adjuvanting vaccines 
(Wang et al. 2012; Pan et al. 2005). Therefore, MPLA was identified as 
a highly promising carrier for the design and development of synthetic 
self-adjuvant glycoconjugate cancer vaccines.  
Guo and Co-workers have also developed a convergent and synthetic 
strategy, for a monophosphorylated N. meningitidis lipid A derivative 
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coupled with globo H, a TACA expressed by several tumors (14, Figure 
7.20) (Zhou et al. 2015). 
 
 
Figure 7.20: Chemical structure of the synthetic N. meningitidis MPLA-globo H 
conjugate 14 and the KLH-globo H conjugate 15. 
 
It was evaluated in mouse and compared with the Keyhole Limpet 
Hemocyanin (KLH) conjugate of globo H 15, as the positive control, 
which is at Phase III clinical trial for the treatment of colon cancer. It was 
discovered that MPLA-globo H conjugate 14 elicited much faster and 
stronger immune responses than that of the KLH conjugate 15, in terms 
of both total and IgG antibodies. It was demonstrated that both 14 and 
15 induced the similar patterns of immune responses. These results 
suggested the great promise of MPLA-TACA conjugates as therapeutic 
cancer vaccines. These two examples, fully synthesized by Guo and co-
workers,  suggested that the introduction of unique functional groups, 
such as an azido or alkyne group, to MPLA can provide the flexibility for 
its regioselective coupling with TACAs or other biomolecules, such as 
carbohydrates, peptides, and proteins, to quickly generate complex 
multicomponent conjugates in a convergent manner for the development 
of synthetic self-adjuvant anticancer glyco-conjugate vaccines.  
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To this aim, we performed the synthesis of two different TACA antigens, 
in order to achieve two novel semi-synthetic self-adjuvant anticancer 
glyco-conjugates following a different strategy for the coupling. Indeed, in 
all the Guo’s total synthetic conjugates the TACA antigens were 
conjugated to the lipid A scaffold through a linker placed at the 
pseudoreducing anomeric site of GlcN I, whereas in our semi-synthetic 
approach the conjugation site was the C-6 atom of GlcN II. The strategy 
described in this thesis should be more biologically well-tolerated, 
because intact LPS and LOS structures always show this GlcN II C-6 
position involved in a linkage with the anomeric carbon of a carboxylic 
acid containing sugar residue such as Kdo or, more rarely, Ko.  
To demonstrate the feasibility of this approach, a first attempt was 
carried out through a thiol-ene coupling (Dondoni et al. 2008) of 5 with 
an amino acid. Indeed, by irradiation of the mixture of 5 and Fmoc-
cysteine at !=366 nm in 1:1 v/v DMF/CH2Cl2 in the presence of 2,2-
dimethoxy-2-phenylacetophenone (DPAP) as photo-initiator (Fiore et al. 
2009) and after mild basic treatment, the conjugate 17 was obtained as 
sole product in 53% (over two steps) yield after extensive 
chromatographic purification (Scheme 7.3) and then fully characterized 
by MALDI-TOF mass spectrometry and 2D-NMR spectroscopy. 
 
 
 
 
 
 
 
Scheme 7.3: Coupling of clickable lipid A 5 with Fmoc-cysteine to give derivative 17 
after Fmoc deprotection. 
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7.3.1 E. coli  MPLA – Tn antigen conjugate 
 
Another common feature of tumours is the overexpression of truncated 
O!glycans. The GalNAc!type O!glycans, also called mucintype 
O!glycans, are frequently found in most transmembrane and secreted 
glycoproteins. During malignancy, aberrant glycosylation also occurs in 
glycoproteins that display abnormal expression of shortened or truncated 
glycans, such as the disaccharide Thomsen–Friedenreich antigen (T 
antigen) and the monosaccharide GalNAc (also known as Tn) and their 
sialylated forms (ST and STn (Neu5Acα2!6GalNAcα!O!R), 
respectively), which result from the incomplete synthesis of O!glycans 
(Kudelka et al., 2015). For the first coupling of 5 with a TACA, Tn 
antigen –the structurally most simple TACA- was selected. To this end, 
the "-allyl glycoside of 2-acetamido-2-deoxy-D-galactopyranose (GalNAc) 
was suitably synthesized, starting from commercially available GlcNAc, 
to give compound 21 (Feng et al. 2004) the allyl aglycone was then 
converted into a 3-thioacetyl-propyl group to give 22, which was then 
treated with ammonium hydroxide to afford 23 (Scheme 7.4).  
 
 
 
 
 
 
 
 
 
 
Scheme 7.4: Synthesis of the Tn antigen derivative 23. 
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Coupling of 5 and crude 23 under the photochemical reaction 
conditions described above furnished conjugate 24 after extensive 
chromatographic purification (Scheme 7.5).  
Notably, compound 24 represents the first example of a lipid A-TACA 
derivative, as self-adjuvant anticancer vaccine candidate, obtained by 
conjugation at the C-6 of GlcN II instead of C-1 of GlcN I (Zhou et al. 
2014; Zhou et al. 2015; Tang et al. 2010). MALDI-TOF mass spectrum 
and full NMR characterization of the major hexa-acylated species 
confirmed its structure (Figures 7.21-7.22; Table 7.4). 
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Scheme 7.5: Coupling of clickable lipid A 5 with Tn Antigen derivative 23 to give 
compound 24. 
 
 
Figure 7.21: MALDI-TOF mass spectrum (negative ions mode) of pure 24. 
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Figure 7.22: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of pure 24. 
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!
! a!1H!(600!MHz,!298K)!and!13C!(125!MHz,!298K)!chemical!shifts!(in!plain!and!in!italic,!respectively)!expressed!in!δ!relative!to!residual!CHCl3!(1H:!δ!7.26!ppm;!13C:!δ!77.0!ppm)!!in!4:1!v/v!CDCl3MCD3OD.!! b!31P!(160!MHz,!298K)!chemical!shifts!expressed!in!δ!relative!to!85%!phosphoric!acid!(external!standard).!
 
 
 
! Sugar!portiona!!!!!!!!!!!!!!!!!!!!!!!!!!1!!!!!!!!!!!!!!2!!!!!!!!!!!!3!!!!!!!!!!!!!!!4!!!!!!!!!!!!!!5!!!!!!!!!!!6!!!! Lipid!portiona!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"!!!!!!!!!!!!!!!!!!!!#!!!!!!!!!!!!!!!$M(%M1)!!!!!!!!!!%! Other!signalsa! Phosphateb!
!
!
!
!
!
!
24!
!
!
!
!GlcN!I!(!)! !5.43!93.8! !4.03!51.3! !5.03!73.0! !3.38!67.9! !3.91!72.4! !3.51!69.7! C14:0(3MOH)![NM2!GlcN!I]! 2.12,!2.21!42.9! 3.76!68.5! 1.28!37.0! !!!1.08M1.16!
29.3!
!!!!!0.71M0.75!
13.5!
!5MSMPentanoyl!amide!!
!:!3.14/38.4;!":!1.45/24.5;!!
#:!1.31/25.0;!$:!1.48/28.6;!!
&:!2.40/31.7!!SCH2CH2CH2O:!2.65/35.6!SCH2CH2CH2O:!1.86/28.2!SCH2CH2CH2O:!3.37,!3.67/66.3!!!
!!!!!M1.7!
C14:0(3MOH)![OM3!GlcN!I]! 2.26,!2.36!42.0! 3.85!68.6! 1.30!37.0!!GlcN!II! !4.54!100.7! !3.80!52.8! !4.88!73.6! !3.56!70.4! !3.68!72.5! !MMM!169.8! C14:0(3MOR)![NM2!GlcN!II]! 2.26,!2.36!41.2! 4.98!70.7! 1.43!33.8!C14:0(3MOR)![OM3!GlcNII]! 2.45,!2.52!39.1! 5.08!69.8! 1.45!33.8!!GalNAc!(!)! !4.69!97.0! !4.14!49.8! !3.59!68.9! !3.82!68.6! !3.66!70.0! !3.67!61.3! C12:0!! !2.15!34.4! !1.44!24.5! !1.08M1.16!29.3!C14:0!!
Table 7.4: NMR data referred to lipid A derivative 24 (major hexa-acylated specie) 
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7.3.2 E. coli  MPLA – TF antigen conjugate 
 
In order to obtain our second self-adjuvant anticancer vaccine candidate, 
a TF antigen derivative equipped with a thiolated aglycone (37, Scheme 
7.6) was firstly synthesized from known galactosyl donor 28 (Ivanova et 
al., 1999) and 2-azido-galactosyl acceptor 31 (Bedini et al., 2012). Their 
glycosylation by catalytic trimethylsiliyl trifluoromethanesulfonate 
(TMSOTf) activation of the trichloroacetimidate leaving group of 28, 
furnished !-linked disaccharide 32 in good yield (84%). The !-
stereoselectivity was proven by NMR (3JH1H2) and allowed through an 
anchimeric assistance of the benzoyl group on the C-2. Azide reduction 
with Zn/Cu couple in 1:1 v/v tetrahydrofuran (THF)-acetic acid (AcOH), 
followed by N-acetylation afforded 33 (52% over two steps), that was in 
turn subjected to benzylidene acetal hydrolysis in 9:1 v/v AcOH-H2O at 
50°C to afford 34 in 95% yield.  
The sequence of protecting groups removal was completed by Zémplen 
transesterification of Bz esters to afford deprotected disaccharide 35 
(98%), carrying an allyl aglycone that was converted in a 3-thiopropyl 
group in two steps. Firstly, by irradiation of a mixture of 35 and 
thioacetic acid at "=366 nm in 2:1 v/v DMF-CH2Cl2 in the presence of 
2,2-dimethoxy-2-phenylacetophenone (DPAP) as photoinitiator (Fiore et 
al., 2009; Dondoni et al., 2009), a thiol-ene reaction converted the allyl 
aglycone into a 3-thioacetyl-propyl one (36, 35%; 69% based on reacted 
35). The latter was then subjected to thioester hydrolysis under mild 
alkaline conditions (7% aq. NH4OH in DMF), to avoid dimerization of 
the resulting thiol to disulfide.  
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Scheme 7.6: Synthesis of TF antigen derivative 37. 
 
The thiolated TF antigen (37) was not purified, but immediately used for 
a further thiol-ene coupling with lipid A derivative 5 to furnish conjugate 
38 (27%) after extensive purification (Scheme 7.7). MALDI-MS 
spectrum and full NMR characterization of the major hexa-acylated 
species confirmed its structure (Figures 7.23-7.24; Table 7.5). 
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Scheme 7.7: Coupling of clickable lipid A 5 with TF Antigen derivative 37 to give 
compound 38. 
 
Figure 7.23: MALDI-TOF mass spectrum (negative ions mode) of pure 38. 
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Figure 7.24: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of pure 38. 
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!
!
!
!
a!1H!(600!MHz,!298K)!and!13C!(150!MHz,!298K)!chemical!shifts!(in!plain!and!in!italic,!respectively)!expressed!in!δ!relative!to!residual!CHCl3!(1H:!δ!7.26!ppm;!13C:!δ!77.0!ppm)!!in!4:1!v/v!CDCl3MCD3OD.!
b!31P!(160!MHz,!298K)!chemical!shifts!expressed!in!δ!relative!to!85%!phosphoric!acid!(external!standard).!
 
 
! Sugar!portiona!!!!!!!!!!!!!!!!!!!!!1!!!!!!!!!!!!2!!!!!!!!!!!!!!3!!!!!!!!!!!4!!!!!!!!!!!!!!!5!!!!!!!!!!!!6!!!! Lipid!portiona!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!C=O!!!!!!!!!!!!!         "!!!!!!!!!!!!!!!!!!!!!!#!!!!!!!!!!!!!!!!!!!!!$M(%M1)!!!!!!!!!!!!!!!!!!!!!%! Other!signalsa! Phosphateb!
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!!1.09M1.18!
22.0!
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M0.9!
C14:0(3MOH)![OM3!GlcN!I]!
MMM!
170.1! 2.25,!2.36!
41.9!
3.84!
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1.29,!1.34!
36.6!
GlcN!II! 4.47!100.9! 3.66!53.1! 4.87!73.7! 3.77!68.4! 3.65!72.4! MMM!169.5!
C14:0(3MOR)![NM2!GlcN!II]!
MMM!
170.4! 2.21,!2.32!
40.5!
4.96!
70.6!
1.41!
33.7!
C14:0(3MOR)![OM3!GlcNII]!
MMM!
170.1! 2.44,!2.52!
38.5!
5.06!
69.8!
1.45!
33.7!
GalNAc! 4.73!97.2! 4.31!48.3! 3.70!77.6! 4.03!68.0! 3.34!74.9! 3.58,!3.64!61.0! C12:0!
MMM!
173.3! !2.15!
33.9!
!1.45!
24.4!
!1.09M1.18!
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174.2!Gal! 4.21!104.2! 3.39!70.8! 3.33!73.0! 3.72!69.4! 3.44!75.0! 3.83!62.2! !
Table 7.5: NMR data referred to lipid A derivative 38 (major hexa-acylated specie) 
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7.4 Biological assays 
 
A panel of immunological assays, on the bone marrow-derived 
macrophages (BMDMs) and THP-1 cells, incubated with ours lipid A 
derivatives 4 – 7, 17, 24, 38, E.coli Monophosphoryl lipid A (2) and 
Salmonella Minnesota MPL® (3) obtained by extraction in our 
laboratory,  together with commercially available E. coli LPS and S. 
Minnesota MPL® 3, were performed, in the laboratories of Prof. Gamian 
at the “L. Hirszfeld” Institute of Immunology and Experimental Therapy 
in Poland, in order to assess their cytotoxicity and immunostimulatory 
activity. Since one of the mechanisms of action of immunoadjuvants is to 
create a local pro-inflammatory environment, the ability of our 
compounds to modulate monocytes and macrophages for cytokine 
production was tested. Activation of macrophages is essential for 
induction of adaptive immune responses. Increased expression of MHC 
class II, activation marker CD86, and maturation marker CD83 leads to 
enhanced ability of antigen presenting cells to induce T lymphocyte 
activation and differentiation. When BMDMs were incubated with the 
lipid A derivatives, we observed very low level of induction of MHC class 
II and costimulatory molecules CD40, CD80, and CD86. Expression 
levels of these molecules were similar to levels in untreated controls and 
substantially lower than those induced by LPS or 3 (data not shown). 
However, BMDMs co-cultured for 6, 24, 48 and 72 h with the tested 
lipid A compounds were found to induce pro-inflammatory cytokines in 
comparison to untreated controls. Among the semi-synthetic lipid As, 
derivatives 4-6 and 38 influenced high level of interleukin-6 (IL-6) 
(Figure 7.25A). Most importantly, 6 induced significantly higher levels of 
IL-6 than 3. We observed that almost all tested compounds induced 
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TNF-! production, however 38 showed minimal statistically non-
significant cytokine induction. It is worth noting that 4, 6, and 24 induced 
higher levels of TNF-! than 3 (Figure 7.25B). Both cytokines were 
detected from 6 hours after stimulation onward and increased thereafter. 
All tested derivatives induced neither the production of IL-2, -4, -5, -10, -
12, interferon gamma (IFN-"), nor granulocyte macrophage colony-
stimulating factor (GM-CSF) in BMDMs (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.25: Cytokine IL-6 (A) and TNF-! (B) concentrations in tissue-culture 
supernatants of BMDM cells stimulated with lipid A derivatives (20 µg/mL). Pooled 
results from three independent experiments are shown. Data are means ± standard 
deviation (SD) (* P<0.05, ** p<0.005, ***P<0.001, **** P<0.0001). 
 
In supernatants collected from THP-1 cells (human monocytic cell line 
derived from an acute monocytic leukemia patients) cultured with semi-
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synthetic lipid A derivatives, the cytokine production patterns appeared 
to be stimulus-dependent, and we observed increased production of IL-
8, IL-6, TNF-!, IL-10, and IFN-". In general, all the tested compounds 
stimulated THP-1 cells to produce large amounts of IL-8 (Figure 7.26A) 
and low level of IL-10, but with highest up-regulation than 3 (Figure 
7.26B). Compounds 4-7, and 38 notably increased the level of TNF-! 
(Figure 7.26C) compared to control. Moreover, after stimulation with 4, 
5 and 24 a significant level of IL-6 was detected (Figure 7.26D). 
Remarkably, most of the tested compounds poorly induced IFN-" 
secretion (Figure 7.26E), with exceptions of those treated with 5, 24 and 
38, which induced significantly higher level of this cytokine compared to 
the control. 
 
 
A"
B"
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Figure 7.26: Cytokine IL-8 (A), IL-10 (B), IL-6 (C), TNF-! (D) and IFN-" (E) 
concentrations in tissue-culture supernatants of THP-1 cells stimulated with lipid A 
derivatives (20 µg/mL). Pooled results from three independent experiments are shown. 
Data are means ± SD (* P<0.05, ** p<0.005, ***P<0.001, **** P<0.0001). 
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Our study shows that some of the tested compounds are able to induce 
the production of pro-inflammatory cytokines at least on the same level 
as commercially available 3 (Powell et al. 1995), thus suggesting that they 
could act as immunostimulant by promoting the generation of a specific 
immune response. 
Vaccine delivery composition should include adjuvants for bolstering the 
immune response, but without the associated cytotoxicity. First and 
foremost, unacceptable side-effects and toxicity preclude the use of many 
adjuvant candidates, and this is particularly true for prophylactic vaccines 
where safety issues are paramount. The cytotoxic effect of the semi-
synthetic lipid A derivatives was examined by performing 
sulforhodamine B (SRB) assay. It is a colorimetric, nondestructive and 
indefinitely stable assay, widely used for assessing cell viability in 
chemosensitivity testing (Skehan et al. 1990). The cell lines, THP-1 and 
BMDM, were incubated with the tested compounds at different 
concentrations: 20, 10, 1 and 0.1 µg/mL. It can be noticed that all semi-
synthesized lipid A derivatives are non-toxic toward THP-1 cells (Figure 
7.27). However, results show that 5, 6, and 24 (20 µg/mL) are slightly 
toxic against BMDM with 5 showing the highest cytotoxicity effect 
(Figure 7.28). 
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Figure 7.27: Cytotoxic effect of semi-synthetic lipid A derivatives toward THP-1 cells. 
Pooled results from three independent experiments are shown. Data are means ± SD 
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Figure 7.28: Cytotoxic effect of semi-synthetic lipid A derivatives toward BMDM cells. 
Pooled results from three independent experiments are shown. Data are means ± SD. 
 
7.5 Multivalent Tn antigens conjugates - MPLA 
 
Following the idea to probe the potential of MPLA as a carrier molecule 
for the development of conjugate cancer vaccines, in the last part of the 
Ph.D. work, we started a collaboration with Prof. Renaudet, (Univ. 
Grenoble Alpes, CNRS, France). The group of Dumy and Renaudet 
have selected cyclopeptide carriers to construct multivalent synthetic 
vaccines (Grigalevicius et al. 2005). In particular, they focused their 
attention to the RAFT cyclodecapeptide platform (Regioselectively 
Addressable Functionalised Template) (Dumy et al. 1995; Dumy et al. 
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1996; Peluso et al. 2001) which is composed of two adjacent proline-
glycine as β-turn inducers that constrain the backbone conformation into 
an antiparallel β sheet. 
 
Figure 7.29: RAFT platform. 
 
Up to six lysine residues can be introduced in the decapeptide sequence, 
in positions 3-4-5-8-9 and 10. The resulting scaffold thus present two 
separate spatial domains where the Lys 3-5-8-10 are oriented in the 
upper plane, while the Lys 4-9 residues, where sometimes one of them is 
substituted by an Ala residue, delineate a second domain in the opposite 
plane (Figure 7.29).! The cyclic nature of such scaffolds offers an 
improved stability towards enzymatic degradation compared to linear 
analogues, which makes cyclopeptides attractive scaffolds for biological 
applications. Renaudet and co-workers have developed an R4(GalNAc)-
alkyne prototype by grafting four Tn antigen analogues as B-cell epitope, 
and a suitable alkyne-peptide for the coupling with our clickable Lipid A 
equipped with an azide moiety (7) as immuno-enhancing element, in 
order to increase and stimulate the T cell dependent response (the 
procedures for the coupling are still under investigation and they will not 
be showed in this thesis) (Figure 7.30). The native Tn antigen is depicted 
as a α-GalNAc unit linked to a Ser/Thr residue through a glycosidic 
bond. For synthetic considerations, Renaudet and Dumy have decided 
to introduce an oxyamine function on the anomeric carbon of the 
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αGalNAc unit to conjugate four copies of this Tn analogue on the upper 
side of the RAFT scaffold by oxime ligation (Ulrich et al. 2014).  
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Figure 7.30: RAFT Tn-scaffold and clickable Lipid A 7. 
 
Other structural modifications such as the presentation of a different 
display and/or higher density of carbohydrate epitopes, or combinations 
of different antigenic peptides or TACA glycopeptide mucin fragments 
represent interesting directions for future development towards 
immunological optimization (Pifferi et al. 2017). 
Altogether, this strategy opens interesting perspectives to employ the 
RAFT scaffold-MPLA platform in engineering potent immunogenic 
conjugates as vaccine candidates. Indeed, the modularity and versatility 
of both the molecular assembly of RAFT and the derivatization of 
MPLA to make it clickable as well as the efficiency of MPLA as T-helper 
cells adjuvant might be exploited to improve the immune response by 
!155!!
combining TACAs with immunoadjuvants in order to develop 
multicomponent therapeutic anti-cancer vaccines. 
 
7.6 Conclusions 
 
A development of a semi-synthetic strategy for the insertion of clickable 
moieties (azide, alkyne, double bond, and a thiol precursor) into 
monophosphoryl lipid A obtained from E. coli has been accomplished. 
The key step was the coupling between a lipid A derivative carrying a 
carboxylic acid moiety at C-6 position of GlcN II and suitably #-
functionalized amines. This reaction was carefully investigated in order 
to find the best conditions for the selective obtainment of carboxyl 
amides and avoid, or at least minimize, the concomitant phosphate 
group amidation. The production of clickable lipid A derivatives opens a 
straightforward access to their conjugation with other interesting 
biomolecules, as, for example, the TACAs. This methodology stands as 
a valuable alternative to recently reported total synthetic approaches, 
based on highly complex syntheses of lipid As carrying at anomeric 
position of their pseudoreducing end a suitable moiety for conjugation 
with TACA antigens (Liao et al. 2016). In order to demonstrate the 
feasibility of our approach, the thiol-equipped derivatives of Tn and TF 
antigens were synthesized and then conjugated with a clickable lipid A 
derivative carrying a double bond moiety through a UV-mediated thiol-
ene reaction, to give  two potential self-adjuvant anticancer vaccine 
candidates. A preliminary evaluation of the immunological activity of 
these lipid A-TACA antigen conjugates, as well as of other semi-
synthesized lipid A derivatives, including a Cys-appended lipid A 
derivative, was performed (Ziaco et al., 2017). It was shown that they 
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ameliorated production of proinflammatory cytokines IL-6, TNF-!, and 
IFN-", which are crucial in the process of activating immune cells and 
fighting infection. The tested derivatives also induce chemokine CXCL8 
(IL-8) which provokes neutrophile migration to the site of infection, and 
immunoregulatory cytokine IL-10, an important B-cell differentiation 
factor, thus highlighting the promising immunobiological applications. As 
it is stated above, the mechanism of action of the examined lipid A 
derivatives is complex, but only such a versatile immunostimulation can 
give a therapeutic effect. Additionally, the described compounds exhibit 
very low toxicity which could facilitate their use in vaccines and give them 
an advantage over the currently used adjuvants. However, further 
experiments to evaluate these concepts are needed. Following this 
strategy, a collaboration with Prof. Renaudet has been started, in order to 
develop the first! RAFT scaffold-MPLA conjugates as potent multivalent 
immunogenic vaccine candidates. 
 
7.7 Experimental section 
 
7.7.1 Lipid A derivative 4 
A solution of 2 (183 mg, 106 µmol) in CH2Cl2 (2.42 mL) was cooled to 
0°C and then treated with H2O (415 mL), 2,2,6,6-tetramethyl-1-
piperidinyloxy free radical (TEMPO, 10.7 mg, 68.5 µmol), 1M aqueous 
NaBr (60 µL), 1M aqueous Bu4NBr (120 µL), 1M aqueous NaHCO3 
(300 µL) and finally with an aqueous solution of NaOCl (365 µL, 
minimum 4% chlorine content). The biphasic mixture was stirred at RT 
for 1 h, then it was neutralized by addition of 1M aqueous HCl. tBuOH 
(1.69 mL), a 2M solution of 2-methylbut-2-ene in THF (3.42 mL), and a 
solution of NaClO2 (122 mg, 1.35 mmol) and NaH2PO4 (93.8 mg, 782 
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mmol) in H2O (320 µL) were successively added. After 3 h stirring at 
RT, the mixture was diluted with sat. aq. NaH2PO4 (15 mL) and 
extracted with CHCl3 (20 mL). The organic phase was collected, dried 
over anhydrous Na2SO4, filtered and concentrated to give 4. For NMR 
data see Figure 7.2B and Table 7.1. MALDI TOF-HRMS for 
C94H175N2O23P (major hexa-acylated specie) (m/z): Mr (calcd) 1731,23, Mr 
(found) 1730.28 (M-H)- (Figure 7.2A). 
 
7.7.2 Lipid A derivative 5 
Procedure A (see Table 7.2, entry 2): Compound 4 (25.0 mg, 14.5 
µmol) was treated under argon atmosphere at 0°C with a solution of 
CDMT (5.6 mg, 32 µmol) in THF (0.5 mL), and then with a solution of 
NMM (3.50 µL, 32 µmol) in THF (35 µL). After stirring at 0°C for 7 
hours, a solution of 4-pentene-1-amine (2.7 mg, 31.8 µmol) in THF (0.2 
mL) was added and the suspension was stirred at rt overnight. The 
reaction mixture was then diluted with CHCl3 (2 mL) and washed with 
H2O (2 mL). The organic phase was collected, dried over anhydrous 
Na2SO4, filtered and concentrated. The residue was subjected to gel 
filtration chromatography on Sephadex® LH-20 (CHCl3/MeOH, 3:2 v/v) 
to afford 5 (10.2 mg, 39%) as a yellowish oil.  
Procedure B (see Table 7.2, entries 3 and 4): Compound 4 (20.0 mg, 
11.6 µmol) was treated under argon atmosphere with a solution of 
PyBOP®, (7.2 mg, 14 µmol) and HOBt (1.9 mg, 14 µmol) in 1:1 v/v 
DMF-CH2Cl2 (0.6 mL) and then a solution of 4-pentene-1-amine (3.0 
mg, 35 µmol) in 1:1 v/v DMF-CH2Cl2 (0.6 mL) was added. In the case of 
reaction of entry 4, H2O (2.0 µL, 111 µmol) was also added. Finally, the 
mixture was treated with DIPEA (9.0 µL, 51 µmol) and stirred at rt for 3 
hours. The reaction mixture was then diluted with CHCl3 (2 mL) and 
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washed with 0.1 M HCl (2 mL). The organic phase was collected, dried 
over anhydrous Na2SO4, filtered and concentrated. The residue was 
subjected to gel filtration chromatography on Sephadex® LH-20 
(CHCl3/MeOH, 3:2 v/v) to afford 5 (14.4 mg, 69% for entry 3, 17.0 mg, 
82% for entry 4) as a white amorphous solid. Procedure C (see Table 
7.2, entry 5 and 6): Compound 4 (20.0 mg, 11.6 µmol) was treated 
under argon atmosphere with a solution of TBTU (4.6 mg, 14 µmol) 
[also containing HOBt (1.9 mg, 14 µmol) in the case of reaction of entry 
6] in 1:1 v/v DMF-CH2Cl2 (0.6 mL) and then a solution of 4-pentene-1-
amine (3.0 mg, 35 µmol) in 1:1 v/v DMF-CH2Cl2 (0.6 mL) was 
subsequently added. Finally, the solution was treated with DIPEA (9.0 
µL, 51 µmol) and stirred at rt for 3 hours. The reaction mixture was then 
diluted with CHCl3 (2 mL) and washed with 0.1 M HCl (2 mL). The 
organic phase was collected, dried over anhydrous Na2SO4, filtered and 
concentrated. The residue was subjected to gel filtration chromatography 
on Sephadex® LH-20 (CHCl3/MeOH, 3:2 v/v) to afford 5 (14.0 mg, 68% 
for entry 5, 17.1 mg, 82% for entry 6) as a yellowish oil. For NMR data 
see Figure 7.11 and Table 7.3. MALDI TOF-HRMS for C99H184N3O22P 
(major hexa-acylated species) (m/z): Mr (calcd) 1798.3109, Mr (found) 
1797.3089 (M-H)-  (Figure 7.10). 
 
7.7.3 Lipid A derivative 6 
Compound 4 (20.0 mg, 11.6 µmol) was treated under argon atmosphere 
with a solution of TBTU (4.6 mg, 14 µmol) and HOBt (1.9 mg, 14 
µmol) in 1:1 v/v DMF-CH2Cl2 (0.6 mL) and then a solution of 5-hexyn-1-
amine (3.4 mg, 35 µmol) in 1:1 v/v DMF-CH2Cl2 (0.6 mL) was 
subsequently added. Finally, the mixture was treated with DIPEA (9.0 
µL, 51 µmol) and stirred at rt for 3 hours. The reaction mixture was then 
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diluted with CHCl3 (2 mL) and washed with 0.1 M HCl (2 mL). The 
organic phase was collected, dried over anhydrous Na2SO4, filtered and 
concentrated. The residue was subjected to gel filtration chromatography 
on Sephadex® LH-20 (CHCl3/MeOH, 3:2 v/v) to afford 6 (13.1 mg, 62%) 
as a yellowish oil. For NMR data see Figure 7.14 and Table 7.3. MALDI 
TOF-HRMS for C100H184N3O22P (major hexa-acylated species) (m/z): Mr 
(calcd) 1810.3109, Mr (found) 1809.3092 (M-H)- (Figure 7.13). 
 
7.7.4 Lipid A derivative 7 
Compound 4 (15.0 mg, 8.67 µmol) was treated under argon atmosphere 
with a solution of PyBOP® (5.4 mg, 11 µmol) and HOBt (1.4 mg, 11 
µmol) in 1:1 v/v DMF-CH2Cl2 (0.6 mL) and then a solution of 6-azido-
hexan-1-amine (3.7 mg, 26 µmol) and H2O (1.5 µL, 84 µmol) in 1:1 v/v 
DMF-CH2Cl2 (0.6 mL) was added. Finally, the mixture was treated with 
DIPEA (6.8 µL, 39 µmol) and stirred at rt for 3 hours. The reaction 
mixture was then diluted with CHCl3 (2 mL) and washed with 0.1 M HCl 
(2 mL). The organic phase was collected, dried over anhydrous Na2SO4, 
filtered and concentrated. The residue was subjected to gel filtration 
chromatography on Sephadex® LH-20 (CHCl3/MeOH, 3:2 v/v) to afford 
7 (5.6 mg, 35%) as a yellowish oil. For NMR data see Figure 7.16 and 
Table 7.3. MALDI TOF-HRMS for C100H187N6O22P (major hexa-acylated 
species) (m/z): Mr (calcd) 1855.3436, Mr (found) 1854.3333 (M-H)- 
(Figure 7.15). 
 
7.7.5 Lipid A derivative 8 
Compound 4 (20.0 mg, 11.6 µmol) was treated under argon atmosphere 
with a solution of PyBOP® (7.2 mg, 14 µmol) and HOBt (1.9 mg, 14 
µmol) in 1:1 v/v DMF-CH2Cl2 (0.6 mL) and then a solution of 5-
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(tritylthio)pentan-1-amine (12.6 mg, 34 µmol) and H2O (2.0 µL, 111 
µmol) in 1:1 v/v DMF-CH2Cl2 (0.6 mL) was added. Finally, the mixture 
was treated with DIPEA (9.0 µL, 51 µmol) and stirred at rt for 3 hours. 
The reaction mixture was then diluted with CHCl3 (2 mL) and washed 
with 0.1 M HCl (2 mL). The organic phase was collected, dried over 
anhydrous Na2SO4, filtered and concentrated. The residue was subjected 
to gel filtration chromatography on Sephadex® LH-20 (CHCl3/MeOH, 
3:2 v/v) to afford 8 (19.8 mg, 83%) as a white amorphous solid. For 
NMR data see Figure 7.18 and Table 7.3. MALDI TOF-HRMS for 
C118H200N3O22PS (major hexa-acylated species) (m/z): Mr (calcd) 
2074.4082, Mr (found) 2073.4060 (M-H)- (Figure 7.17). 
 
7.7.6 Lipid A derivative 17 
A mixture of 5 (20.2 mg, 11.2 µmol), Fmoc-cysteine (35.6 mg, 103 
µmol), and 2,2-dimethoxy-2-phenylacetophenone (DPAP; 2.7 mg, 10.3 
µmol) was dissolved in DMF/CH2Cl2 (500 µL, 1:1 v/v) under argon 
atmosphere. The solution was briefly degassed and then irradiated at 
$=366 nm for 1 h. The residue obtained after rotary evaporation was 
subjected to silica-gel column chromatography (CHCl3, then 
CHCl3/acetone, 9:1 to 7:3 v/v, then CHCl3/MeOH, 9:1 to 8:2 v/v, then 
CHCl3/MeOH/H2O, 18:6:1 v/v/v) to afford 16 (22.2 mg, 92%) as a 
slightly yellow amorphous solid. Compound 16 was dissolved in dry 
CH2Cl2 (400 µL), treated with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU; 
4 µL, 16.5 µmol) and stirred at rt for 30 minutes. The reaction mixture 
was neutralized with Dowex 50WX8 (H+ form) and then filtered and 
concentrated by rotary evaporation. The obtained residue was subjected 
to silica-gel column chromatography (CHCl3, then CHCl3/MeOH, 9:1 to 
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7:3 v/v, then CHCl3/MeOH/H2O, 18:6:1 v/v/v) to afford 17 (10.2 mg, 
53%) as a slightly yellow amorphous solid. 
 
 
7.7.7 3’-Thioacetyl-propyl 2-acetamido-2-deoxy-a-d-galactopyranoside 
(22) 
Allyl galactoside 21 (225 mg, 0.861 mmol) and DPAP (66.3 mg, 0.258 
mmol) were dissolved in DMF/CH2Cl2 (3.6 mL, 2:1 v/v) and then 
thioacetic acid (183 µL, 2.58 mmol) was added under argon atmosphere. 
The solution was briefly degassed and then irradiated at $=366 nm for 4 
h. The residue obtained after rotary evaporation was subjected to silica-
gel column chromatography (CHCl3/MeOH, 94:6 to 85:15 v/v) to afford, 
as first eluted fraction, 22 (123 mg, 42%) as a white powder. As second 
eluted fraction, unreacted 21 (106 mg, 0.406 mmol) was recovered as a 
white powder. Compound 22: [!]D=+146 (c=0.7, MeOH); 1H NMR (400 
MHz, D2O): %=4.91 (d, J 3.5 Hz, 1H; H-1), 4.18 (dd, J 10.9, 3.5 Hz, 1H; 
H-2), 4.01–3.77 (m, 6H; H-3, H-4, H-5, H-6a, H-6b, 
OCHHCH2CH2SAc), 3.51 (dt, J 10.2, 5.9Hz, 1H; OCHHCH2CH2SAc), 
3.02 (t, J 6.6 Hz, 2H; OCH2CH2CH2SAc), 2.40 (s, 3H; SCOCH3), 2.07 
(s, 3H; NCOCH3), 1.91 ppm (quintet, J 6.4 Hz, 2H; 
OCH2CH2CH2SAc); 13C NMR (100 MHz, D2O): %=174.4 (NCOCH3, 
SCOCH3), 96.8 (C-1), 70.7, 68.3, 67.6, 66.0, 61.0 (C-3, C-4, C-5, C-6, 
OCH2CH2CH2SAc), 49.8 (C-2), 29.8, 28.0, 25.5, 21.7 ppm (NCOCH3, 
OCH2CH2CH2SCOCH3). 
 
7.7.8 Lipid A derivative 24 
Compound 22 (76.0 mg, 0.226 mmol) was suspended under argon 
atmosphere in a previously degassed 4:1 v/v mixture of DMF and 
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aqueous 33% NH4OH (1.7 mL). After 3 h stirring at RT, the reaction 
mixture was neutralized with Dowex® 50WX8 (H+ form) and then 
filtered and concentrated by rotary evaporation. The residue was mixed 
with 5 (20.0 mg, 11.1 µmol) and DPAP (21.2 mg, 82.7 µmol) and then 
dissolved in DMF/CH2Cl2 (2.0 mL, 1:1 v/v) under argon atmosphere. 
The solution was briefly degassed and then irradiated at $=366 nm for 3 
h. The residue obtained after rotary evaporation was subjected to silica-
gel column chromatography (CHCl3, then CHCl3/acetone, 9:1 to 7:3 v/v, 
then CHCl3/MeOH, 98:2 to 7:3 v/v, then CHCl3/MeOH/H2O, 18:6:1 
v/v/v). The fractions containing the product were pooled, concentrated 
and the obtained residue was further purified on Sephadex® LH-20 
(CHCl3/MeOH, 3:2 v/v) to afford 24 (7.4 mg, 32%) as a white powder. 
For NMR data see Figure 7.22 and Table 7.4.  
 
7.7.9 Allyl 2,3,4,6-tetra-O-benzoyl-!-D-galactopyranosyl-(1→3)-2-azido-
4,6-O-benzylidene-2-deoxy-!-D-galactopyranoside (32) 
A mixture of 28 (1.14 g, 1.54 mmol) and 31 (0.284 mg, 0.850 mmol) was 
coevaporated three times with dry toluene (5 mL). The residue was 
dried, mixed with freshly activated AW-300 4Å molecular sieves, and 
then suspended under argon atmosphere in CH2Cl2 (10 mL) at 0°C. A 
0.84 M TMSOTf solution in CH2Cl2 (366 µL, 0.308 mmol) was then 
added. The mixture was stirred for 2 h at 0°C and then quenched by 
adding one drop of Et3N, filtered over a Celite pad, and concentrated. 
Silica-gel chromatography (4:1 to 2:1 v/v hexane–ethyl acetate) afforded 
32 (0.657 g, 85%) as a yellowish solid. [!]D +97 (c 0.8, CHCl3); 1H NMR 
(600 MHz, CDCl3): % 8.08 (d, 2H, J 7.1 Hz, Hortho Bz), 8.03 (d, 2H, J 7.6 
Hz, Hortho Bz), 8.01 (d, 2H, J 7.2 Hz, Hortho Bz), 7.80 (d, 2H, J 7.1 Hz, Hortho 
Bz), 7.58-7.25 (m, 17H, H-Ar), 5.99 (d, 1H, J 3.4 Hz, H-4B), 5.91 (dd, 
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1H, J 10.3, 7.9 Hz, H-2B), 5.87 (m, 1H, OCH2CH=CH2), 5.58 (dd, 1H, J 
10.3, 3.4 Hz, H-3B), 5.49 (s, 1H, OCHPh), 5.31 (dd, 1H, J 17.2, 1.6 Hz, 
trans OCH2CH=CHH), 5.22 (dd, 1H, J 10.4, 1.6 Hz, cis 
OCH2CH=CHH), 5.15 (d, 1H, J 7.9 Hz, H-1B), 5.01 (d, 1H, J 3.5 Hz, 
H-1A), 4.77 (m, 1H, H-5B), 4.46 (d, 1H, J 3.1 Hz, H-4A) 4.40 (m, 2H, H-
3A, H-6aB), 4.17-4.12 (m, 3H, H-6aA, H-6bB, OCHHCH=CH2), 4.02 (dd, 
1H, J 12.6, 5.6 Hz, OCHHCH=CH2), 3.83 (dd, 1H, J 10.7, 3.4 Hz, H-
2A), 3.73 (d, 1H, J 12.3 Hz, H-6bA), 3.50 (bs, 1H, H-5A); 13C NMR (100 
MHz, CDCl3): % 165.9-165.2 (4 CO Bz), 137.7-133.1 (Cipso, 
OCH2CH=CH2), 130.0-126.1 (C-Ar), 118.2 (OCH2CH=CH2), 103.0, 
100.6, 97.6 (C-1A, C-1B, OCHPh), 76.3, 76.0, 72.0, 71.6, 69.6, 68.9, 68.8, 
68.3, 63.1, 62.5, 58.7 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, C-6A, 
C-6B, OCH2CH=CH2). MALDI TOF-HRMS for C50H45N3O14 (m/z): Mr 
(calcd) 911.2902, Mr (found) 934.2811 (M+Na)+. Anal. Calcd: C, 65.86, 
H, 4.97, N, 4.61; Found: C, 65.78, H, 5.01, N, 4.59. 
 
7.7.10 Allyl 2,3,4,6-tetra-O-benzoyl-!-D-galactopyranosyl-(1→3)-2-
acetamido-2-deoxy-!-D-galactopyranoside (34) 
To a solution of 32 (0.657 g, 0.721 mmol) in THF (25 mL) and AcOH 
(25 mL), Zn/Cu alloy (1.97 g) was then added and the mixture was 
vigorously stirred at rt overnight. The mixture was then diluted with ethyl 
acetate (10 mL), filtered over a Celite pad, and concentrated. The 
residue was coevaporated two times with toluene (50 mL) then diluted 
with ethyl acetate (150 mL) and washed with a saturated NaHCO3 
aqueous solution (150 mL). The organic phase was collected, dried over 
anhydrous Na2SO4, filtered and concentrated. The residue was then 
dissolved in pyridine (3 mL) and treated with acetic anhydride (3 mL). 
The solution was stirred at rt overnight and then quenched by dilution 
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with CH2Cl2 (100 mL) and washing with 0.1M HCl (100 mL). The 
organic phase was collected, dried over anhydrous Na2SO4, filtered and 
concentrated. Silica-gel chromatography (3:1 to 1:3 v/v hexane–ethyl 
acetate) afforded 33 (0.349 g, 52% over two steps from 14) as a yellowish 
solid. 1H NMR (600 MHz, CDCl3): % 8.07 (d, 2H, J 7.3 Hz, Hortho Bz), 
8.00 (d, 2H, J 7.6 Hz, Hortho Bz), 7.95 (d, 2H, J 7.6 Hz, Hortho Bz), 7.78 (d, 
2H, J 7.7 Hz, Hortho Bz), 7.61-7.24 (m, 17H, H-Ar), 5.99 (d, 1H, J 3.4 Hz, 
H-4B), 5.83 (m, 2H, H-2B, OCH2CH=CH2), 5.60 (dd, 1H, J 10.1, 3.4 Hz, 
H-3B), 5.42 (d, 1H, J 8.0 Hz, NH), 5.39 (s, 1H, OCHPh), 5.25 (d, 1H, J 
17.4 Hz, trans OCH2CH=CHH), 5.18 (d, 1H, J 10.1 Hz, cis 
OCH2CH=CHH), 5.16 (d, 1H, J 7.8 Hz, H-1B), 5.11 (d, 1H, J 3.4 Hz, 
H-1A), 4.70 (dd, 1H, J 11.5, 6.8 Hz, H-6aB), 4.62 (m, 1H, H-5B), 4.46 (dd, 
1H, J 11.4, 5.5 Hz, H-2A), 4.40 (m, 2H, H-4A, H-6bB), 4.14 (m, 2H, H-
6aA, OCHHCH=CH2), 4.08 (dd, 1H, J 11.3, 3.4 Hz, H-3A), 3.98 (dd, 1H, 
J 13.1, 5.9 Hz, OCHHCH=CH2), 3.76 (d, 1H, J 11.7 Hz, H-6aB), 3.54 
(bs, 1H, H-5A), 1.41 (s, 3H, COCH3). MALDI TOF-HRMS for 
C52H49NO15 (m/z): Mr (calcd) 927.3102, Mr (found) 950.3008 (M+Na)+.  
A solution of 33 (0.349 g, 0.376 mmol) in 9:1 v/v AcOH–H2O (20 mL) 
was stirred at 50°C for 7h, then cooled to rt, concentrated and 
coevaporated two times with toluene (5 mL). Silica-gel chromatography 
(99:1 to 8:2 v/v CH2Cl2–MeOH) afforded 34 (0.300 g, 95% from 33) as a 
yellowish solid. [!]D +139 (c 0.4, CHCl3); 1H NMR (600 MHz, CDCl3): 
% 8.10 (d, 2H, J 8.1 Hz, Hortho Bz), 8.02 (d, 2H, J 8.2 Hz, Hortho Bz), 7.96 
(d, 2H, J 8.3 Hz, Hortho Bz), 7.75 (d, 2H, J 8.2 Hz, Hortho Bz), 7.66-7.23 (m, 
12H, H-Ar), 5.97 (d, 1H, J 3.2 Hz, H-4B), 5.83 (m, 2H, H-2B, 
OCH2CH=CH2), 5.58 (dd, 1H, J 10.4, 3.4 Hz, H-3B), 5.18 (m, 3H, H-1B, 
OCH2CH=CH2), 4.95 (d, 1H, J 7.9 Hz, NH), 4.89 (d, 1H, J 3.5 Hz, H-
1A), 4.56 (m, 3H, H-2A, H-5B, H-6aB), 4.38 (m, 1H, H-6bB), 4.18 (s, 1H, 
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H-4A), 4.10 (dd, 1H, J 12.7, 5.3 Hz, OCHHCH=CH2), 3.92 (dd, 1H, J 
12.7, 5.3 Hz, OCHHCH=CH2), 3.81 (dd, 1H, J 8.2, 2.0 Hz, H-6aA), 3.74 
(m, 2H, H-3A, H-5A), 3.52 (dd, 1H, J 8.2, 2.0 Hz, H-6bA), 1.30 (s, 3H, 
COCH3); 13C NMR (100 MHz, CDCl3): % 169.7 (COCH3), 166.1, 165.6, 
165.5, 164.7 (4 CO Bz), 133.8-133.4 (Cipso, OCH2CH=CH2), 130.1-128.3 
(C-Ar), 117.8 (OCH2CH=CH2), 102.0, 97.0 (C-1A, C-1B), 79.9, 72.1, 71.4, 
69.7, 69.3, 68.9, 68.4, 68.1, 62.7, 62.5 (C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, 
C-5B, C-6A, C-6B, OCH2CH=CH2), 47.7 (C-2A), 22.4 (COCH3). MALDI 
TOF-HRMS for C45H45NO15 (m/z): Mr (calcd) 839.2789, Mr (found) 
862.2700 (M+Na)+. Anal. Calcd: C, 64.36, H, 5.40, N, 1.67; Found: C, 
64.29, H, 5.44, N, 1.66. 
 
7.7.11 Allyl !-D-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-!-D-
galactopyranoside (35) 
A solution of 34 (0.330 g, 0.393 mmol) in dry CH3OH (11 mL) was 
treated with a 0.94 M methanolic solution of CH3ONa (2.1 mL, 2.0 
mmol). After 3 h stirring at rt, the solution was diluted with H2O (10 
mL), neutralized with Amberlist-15 (H+ form), concentrated and 
coevaporated two times with toluene (5 mL). Silica-gel chromatography 
(99:1 to 7:3 v/v CH2Cl2–MeOH) afforded 35 (0.163 g, 98%) as a white 
fluffy solid. [!]D +9.4 (c 1.3, H2O); 1H NMR (600 MHz, D2O): % 5.98 (m, 
1H, OCH2CH=CH2), 5.35 (dd, 1H, J 15.8, 1.5 Hz, trans 
OCH2CH=CHH), 5.26 (dd, 1H, J 10.4, 1.5 Hz, cis OCH2CH=CHH), 
4.94 (d, 1H, J 3.7 Hz, H-1A), 4.46 (d, 1H, J 7.7 Hz, H-1B), 4.24-3.35 (m, 
14H, H-2A, H-2B, H-3A, H-3B, H-4A, H-4B, H-5A, H-5B, H-6aA, H-6bA, H-
6aB, H-6bB, OCH2CH=CH2), 2.02 (s, 3H, NHCOCH3); 13C NMR (100 
MHz, D2O): % 174.6 (COCH3), 133.7 (OCH2CH=CH2), 117.9 
(OCH2CH=CH2), 104.7, 96.4 (C-1A, C-1B), 77.2, 75.0, 72.5, 70.6, 70.5, 
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68.7, 68.6, 68.4, 61.2, 61.0 (C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, C-6A, 
C-6B, OCH2CH=CH2), 48.6 (C-2A), 22.0 (COCH3). MALDI TOF-
HRMS for C17H29NO11 (m/z): Mr (calcd) 423.1741, Mr (found) 446.1629 
(M+Na)+. Anal. Calcd: C, 48.22, H, 6.90, N, 3.31; Found: C, 48.08, H, 
6.96, N, 3.28.  
 
7.7.12 3’-Thioacetyl-propyl &-D-galactopyranosyl-(1→3)-2-acetamido-2-
deoxy-!-D-galactopyranoside (36) 
Derivative 35 (0.190 g, 0.449 mmol) and DPAP (34.5 mg, 0.135 mmol) 
were dissolved in 2:1 v/v DMF–CH2Cl2 (1.8 mL) and then thioacetic acid 
(95.0 µL, 1.35 mmol) was added under argon atmosphere. The solution 
was briefly degassed and then irradiated at $=366 nm for 6 h. The 
residue obtained after rotoevaporation was subjected to a silica-gel 
column chromatography (7:3:0 to 7:3:0.3 v/v/v CH2Cl2–MeOH–H2O) to 
afford, as first eluted fraction, 36 (66.2 mg, 35%; 69% based on reacted 
35) as a yellowish powder and starting compound 35 (82.0 mg, 0.194 
mmol) as second eluted fraction. [!]D +19.6 (c 1.0, H2O); 1H NMR (600 
MHz, D2O): % 4.85 (d, 1H, J 3.0 Hz, H-1A), 4.44 (d, 1H, J 7.6 Hz, H-1B), 
4.30-3.47 (m, 14H, H-2A, H-2B, H-3A, H-3B, H-4A, H-4B, H-5A, H-5B, H-
6aA, H-6bA, H-6aB, H-6bB, OCH2CH2CH2S), 2.98 (m, 2H, 
OCH2CH2CH2S), 2.34 (s, 3H, SCOCH3), 2.00 (s, 3H, NHCOCH3), 1.87 
(m, 2H, OCH2CH2CH2S); 13C NMR (100 MHz, D2O): % 202.5 
(SCOCH3), 175.2 (NHCOCH3), 105.4, 97.8 (C-1A, C-1B), 77.9, 75.6, 
73.2, 71.3, 71.2, 69.4, 69.2, 66.8, 61.8, 61.6 (C-2B, C-3A, C-3B, C-4A, C-4B, 
C-5A, C-5B, C-6A, C-6B, OCH2CH2CH2S), 49.3 (C-2A), 30.7, 28.9, 26.4, 
22.7 (OCH2CH2CH2S, SCOCH3, NHCOCH3). MALDI TOF-HRMS 
for C19H33NO12S (m/z): Mr (calcd) 499.1723, Mr (found) 522.1609 
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(M+Na)+. Anal. Calcd: C, 45.68, H, 6.66, N, 2.80, S, 6.42; Found: C, 
45.49, H, 6.73, N, 2.76, S, 6.38. 
 
7.7.13 Lipid A derivative 38 
Compound 36 (30.0 mg, 60.1 µmol) was suspended under argon 
atmosphere in a previously degassed 4:1 v/v mixture of DMF and 
aqueous 33% NH4OH (1.0 mL). After 3 h stirring at rt, the reaction 
mixture was neutralized with Dowex® 50WX8 (H+ form), then filtered 
and concentrated by rotoevaporation. The residue was immediately 
mixed with 5 (13.0 mg, 7.23 µmol) and DPAP (1.9 mg, 7.3 µmol) and 
then dissolved in 1:1 v/v DMF–CH2Cl2 (2.0 mL) under argon 
atmosphere. The solution was briefly degassed and then irradiated at 
$=366 nm overnight. The residue obtained after rotoevaporation was 
subjected to column chromatography (CHCl3, then 9:1 to 7:3 v/v 
CHCl3/acetone, then 97:3 to 8:2 v/v CHCl3/MeOH, then 18:6:1 to 12:6:1 
v/v/v CHCl3/MeOH/H2O). The fractions containing the product were 
pooled, concentrated and the obtained residue was further purified by 
gel filtration chromatography to afford 38 (4.4 mg, 27%) as a white 
powder. For NMR data see Figure 7.24 and Table 7.5. MALDI TOF-
HRMS for C116H215N4O33PS (major hexa-acylated species) (m/z): Mr 
(calcd) 2255.4727, Mr (found) 2271.4939 (M+NH4+-2H)- (Figure 7.23). 
 
7.7.14 Cell lines and culture 
To evaluate the potential cytotoxicity and immunomodulatory effect of 
the semi-synthetic lipid A derivatives, the human monocytic leukemia 
cell line THP-1 and BMDMs from wild type of C57BL/6 mice were 
stimulated. BMDMs were a gift of dr. Jakub Siednienko (Siednienko et 
al. 2010), whereas THP-1 cell line (ATCC) was obtained from a cell 
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bank at the Ludwik Hirszfeld Institute of Immunology and Experimental 
Therapy, Polish Academy of Sciences. Cells were grown on 75 cm2 cell 
culture flasks (BD Bioscience) in Roswell park memorial institute 
(RPMI) medium (Sigma-Aldrich), supplemented with 10 % fetal bovine 
serum (FBS) (v/v, Sigma-Aldrich), penicillin (100 µg/mL, Sigma-
Aldrich), streptomycin (100 µg/mL, Sigma-Aldrich), and, for BMDMs 
cultivation, additionally with gentamycin (5 mg/mL, Sigma-Aldrich). Cells 
were maintained at 37 °C in a humidified atmosphere containing 5% 
CO2.  
 
7.7.15 Activation of THP-1 and BMDMs cells 
THP-1 or BMDMs cells were seeded (0.5 × 106 cells/well) on 48-well 
plates and grown for 24 h. The complete medium was replaced and cells 
were then treated with a medium solution of the tested derivatives (20 
µg/mL) for 6, 24, 48 and 72 h. 2, 3 (Sigma-Aldrich), 3 obtained in our 
laboratory and LPS from Escherichia coli 0111:B4 (Sigma-Aldrich) were 
used as positive controls. After incubation period, the cell-free 
supernatants were removed and analysed for cytokine content according 
to the manufacturer's instructions. For THP-1 the following cytokines 
were measured: IL-8, IL-6 (ELISA Ready-Set-Go! Kit, BD Bioscience) 
and IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, IFN-", GM-CSF, TNF-! (Bio-
Plex Pro Human Cytokine Th1/Th2 Immunoassay, Bio-Rad). For 
BMDMs the level of following cytokines was determined: IL-6, TNF-! 
(ELISA Ready-Set-Go! Kit, Invitrogen) and IL-2, IL-4, IL-5, IL-10, IL-
12, IFN-", GM-CSF (Bio-Plex Pro Mouse Cytokine Th1/Th2 
Immunoassay, Bio-Rad). Induced BMDMs cells were additionally 
labeled with monoclonal antibodies CD40, CD80, or CD86 (each 
conjugated to phycoerythrin; eBioscience) and  MHC class II 
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(conjugated to allophycocyanin; eBioscience). Appropriate isotype 
antibodies were used as controls to determine nonspecific binding. Cells 
were analyzed using a FACSCalibur® flow cytometer (Becton-Dickinson), 
and obtained data were analyzed with Flowing Software 2.5.1. Three 
independent experiments were carried out. Statistical analysis was 
performed by two-way analysis of variance (ANOVA) followed by 
Dunnet’s multiple comparison test using Prism 5.04 software 
(GraphPad, San Diego, CA). P values of  < 0.05 were considered 
significant. 
 
7.7.16 Cytotoxicity of semi-synthetic lipid A derivatives 
To study the cytotoxic effect of semi-synthetic lipid A derivatives, the 
SRB assay was performed. In our research the following parameters of 
the assay were applied. THP-1 or  BMDMs cells were seeded (2 × 10^4 
cells/well) on 96-well plates and grown for 24 h. The complete medium 
was replaced and cells were then treated with a medium solution of the 
tested derivatives (20, 10, 1 or 0.1 µg/mL in DMSO) for 6, 24 and 48 h. 
Then, cultures fixed with trichloroacetic acid were stained for 30 minutes 
with 0.4% (wt/vol) sulforhodamine B (SRB, Sigma-Aldrich) dissolved in 
1% acetic acid. Unbound dye was removed by four washes with 1% 
acetic acid, and protein-bound dye was extracted with 10 mM unbuffered 
Tris base. The absorbance was measured at 510 nm using microtiter 
plate reader (Biotek, Tekane). Three independent experiments were 
carried out. 
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Chapter 8: Lipid pattern modification of E. coli 
monophosphoryl lipid A 
 
8.1 Selective deacylation reactions 
 
To further explore the possibility of site-selective transformations on 
lipid A, the modification of the lipid pattern was then investigated. 
According to the general guideline of a lower TLR4 agonist activity 
associated with underacylated lipid A structures (Li et al. 2013; Rietschel 
et al. 1994), compound 2 was subjected to mild ester hydrolysis with 28% 
aqueous NH4OH.  
 
 
 
 
 
 
 
 
 
 
Scheme 8.1: Deacylation reaction on monophosphoryl lipid As 2 and 4. 
 
In line with previous studies conducted on analytical scale (Silipo et al. 
2002), the reaction proceeded with high regioselectivity, with tri-acylated 
lipid A 39 being obtained as the sole product (Scheme 8.1; Figures 8.1-
8.2) as a result of the lower stability of acyl and acyloxyacyl esters to 
hydrolysis with respect to acyl esters of acyloxyacyl amides. 
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Figure 8.1: MALDI-TOF mass spectrum (negative ions mode) of 39. 
Figure 8.2: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of 39. 
 
Furthermore, this reaction was also performed on oxidized lipid A 4 
under slightly modified conditions (CHCl3/14 % aq. NH4OH, 1:1 v/v, at 
5°C), again affording the tri-acylated lipid A derivative 40 as the sole 
product, as detected by MALDI-MS and NMR spectroscopic analysis 
(Figure 8.3-8.4 and Table 8.1). 
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Figure 8.3: MALDI-TOF mass spectrum (negative ions mode) of 40.
 
Figure 8.4: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of 40. 
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                                           Sugar portiona 
                        1             2              3              4               5                 6 
                                                            Lipid portiona 
                                      !                  "                #                  $-(%-1)              % 
Phosphateb 
39 
GlcN 
I (!) 
5.01 
90.8 
3.75 
53.5 
3.29c 
70.1 
3.57 
71.7 
3.32 c 
69.7 
3.94, 
3.99 
64.4 
C14:0(3-OH) 
[N-2 GlcN I] 
2.14, 2.22 
41.8 
3.82 
67.9 
1.34 
36.5 
1.07-1.18 
29.0 0.71-0.74 
13.5 
-0.4 
GlcN 
II 
4.32 
101.4 
3.55 
55.3 
3.39 
73.9 
3.69 
71.0 
3.18 
75.7 
--- 
C14:0(3-OR) 
[N-2 GlcN II] 
2.36, 2.42 
39.1 
5.09 
70.4 
1.47 
33.6 
C12:0 
2.18 
33.9 
1.49 
24.4 
1.07-1.18 
29.0 
40d 
GlcN 
I (!) 
5.32 
93.1 
3.67 
52.6 
3.31 c 
71.7 
3.46 
70.8 
3.36 c 
71.8 
3.77, 
3.83 
64.5 
C14:0(3-OH) 
[N-2 GlcN I] 
1.97 
43.3 
3.66 
67.6 
1.15 
36.8 0.93-0.98 
29.1 0.53-0.58 
13.2 
3.3 
GlcN 
II 
4.38 
104.2 
3.59 
53.5 
3.46 
70.8 
3.54 
68.3 
2.88 
71.0 
--- 
 
C14:0(3-OR) 
[N-2 GlcN II] 
2.22 
40.7 
4.90 
70.2 
1.31 
33.9 
C12:0 
 
2.00 
34.0 
1.31 
24.5 
0.93-0.98 
29.1 
Table 8.1: NMR data referred to lipid A derivatives 39 and 40. !
a 1H (600 MHz, 298K) and 13C (125 MHz, 298K) chemical shifts (in plain and in italic, respectively) expressed in δ relative to residual CHCl3 (1H: δ 7.26 ppm; 13C: δ 77.0 ppm) in 4:1 v/v CDCl3-CD3OD, except where 
differently indicated. 
b 31P (160 MHz, 298K) chemical shifts expressed in δ relative to 85% phosphoric acid (external standard). 
c Interchangeable assignments. 
d Chemical shift values measured in 1:1 v/v CDCl3-CD3OD.!
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8.2 Selective re-acylation with shorter lipid chains 
 
Lipid A derivatives with some shortened acyl chains have previously 
been obtained by total synthesis and shown to possess interesting 
immunostimulating activities (Jiang et al. 2007; Johnson et al. 1999; 
Fukase et al. 1998). Along these lines, in collaboration with Dr. 
D’Alonzo (Department of Chemical Sciences, University of Naples 
Federico II), during this PhD work, we finely tuned the conditions 
suitable for the semisynthesis of some new lipid A derivatives from the 
tri-acylated lipid A 39. Given that the direct acetylation or succinylation 
of a tetra-acylated lipid A very similar to 39 afforded exclusively per-O-
acylated products (Tanamoto 1994), a three-step approach based on a 
regioselective protection–acylation–deprotection sequence was 
considered. The most reactive functionalities of 39 could be identified as 
the hydroxyl groups at the anomeric position of GlcN I and at position 6 
of GlcN II as well as the phosphate group. By reacting 39 under 
common silylation conditions (TBDPSCl/ImH), a double protection 
product 41 was obtained in 50% yield after 1h (Scheme 8.2; Figures 8.5-
8.6).  
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Scheme 8.2: Reactions sequence on the Tri-acylated monophosphoryl lipid A 39. 
 
!178!!
 
Figure 8.5: MALDI-TOF mass spectrum (negative ions mode) of crude 41. 
 
Figure 8.6: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of pure 41. 
 
Furthermore, the ROESY spectrum clearly indicated through-space 
correlations between one TBDPS aromatic signal (!=7.60 ppm) and 
GlcN I anomeric (!=5.57 ppm) and one of the two H-6 signals (! = 3.45 
ppm), as well as correlations between the second TBDPS aromatic signal 
(!=7.52 ppm) and GlcN II H-4, H-5 and both H-6 signals (!=3.32, 3.23, 
3.72, and 3.82 ppm, respectively) (Figure 8.7-a).  
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Figure 8.7: Zoom of 1H and ROESY NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) for 41 (a) and 42 (b). 
 
This strongly suggested that one TBDPS was placed at the anomeric 
position (singularly, with an axial orientation) of GlcN I and the second 
group was either at position O-6 of GlcN II or on the phosphate group. 
Conversely, at this stage, we could not clearly assign the position of the 
latter. Interestingly, we also observed that when the silylation reaction 
was carried out for longer times (6 h), a tri-silylated compound 43 was 
isolated as the major product (42% yield) (Scheme 8.3; Figures 8.8-8.9). 
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Scheme 8.3: Second reactions sequence on the tri-acylated monophosphoryl lipid A 39 
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Figure 8.8: MALDI-TOF mass spectrum (negative ions mode) of 43. 
 
Figure 8.9: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of 43. 
 
In this case, ROESY experiments showed correlations similar to those 
found for the di-silylated derivative, and an additional interaction 
between a TBDPS aromatic signal (!=7.46ppm) and H-b of C14:0 (3-
OR) chain on GlcN I (!=3.96 ppm) (Figure 8.7-b), thus suggesting that 
installation of the third TBDPS group occurred at the secondary 
hydroxyl at the "-position of the acyl chain on GlcN I. Both silylated 
derivatives were employed in preliminary acylation studies (Scheme 8.2-
8.3). Di-silylated lipid A 41 was treated with freshly prepared hexanoic 
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anhydride and N,N-dimethylaminopyridine (DMAP) in 
dichloromethane. After 16h at room temperature, a complex mixture 
(NMR) was obtained, although MALDI-MS analysis indicated the 
presence of one major reaction product having five hexanoyl chains and 
only one TBDPS group (Scheme 8.2). De-O-silylation of the crude 
mixture under standard conditions [tetrabutylammonium fluoride 
(TBAF)] yielded, after chromatographic purification, lipid A derivative 
42 as the major species in 31% yield over two steps (Figures 8.10-8.11).  
 
Figure 8.10: MALDI-TOF mass spectrum (negative ions mode) of pure 42. 
 
Figure 8.11: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of 42. 
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The latter was characterized by the presence of eight acyl chains; 2D-
NMR studies clearly established that the five shorter ones were placed at 
the C-3 and C-4 positions of GlcN I, the C-3 position of the N-acyl chain 
of GlcN I and the C-3 and C-6 positions of GlcN II (Table 8.2). 
Likewise, this suggested a structure with TBDPS group at position O-1 
of GlcN I and on phosphate group for di-silylated synthetic intermediate 
41. Interestingly, the lack of TBDPS protection on the hydroxyl at 
position 6 of GlcN II was in agreement with the sluggish reactivity of this 
alcohol as already highlighted above. Acylation of tri-silylated lipid A 43 
derivative was eventually studied (Scheme 8.3). Its treatment with 
hexanoic anhydride and DMAP again provided a complex mixture 
(MALDI-MS, NMR). Therefore, the crude reaction mixture was directly 
subjected to de-O-silylation, as in the previous case, affording hexa-
acylated lipid A derivative 44 as the major species (54% yield over two 
steps) (Figures 8.12-8.13; Table 8.2), with three hexanoyl chains at 
positions C-3 and C-4 of GlcN I and C-6 of GlcN II, as detected by 2D-
NMR spectroscopic analysis.  
 
Figure 8.12: MALDI-TOF mass spectrum (negative ions mode) of 44. 
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Figure 8.13: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of 44. 
 
The presence of the acyl chain on O-6 of GlcN II was due again to the 
absence of TBDPS protection at this position on tri-silylated synthetic 
intermediate 43. The lack of an ester group at position C-3 of GlcN II of 
44 could not be easily explained, although a steric hindrance of the 
TBDPS group at the "-position of the acyl chain on GlcN I could be 
invoked. 
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! Sugar!portiona!!!!!!!!!!!!!!!!!!!!!!!!1!!!!!!!!!!!!2!!!!!!!!!!!!!!!3!!!!!!!!!!!!!!!4!!!!!!!!!!!!!!!5!!!!!!!!!!!!!!!!6!!!! Lipid!portiona!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"!!!!!!!!!!!!!!!!!!!!!!!!#!!!!!!!!!!!!!!!!!!$5(%51)!!!!!!!!!!!!!!!!!!!!!!!!!%! Other!signalsa! Phosphateb!
!
!
!
!
41!
GlcN!I!(!)!
!
5.57!
92.9!
3.61!
53.8!
3.35!
70.6!
3.49!
71.7!
3.26!
69.5!
3.45,!3.71!
67.3!
C14:0(35OH)![N52!GlcN!I]! 2.05,!2.10!42.2! 3.70!68.0! 1.30!36.8! !!1.0751.18!
29.0!
!
!!!0.7150.74!
13.5!
TBDPS!CH3:!0.85/26.1!!!!!!!!!!0.87/26.1!Ph:!7.15/129.3!!!!!!!7.18/127.1!!!!!!!7.20/129.3!!!!!!!7.52/135.1!!!!!!!7.60/134.8!
!!!!512.7!!GlcN!II! !4.34!100.6! !3.48!55.2! !3.37!74.5! !.32!70.5! !.23!75.6! !3.72,!3.82!63.4! C14:0(35OR)![N52!GlcN!II]! 2.34,!2.39!41.2! 5.02!71.2! 1.41!33.9!C12:0!! 2.13!34.0! 1.39!24.7! 1.0751.18!29.0!
!
!
!
42!
GlcN!I!(!)!
!
5.30!
92.2!
4.00!
51.1!
5.12!
70.1!
4.80!
67.4!
3.35!
67.9!
3.58,!3.71!
66.6!
C14:0(35OR)![N52!GlcN!I]! 2.25,!2.35!39.6! !5.02!
70.3!
!1.41!
33.1!
!1.0851.18!
29.1!
!!!0.7150.75!
13.3!
!!!555!!
!!!0.7!!GlcN!II! !4.41!100.5! !3.75!52.9! !4.84!74.3! !4.03!68.7! !3.39!73.5! !4.11,!4.22!62.6! C14:0(35OR)![N52!GlcN!II]! 2.33,!2.45!40.5!C6:0,!C12:0! 2.09,!2.19!
33.6! 1.3851.46!24.1! 1.0851.18!29.1!
!
!
!
!
43!
!GlcN!I!(!)!
!
!5.27!
93.0!
!3.56!
53.1!
!3.14!
71.8!
!2.99!
70.7!
!3.73!
72.6!
!3.59,!3.85!
66.8!
!C14:0(35OTBDPS)![N52!GlcN!I]! !1.70,!1.92!43.1! !3.96!69.8! !1.12!36.0! !1.0751.18!28.9! !!!!0.7150.74!
13.4!
TBDPS!CH3:!0.86/26.0!!!!!!!!!!0.88/25.8!!!!!!!!!!0.91/25.1!Ph:!7.1557.23/127.0!!!!!!!7.2157.24/129.0!!!!!!!7.46/135.2!!!!!!!7.51/135.3!
!!!!!!7.55/134.9!!!!!!!7.69/134.4!
!!!!!511.8!!GlcN!II! !4.56!99.9! !3.47!55.1! !3.36!74.6! !3.30!70.5! !3.26!75.5! !3.73,!3.82!63.1! C14:0(35OR)![N52!GlcN!II]! 2.33,!2.38!40.6! 5.04!70.8! 1.37!33.4! 1.0751.18!28.9!C12:0!! 2.12!34.0! 1.40!24.2! 1.0751.18!28.9!
!
!
!
44!
GlcN!I!(!)!
!
5.41!
91.8!
4.13!
51.1!
5.18!
70.3!
4.74!
68.1!
4.14!
71.6!
3.46,!3.64!
65.5!
C14:0(35OH)![N52!GlcN!I]! 2.08,!2.14!42.9! 3.75!68.2! 1.27!n.d.! !1.0851.18!
29.1! !!!0.7250.77!
13.3!
!!!555!!
!!!51.5!!GlcN!II! !4.78!98.8! !3.55!55.5! !3.37!73.0! !3.18!70.2! !3.37!73.8! !4.11,!4.27!62.9! C14:0(35OR)![N52!GlcN!II]! 2.52,!2.58!40.3! 5.15!71.3! 1.48!33.3!C6:0,!C12:0! 2.09,!2.21!33.6! 1.4251.47!24.1! 1.0851.18!29.1!
a 1H (600 MHz, 298K) and 13C (125 MHz, 298K) chemical shifts (in plain and in italic, respectively) expressed in δ relative to residual CHCl3 (1H: δ 7.26 ppm; 13C: δ 77.0 ppm) in 4:1 v/v CDCl3-CD3OD. 
b 31P (160 MHz, 298K) chemical shifts expressed in δ relative to 85% phosphoric acid (external standard). 
Table 8.2: NMR data referred to lipid A derivatives 41-44. !
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8.3 Biological assays 
 
Preliminary immunological assays were performed on lipid A derivatives 
40, 42 and 44, in collaboration with Prof. Giuliano at the University of 
Campania “L. Vanvitelli”, with the aim of studying whether these 
molecules be easily detected by human monocytic cell line (THP-1) and 
could trigger cellular responses in terms of cytokine amounts and length 
of stimulation (Figure 8.14). The amounts of different cytokines were 
examined in tissue culture supernatants of THP-1, and detected by using 
Enzyme-Linked Immunosorbent Assay (ELISA). E. coli O111-B4 LPS 
and MPL® from S. Minnesota R595 (3) were used as positive controls 
for an agonist and immunoadjuvant response profile, respectively. 
However, as the former showed an inflammatorypotential exceedingly 
greater than that of the latter and of thesynthesized compounds (e.g., 
IL-6, up to >4000 pg mL-1; IL-8,up to >10000 pg mL-1; TNF-!, up to 
>10000 pg mL-1) data inFigure 8.14 are shown related to 3 only. The 
semisynthetic lipid A derivatives showed cytokine profiles comparable to 
those of the immunoadjuvating drug 3, but with interesting peculiarities. 
Antimicrobial substances and proinflammatory cytokines such as TNF-
!, IL-6 and IL-8 create a local proinflammatory environment, which 
helps to recruit and activate phagocytic cells, activate the complement 
cascade, contain the invading pathogen and chemo-attract the effector 
cells of the adaptive immune response. However, overstimulation can 
also result in septic proinflammatory responses such as secretion of 
TNF-! and IL-8, which, in severe cases, can be detrimental to the host. 
In this regard, all the tested derivatives further reduced IL-8 production, 
which is a key mediator associated with inflammation, driving towards a 
less proinflammatory profile than the one induced by 3.  
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Figure 8.14: Cytokine concentrations (Mabtech’s ELISAPRO) in tissue-culture 
supernatants of THP-1 cells stimulated with lipid A derivatives (20 µgmL-1). Ctrl 
represents the cells not treated. 
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8.4 Conclusions 
 
Investigations into the peculiar reactivity of lipid A, leading to novel 
derivatives with immunostimulating activity, has been carried out through 
site-selective chemical reactions on monophosphoryl lipid A 2 and its 
oxidized 4. In particular, we finely tuned the conditions suitable for the 
semisynthesis of some new lipid A derivatives, by selective modification 
of the lipid pattern (selective deacylation and re-acylation with shorter 
chains). In this way, a small collection of new lipid A derivatives was 
rapidly prepared, avoiding lengthy total synthetic approaches. Notably, 
potential access to several other modified lipid A structures could be 
opened by this strategy, because the reactions developed on E. coli lipid 
A scaffold should also be applicable on lipid A substrates from different 
bacterial sources. Some of the new compounds were assayed for 
preliminary in vitro immunological tests, showing somewhat reduced 
inflammatory activity and a cytokine production profile similar to the 
already used immunomodulant lipid A derivative 3, thus highlighting the 
promising immunobiological applications.  
 
8.5 Experimental section 
 
8.5.1 Lipid A derivative (40)  
A suspension of 4 (33.5 mg, 20.5 µmol) in 1:1 v/v CHCl3-14% aqueous 
NH4OH (4.7 mL) was stirred at 5°C. After 48 h stirring at 5°C, the 
reaction mixture was concentrated. The residue was subjected to silica-
gel column chromatography (CHCl3/MeOH, 97:3 to 3:2 v/v) to give 40 
(10.5 mg, 48%) as a white powder. 
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8.5.2 Lipid A derivative (41)  
A suspension of compound 2 (131 mg, 76.3 µmol) in 28% aqueous 
NH4OH (3.0 mL) was stirred at RT overnight. The reaction was worked 
up by concentration to give crude 39 (130 mg) as a white powder. The 
latter was co-evaporated with anhydrous DMF (3 x 5 mL). The resulting 
oil was dissolved in further anhydrous DMF (5 mL), the mixture was 
cooled to 0°C and treated with TBDPSCl (339 µL, 1.2 mmol) and 
imidazole (84 mg, 1.2 mmol). The solution was then warmed to RT and 
stirred for 1 h. Afterwards, the reaction mixture was diluted with 
chloroform (50 mL) and washed with brine. The organic phase was 
dried over anhydrous Na2SO4, filtered and concentrated. Silica-gel 
chromatography of the crude residue (CHCl3/MeOH, 100:0 to 95:5 v/v) 
gave pure 41 (58 mg, 50% overall yield from 2) as a colorless oil. 
 
8.5.3 Hexanoic anhydride 
DCC (89 mg, 430 µmol) was added to a solution of hexanoic acid (100 
mg, 860 µmol) in anhydrous CH2Cl2 (5 mL). The resulting suspension 
was stirred at RT for 16 h; then it was filtered, washing the solid with cold 
hexane (50 mL). The filtrate was concentrated under reduced pressure 
to give hexanoic anhydride (92 mg, 99% yield) as a colorless oil. 1H and 
13C NMR data of the latter were fully in line with those reported 
elsewhere (Park et al. 2005). 
 
8.5.4 Lipid A derivative (42)  
Hexanoic anhydride (92 mg, 429 µmol) and DMAP (3.5 mg, 2.9 µmol) 
were added to a stirring solution of silylated lipid A derivative 41 (45 mg, 
29 µmol) in anhydrous CH2Cl2 (3 mL). The mixture was stirred at RT 
for 16 h; then it was transferred to a separatory funnel, extracted with 
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CHCl3 (3 x 25 mL) and washed with brine. The combined organic layers 
were dried over anhydrous Na2SO4, filtered and concentrated. To a 
solution of the crude acylated product (25 mg) was added a solution of 
TBAF (11 µL, 1M in THF) and the mixture was stirred at RT for 48 h. 
The solvent was then removed under reduced pressure. Silica-gel 
chromatography of the crude residue over silica gel (CHCl3/MeOH, 
100:0 to 85:15 v/v) provided lipid A derivative 42 (12 mg, 31% overall 
yield over two steps) as a colorless oil. 
 
8.5.5 Lipid A derivative (43)  
TBDPSCl (260 µL, 1 mmol) and imidazole (68 mg, 1 mmol) were 
added to a cooled (0°C) solution of crude 39 (100 mg, obtained from 
130 mg of 2) in anhydrous DMF (5 mL). The reaction mixture was 
warmed to RT and stirred at the same temperature for 6 h. The solution 
was then diluted with chloroform (50 mL) and washed with brine. The 
organic phase was dried over anhydrous Na2SO4, filtered, and 
concentrated. Silica-gel chromatography of the crude residue 
(CHCl3/MeOH, 100:0 to 95:5 v/v) gave 43 (56.2 mg, 42% overall yield 
from 2) as a colorless oil. 
 
8.5.6 Lipid A derivative (44)  
Under the same conditions reported for the synthesis of 42, lipid A 
derivative 44 (12 mg, 9 µmol) was obtained from TBDPS ether 43 (29 
mg, 17 µmol) after acylation of the latter (hexanoic anhydride, 14 mg, 66 
µmol; DMAP, 0.2 mg, 2 µmol) and subsequent de-O-silylation (TBAF, 
17 µL, 1M in THF) of the resulting acylated product (52% overall yield 
over two steps). 
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8.5.7 Immunological assays  
Immunological activities were evaluated by stimulating the human 
monocytic leukemia cell line THP-1 (ATCC TIB-202) (Pieretti et al. 
2014). Briefly, monocytic THP-1 cells (LGC, Promochem, Milan, Italy) 
were grown in suspension in RPMI 1640 medium supplemented with 
10% fetal bovine serum at 37°C in a humidified incubator with a 5% CO2 
atmosphere and stimulated with the lipid A derivatives at 20 µg mL-1. 
LPS form E. coli O111:B4 (Sigma, Milan, Italy) and MPLA from S. 
Minnesota R595 (Avanti Polar Lipids, Spectra 2000, Milan, Italy) were 
used as positive controls. Mabtech’s ELISAPRO kits and Enzo Life Science 
EIA Kit (BioRad, Milan, Italy) were used to quantify IL-6, IL-8 and 
TNF-! production in tissue-culture supernatants, following 
manufacturer’s instructions.  
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Chapter 9: Fluorescent derivatives of E. coli lipid A 
 
The last chapter of this thesis is dedicated to an ongoing study that we 
have in collaboration with Prof. Robert Tampé from the Institute of 
Biochemistry, at the Goethe-University in Frankfurt. Tampé and co-
workers have performed several studies during these last years in the 
field of membrane and trans-membrane proteins. Among the plethora of 
factors that govern the stability and function of membrane proteins, the 
local lipid environment is emerging as one of the most important. The 
topological organization of protein subunits, as well as their stability and 
activity have all been linked directly to the effects of neighbouring lipids 
(Bao et al., 2013; Dowhan et al., 2011; Betaneli et al., 2012; Obara et al., 
2005; Leganowsky et al., 2014). The first shell of lipid molecules, in 
direct contact with the membrane protein, is often referred to as the lipid 
annulus (Lee et al., 2011). Spin-labelling and fluorescence-quenching 
studies have demonstrated that these annular lipids form only weak, non-
specific interactions with membrane proteins (Lee et al., 2003). Annular 
lipids are therefore often lost during solubilization and/or purification of 
membrane proteins and are usually not observed in X-ray structures. 
Lipids identified through crystallography in detergent micelles are bound 
specifically to the protein and therefore represent a special case of 
annular lipids. To distinguish lipids that induce a direct effect on 
membrane proteins from loosely associated ones remains a challenging 
task and raises questions about whether or not the lipid annulus is 
constant in composition or variable. 
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9.1 Flippases 
 
The ATP-binding cassette (ABC) exporters reside in the membrane 
lipid bilayer of all cells and are responsible for multidrug resistance 
phenotypes, extruding antibiotics or chemotherapeutics from target cells 
(Schweizer et al., 2012; Huang et al., 2006; Gottesman et al. 2002). This 
renders them a prime target for clinical research. It has been established 
that some ABC transporters (as P-glycoprotein (MDR1, ABCB1), 
TmrAB, LmrA and MsbA) act as lipid pumps or ‘flippases’, either 
effluxing or transporting lipids from the inner to the outer leaflet, 
respectively (Borst et al., 2000; Reuter et al., 2003; Hendrich et al., 2003; 
King et al., 2012). In particular, MsbA was found in Gram-negative 
bacteria and is an ABC transporter involved in the lipid A and LPS 
transport from the cytoplasmic leaflet (inward-facing) to the periplasmic 
leaflet (outward-facing) of the plasma membrane (Karow et al. 1993; 
Polissi et al. 1996; Wang et al. 2004). Almost half of the 48 human ABC 
transporters have been linked directly or indirectly with lipid transport 
(Tarling et al., 2013). Moreover, lipids have been shown to bind directly 
to some ABC transporters or to have an effect on the activity of others 
(Bao et al., 2013; Shintre et al., 2013; Doerrler et al., 2002; Marek et al., 
2011; Eggensperger et al., 2014). Tampé and co-workers have recently 
identified and monitored the composition of part of an endogenous 
annular lipid belt bound to a heterodimeric membrane protein complex 
(Bechara et al. 2015). Twenty-four different phospholipid species were 
detected together with various tetra- and hepta-acylated lipid A species in 
four independent protein preparations. The majority of phospholipids in 
close contact with the protein had similar acyl chain lengths (between 16 
and 18 carbon atoms). Classifying lipids and their potential role in 
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contributing to protein stability, or in mediating drug export, is therefore 
of paramount interest for drug discovery and for understanding the 
mechanisms of ABC transporters. 
 
9.2 Fluorescent mono/diphosphoryl lipid As and ABC 
transporters 
 
A further step for the ABC transporters mechanisms comprehension 
was the synthesis of fluorescent-lipid As in order to develop some in 
vitro fluorescence-based lipid A flippase assays. Towards this direction, 
in this thesis two different kind of nitro-benzofurazan (NBD)-labeled 
lipid A derivatives were synthesized. The soundness of the preliminary 
data and a pending patent, forces us to describe this topic only  as an 
overview without furnishing some experimental data and results in full 
details. However, the first derivative that was synthesized, according to 
the strategy showed in the previous chapters, was obtained from the 
mono-phosphoryl lipid A derivative oxidized on the position C-6 of the 
GlcNII (4, see paragraph 7.1). Indeed, after having synthesized an 
amine-appended NBD derivative from commercially available 4-Chloro-
7-nitrobenzofurazan (Yamaguchi et al. 2014), the optimized coupling 
conditions (described in paragraph 7.2) gave the first semi-synthetic 
fluorescent mono-phosphoryl lipid A derivative (NBD-MPLA) 45. 
MALDI-TOF mass spectrum and full NMR characterization of the 
major hexa-acylated species confirmed its structure (Scheme 9.1; Figures 
9.1-9.2; Table 9.1). 
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Scheme 9.1: Semi-synthesis of fluorescent mono- and di-phosphryl lipid As 45 and 46. 
 
 
Figure 9.1: MALDI-TOF mass spectrum (negative ions mode) of 45. 
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Figure 9.2: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of 45. 
 
It is worth noting that, similarly to lipid A derivatives described in 
chapter 7, the strategy for the coupling was focused on the possibility to 
tag the lipid A, with a fluorescent moiety without any derivatization on 
some moieties (phosphate group, anomeric position or acyl pattern) 
which could be important for the interactions with the proteins. Indeed, 
also in this case, the coupling through the C-6 of GlcNII should be 
highly bio-mimetic.  
In collaboration with Prof. Tampé, the fluorescent monophosphoryl 
lipid A 45 was exposed to several biological assays. They first tested 
whether our NDB-MPLA 45 (0.1, 1.0 and 1.5 mol%) could affect the 
transport activity of TmrAB. The hypothesis was that lipid A and other 
substrates compete for the same translocation pathway. Derivative 45 was 
offered in 1, 10, 100 nM and 1 µM to TmrAB 1 µM in order to 
understand if it was associated or loaded onto isolated detergent-
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solubilized TmrAB. In these studies we were excited to see that NBD-
MPLA 45 co-migrates with TmrAB (200 kDa) in a fluorescence-based 
SEC (Figure 9.3). 
Figure 9.3: Co-migration of TmrAB/NBD-MPLA (45). 
 
Subsequently, it was examined if NBD-MPLA was released from 
TmrAB in an ATP-dependent manner, similarly to what observed for 
endogenous phosphoglycolipids by ESI-MS (Bechara et al. 2015). 
However, as demonstrated by several independent experiments, NBD-
MPLA appears just to participate in the detergent-protein micelles and 
no ATP- and TmrAB-dependent release of NBD-MPLA 45 was 
observed under different conditions tested. Probably, a reason of this 
difference with respect to similar endogenous phosphoglycolipids 
observed in the previous work (Bechara et al. 2015) could be explained 
with the lack on the NBD-MPLA 45 of the anomeric phosphate moiety. 
Indeed, typical MsbA substrates are thought to contain two phosphate 
groups. The lack of the anomeric phosphate group on the lipid A 
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reduces the toxicity, due to the selective induction of the TLR-4–TRIF 
signaling pathway over the TLR-4–MyD88 one, but leaving a solid 
interaction with the receptors and the immunostimulatory properties 
unaffected, whereas the same structural difference could presumably not 
leave the interaction with the ABC transporters unaltered. To clarify this 
point, the semi-synthesis of a fluorescent diphosphoryl lipid A (NBD-
DPLA) was performed (46, Scheme 9.1). At first, several attempts, 
focused on the use of diphosphoryl lipid A 1 (see chapter 6) and its 
oxidation on the C-6 of GlcNII following the same conditions used on 
the monophosphoryl lipid A 2 (see paragraph 7.1), were tested without 
good results. Probably, in the conditions tested, the presence in the 
diphosphoryl lipid A structure of two polar heads, increases the 
formation of aggregates like inverse micells which hamper the exposition 
of the C-6 moiety to the oxidation reagents. Alternatively, we tried to 
install a further phosphate group on the anomeric position of 45, but 
even in this case we did not achieve the desired compound. Finally, 
working on NBD derivative alternative to the amine obtained for the 
previous case, together with a different approach for the reaction on 1, 
we achieved the synthesis of 46, MALDI-TOF mass spectrum and full 
NMR characterization of the major hexa-acylated species confirmed its 
structure (Scheme 9.1; Figure 9.4-9.5; Table 9.1). Contrary to the results 
obtained for NBD-MPLA (45), the first biological tests on NBD-DPLA 
(46) clearly showed a better interaction/release with the ABC tranporters 
protein, but the biological assays are still in progress and will not be 
showed in this thesis. 
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Figure 9.4: MALDI-TOF mass spectrum (negative ions mode) of 46. 
 
 
Figure 9.5: 1H and HSQC-DEPT NMR spectra (600 MHz, 298K, 4:1 v/v CDCl3-
CD3OD) of 46. 
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 Sugar portion
a 
                    1          2            3           4           5               6 
Lipid portiona 
                                !               "            #         $-(%-1)              % 
Other 
signalsa Phosphate
b 
45 
GlcN I (!) 5.01 90.8 
3.98 
51.5 
4.94 
72.8 
3.57 
70.1 
3.62 
72.2 
3.74/3.99 
67.5 
C14:0(3-OH) 
[N-2 GlcN I] 
2.10, 2.20 
41.8 
3.72 
67.5 
1.31 
36.8 
1.07-1.18 
29.1 0.71-0.74 
13.5 
Linker: 
!: 2.30/34.2; ": 1.61/24.7;  
#: 1.27/26.5; $: 1.45/27.6;  
%: 1.70/29.1; &: 3.45/44.6 
 
NBD: 
I:--/145.2; II:--/144.8;  
III:--/143.7; IV:--/122.5;  
V: 6.19/97.7;  
VI: 8.50/136.0 
-1.1 
C14:0(3-OH) 
[O-3 GlcN I] 
2.24, 2.35 
41.0 
3.82 
69.1 
1.31 
36.9 
C14:0(3-OR) 
[N-2 GlcN II] 
2.23, 2.34 
40.8 
4.97 
70.5 
1.39 
33.6 
GlcN II 4.74 101.3 
3.99 
52.5 
5.00 
73.6 
3.62 
71.1 
3.72 
71.8 
--- 
173.2 
C14:0(3-OR) 
[O-3 GlcNII] 
2.42, 2.51 
38.8 
5.06 
69.7 
1.47 
33.5 
C12:0 2.15 
33.9 
1.46 
24.3 
1.07-1.18 
29.1 C14:0 
46 
GlcN I (!) 5.38 93.2 
4.05 
51.3 
5.03 
70.2 
3.31 
68.3 
3.94 
73.2 
3.69/3.87 
66.9 
C14:0(3-OH) 
[N-2 GlcN I] 
2.09, 2.17 
43.1 
3.75 
68.2 
1.30 
36.6 
1.09-1.18 
29.0 0.71-0.75 
13.5 
Linker: 
!: 2.27/33.5; ": 1.57/24.0;  
#: 1.37/25.7; $: 1.66/27.4;  
%: 3.38/43.1 
 
NBD: 
I:--/145.1; II:--/144.6;  
III:--/143.4; IV:--/122.1;  
V: 6.08/97.8;  
VI: 8.37/136.9 
1.2/-0.4 
C14:0(3-OH) 
[O-3 GlcN I] 
2.27, 2.37 
41.7 
3.85 
67.8 
1.35 
36.8 
C14:0(3-OR) 
[N-2 GlcN II] 
2.21, 2.32 
40.6 
4.99 
70.7 
1.41 
33.8 
GlcN II 4.80 99.5 
3.70 
53.6 
5.05 
73.3 
4.14 
72.0 
3.60 
72.4 
4.40/--- 
63.0 
C14:0(3-OR) 
[O-3 GlcN II] 
2.45, 2.52 
38.5 
5.07 
69.9 
1.44 
33.7 
C12:0 2.17 
33.9 
1.47 
24.5 
1.09-1.18 
29.0 C14:0 
 
 
 
 
 
 
a 1H (600 MHz, 298K) and 13C (125 MHz, 298K) chemical shifts (in plain and in italic, respectively) expressed in δ relative to residual CHCl3 (1H: δ 7.26 ppm; 13C: δ 77.0 ppm) in 4:1 v/v CDCl3-CD3OD. 
b 31P (160 MHz, 298K) chemical shifts expressed in δ relative to 85% phosphoric acid (external standard). 
Table 9.1: NMR data referred to lipid A derivative 45 and 46 (major hexa-acylated specie) 
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9.3 Imaging on HEK and macrophages cells 
 
Compounds 45 and 46 were subjected to a preliminary cell imaging test, 
in collaboration with Prof. Huser (Department of Physics, University of 
Bielefeld, Germany), aimed to observe their staining with cells on a 
deconvolution microscope.  
Two different cell lines were used, Human Embryonic Kidney (HEK) 
blue cells and J774 macrophages (received from  the Center for 
Cooperative Research in Biomaterials-CIC biomaGUNE, Spain). The 
former are commonly used in immuonological studies, equipped with 
the entire receptor complex (TLR4/MD-2/CD14), in response to LPS 
stimuli and also reactive to the (commercially available) LPS conjugated 
with the fluorescent dye Alexa Fluor 568 (LPS568). Such conjugate was 
used as positive control (Figure 9.6 A), while the (commercially available) 
4-chloro-7-nitrobenzofurazan (NBD-Cl) was used as negative one (Figure 
9.6 B), with a dosage of 1µg mL-1 and 2µg mL-1 respectively.  
Cells were grown on glass-bottom chamber slides and incubated with 45 
and 46, at a concentration of 2µg mL-1, and then prepared for imaging on 
DV Elite microscope system. In the case of the HEK blue cells, both 
types of lipid As showed positive staining, which indicates their uptake in 
endocytotic vesicles on the cells.  
Surprisingly, 45 emitted strong signals as small green spots and had 
general localization on nearly all the observed cells (Figure 9.6 C), while 
46 had weaker intensity in overall cell population, where only a few cells 
were found to be preferentially reactive (Figure 9.6 D). On J774 
macrophages cells, although LPS568 was not reactive (Figure 9.7 A), 
staining results of 45 and 46 were comparable with those obtained on 
HEK cells (Figure 9.7 C and D), which confirm their recognition. These 
studies are still in progress and further experiments will be performed on 
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derivatives, in order to optimize the conditions for the obtainment of 
super-resolution microscopy and 3D imaging. 
!203!! 
Figure 9.6: Fluorescent staining on HEK blue cells of LPS568, NBD-Cl, 45 
and 46. 
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Figure 9.7: Fluorescent staining on J774 macrophages cells of LPS568, 
NBD-Cl, 45 and 46. 
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9.4 Conclusions 
 
In the last part of this PhD work, two different fluorescent lipid A 
derivatives were for the first time semi-synthesized, in order to improve 
the understanding of lipids role in the mechanisms of ABC transporters. 
The first one was the mono-phosphoryl lipid A tagged with a NBD dye 
(NBD-MPLA; 45). In collaboration with Prof. Tampé, 45 was employed 
for the development of some in vitro fluorescence-based lipid A-flippase 
assays, focused on the ABC transporters mechanisms comprehension. 
After the first data collected, we were excited to see that NBD-MPLA 45 
co-migrates with TmrAB (200 kDa) in a fluorescence-based SEC, but 
unfortunatly, by several independent experiments. It was observed, that 
45 does not give a perfect interaction with the ABC transporters system, 
probably due to the lack of the anomeric phosphate. Therefore, after 
several attempts, a second fluorescent lipid A derivative was obtained. 
The E. coli diphosphoryl lipid A 1 was coupled with a suitable 
synthesized fluorescent tag to give the second semi-synthetic fluorescent 
diphosphoryl lipid A derivative (NBD-DPLA; 46), which clearly showed 
a better interaction/release with the ABC tranporters protein (biological 
assays are still in progress). 
Finally, 45 and 46, were subjected to a preliminary cell imaging test in 
collaboration with Prof. Huser, in order to observe their staining with 
two different cell lines on a deconvolution microscope (experiments are 
still in progress). 
 
9.5 Experimental section 
 
9.5.1 Lipid A derivative 45 
Compound 4 (20.0 mg, 11.6 µmol) was treated under argon atmosphere 
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with a solution of TBTU (4.6 mg, 14 µmol) and HOBt (1.9 mg, 14 
µmol) in 1:1 v/v DMF-CH2Cl2 (0.6 mL). The synthesized amine-
appended NBD derivative, obtained from commercially available 4-
Chloro-7-nitrobenzofurazan (Yamaguchi et al. 2014), was subsequently 
added (9.6 mg, 34.8 µmol). Finally, the solution was treated with DIPEA 
(9.0 µL, 51 µmol) and stirred at rt for 3 hours. The reaction mixture was 
then diluted with CHCl3 (2 mL) and washed with 0.1 M HCl (2 mL). 
The organic phase was collected, dried over anhydrous Na2SO4, filtered 
and concentrated. The residue was subjected to gel filtration 
chromatography on Sephadex® LH-20 (CHCl3/MeOH, 3:2 v/v) to afford 
45 (17.9 mg, 78%) as a orange wax. For NMR data see Figure 9.2 and 
Table 9.1. MALDI TOF-HRMS for C106H190N7O25P (major hexa-acylated 
species) (m/z): Mr (calcd) 1993.3583, Mr (found) 1992.4039 (M-H)-  
(Figure 9.1). 
 
9.5.2 Lipid A derivative 46 
Compound 1 (11.5 mg, 6.4 µmol) was treated under argon atmosphere 
with a solution of DMAP (0.8 mg, 3.8 µmol) and 2,4,6-Collidine (3.6 
mg, 28 µmol) in 1:1 v/v DMF-CHCl3 (0.8 mL). The synthesized 
anhydryde NBD derivative starting from the suitable synthesyzed 6-((7-
nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)hexanoic acid, obtained from 
commercially available 4-Chloro-7-nitrobenzofurazan (Woodland et al. 
2016), was subsequently added (6 mg, 10.6 µmol). The solution was 
stirred at rt for 16 hours. The reaction mixture was then diluted with 
CHCl3 (2 mL) and washed with 0.1 M HCl (2 mL). The organic phase 
was collected, dried over anhydrous Na2SO4, filtered and concentrated. 
The residue was subjected to gel filtration chromatography on Sephadex® 
LH-20 (CHCl3/MeOH, 3:2 v/v) to afford 46 (7.2 mg, 30%) as a orange 
!207!!
wax. For NMR data see Figure 9.5 and Table 9.1. MALDI TOF-HRMS 
for C106H190N6O29P2 (major hexa-acylated species) (m/z): Mr (calcd) 
2073.9086, Mr (found) 2072.9973 (M-H)-  (Figure 9.4). 
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PhD Course Activity Summary 
 
1)! Attended Courses: 
•! Tecniche estrattive Solido-Liquido impiegate nella preparazione del 
campione per l'analisi chimica e nella produzione di estratti per usi 
industriali; Naviglio D.; 09-17/12/2014; 3 CFU. 
•! Sintesi, struttura ed applicazioni di oligonucleotidi naturali e modificati; 
Montesarchio D.; 04-13/02/2015; 3 CFU.  
•! Glicoscienza; Parrilli M., Bedini E.; 6-10/07/2015; 3 CFU. 
•! Spettrometria di Massa; Pucci P.; from 6/07/2015 to 10/07/2015; 4 
CFU. 
•! Neutron scattering techniques; C. Zorn; 27-30/10/2015; 3 CFU. 
•! Applications of neutron scattering techniques in soft matter and bio-
relevant systems. How to study their structure and dynamics; Y. 
Gerelli; 9-13/11/2015; 3 CFU.  
 
2)! Attended Seminars: 
Title Speaker Place Date 
Multifunctional bioinspired 
cathechol - based coatings and 
nanoparticles 
Daniel Ruiz-
Molina 
Dept Chemical Sciences, University 
of Naples Federico II 
05/11/
2014 
Le fitotossine: un'avventura 
lunga 40 anni 
Antonio 
Evidente 
Dept Chemical Sciences, University 
of Naples Federico II 
10/12/
2014 
New chiral catalysts derived 
from Iron(II) and Bismut (III) 
for asymmetric synthesis 
Thierre 
Ollevier 
Dept Chemical Sciences, University 
of Naples Federico II 
15/12/
2014 
DNA-based strategies for the 
inihibitor of HMGB1 cytochine 
activity 
Domenica 
Musumeci 
Dept Chemical Sciences, University 
of Naples Federico II 
22/01/
2015 
Gli accertamenti sulle impronte 
del Ra.C.I.S  
Luca Niola 
Dept Chemical Sciences, University 
of Naples Federico II 
17/03/
2015 
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Dall'analisi dei reflui alla 
depurazione degli impianti 
Antonio 
Riccio 
Dept Chemical Sciences, University 
of Naples Federico II 
30/04/
2015 
Matrix metalloproteinase: inter-
domain flexibility and 
recognition of substrates 
Marco Fragai 
Dept Chemical Sciences, University 
of Naples Federico II 
08/05/
2015 
European large scale facilities: 
neutron and synchroton source 
Serge Perez 
Dept Chemical Sciences, University 
of Naples Federico II 
06/05/
2015 
Lectins from bacteria and fungi: 
therapeutical targets and 
research tools 
Anne Imberty 
Dept Chemical Sciences, University 
of Naples Federico II 
15/05/
2015 
Characterizing biomolecular 
interactions: Biacore experience 
Silvia Pileri 
Dept Chemical Sciences, University 
of Naples Federico II 
19/05/
2015 
Pharmaceutical companies: 
external manufacturing and 
quality assurance 
D. Demasi 
Dept Chemical Sciences, University 
of Naples Federico II 
25/05/
2015 
Biosensing and bioelectronics 
based on organic 
electrochemical devices: from 
monitoring drug dynamics to 
hybrid bio-organic devices 
Salvatore 
Iannotta 
Dept Chemical Sciences, University 
of Naples Federico II 
11/06/
2015 
The bacterial cell wall by liquid 
state, standard and DNP solid 
state NMR 
Jean-Pierre 
Simorre 
Dept Chemical Sciences, University 
of Naples Federico II 
29/06/
2015 
Synthetic and biofunctional 
studies of microbial and animal 
glycan toward immunoregulation 
Koichi 
Fukase 
Dept Chemical Sciences, University 
of Naples Federico II 
29/09/
2015 
Innovative approaches for 
polysaccharide-based vaccines 
Francesco 
Berti 
Dept Chemical Sciences, University 
of Naples Federico II 
20/11/
2015 
 Industria e ricerca nel settore 
biofarmaceutico: bisogni attuali e 
sviluppi futuri 
Sara Carillo 
Dept Chemical Sciences, University 
of Naples Federico II 
25/02/
2016 
Basics of detergents 
formulations and challenges 
Giulia 
Bianchetti 
Dept Chemical Sciences, University 
of Naples Federico II 
16/03/
2016 
La Chimica: un diamante 
Mario 
Marzullo 
Dept Chemical Sciences, University 
of Naples Federico II 
21/04/
2016 
Chemical biology and medicinal 
chemistry of glycosphingolipid 
metabolism 
Herman 
Overkleeft 
Dept Chemical Sciences, University 
of Naples Federico II 
19/12/
2016 
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Modified nucleosides and 
oligonucleotides for biomedical 
applications 
Daniela 
Montesarchio 
Dept Chemical Sciences, University 
of Naples Federico II 
18/01/
2017 
Antigens on the move – 
Structure and mechanism of 
translocation machineries in 
adaptive immunity 
Robert 
Tampé 
Dept Chemical Sciences, University 
of Naples Federico II 
20/09/
2017 
 
3)! Publications: 
•! Ziaco M, Górska S, Traboni S, Razim A, Casillo A, Iadonisi A, 
Gamian A, Corsaro MM and Bedini E “Development of clickable 
monophosphoryl lipid As towards semi-synthetic conjugates with 
tumor-associated carbohydrate antigens”. J. Med. Chem. 2017, 60, 
9757-9768. 
 
•! Ziaco M, Hank S, Molinaro A, Corsaro MM, Tampé R and Bedini E 
“Fluorescence-based lipid A-flippases assays and ABC transporters 
mechanisms comprehension” (in preparation). 
 
•! Casillo A, Parrilli E, Ziaco M, Tutino ML, Corsaro MM 
“Psychrophiles lipopolysaccharides: isolation, characterization and 
biological activity” (submitted). 
 
•! Casillo A, Ziaco M, Lindner B, Parrilli E, Schwudke D, Holgado A, 
Verstrepen L, Sannino F, Beyaert R, Lanzetta R, Tutino ML and 
Corsaro MM “Unusual Lipid A from a Cold-Adapted Bacterium: 
Detailed Structural Characterization” ChemBioChem 2017, 18, 1845 – 
1854. 
 
•! Casillo A, Papa R, Ricciardelli A, Sannino F, Ziaco M, Tilotta M, Selan 
L, Marino G, Corsaro MM, Tutino ML, Artini M, and Parrilli E “Anti-
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